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ABSTRACT 
 
Much research has been done on aflatoxins since their discovery in the 1960’s 
where it was concluded that aflatoxins have carcinogenic, mutagenic, teratogenic 
and immunosuppressive properties. Aflatoxin M1 exists in milk and since milk is a 
major component of the diet of infants, the maximum permissible limit set by the 
EU is 50 parts per trillion (ng L-1).   
 
Current methods of analysis for aflatoxin M1 is primarily based around techniques 
such as HPLC and TLC which require extensively trained operators and equipped 
laboratories. Using antibodies as receptors in an enzyme linked immunosorbent 
assay (ELISA), the analysis costs can be reduced and simplified, however, an 
equipped laboratory is still required. Hence there is a need for a low cost, rapid, 
portable instrument which is easy to use at the point of source for the detection of 
aflatoxin M1.  
 
This thesis describes the development of affinity sensors to meet these 
requirements. Firstly the design and optimisation of an ELISA method was carried 
out, utilising a commercially sourced monoclonal antibody.  
 
Once the antibodies suitability for sensing aflatoxin M1 was determined the 
antibody was successfully employed as the receptor for a screen printed HRP/TMB 
based immunosensor.  Upon the analysis of milk it was observed that milk caused 
extensive interference and through a series of chemical extractions the 
interference was attributed to whey proteins in the milk with suspicion towards α-
lactalbumin. A simple pre-treatment technique of adding calcium chloride was 
performed and the interference from the whey proteins was removed. The resulting 
immunosensor achieved a sensitivity of 39 ng L-1 (Figure 3.26), however, poor 
reproducibility was observed due to the screen printed electrode production (%CV 
= 21% variance for screen printed electrode production). 
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Gold cell on a chip microelectrode arrays were used to replace the screen printed 
electrodes and the successful covalent attachment of the antibody to the 
microelectrode array through PDITC cross linking compound was monitored using 
atomic force microscopy and scanning electron microscopy. It was shown that the 
majority of the antibodies during immobilisation orientate in a ‘side on’ orientation 
and therefore a cheap capture polyclonal antibody was first immobilised before the 
addition of the sensing anti-aflatoxin M1 monoclonal antibody. Using the 
microelectrode array an improvement of the sensitivity as well as a reduction of the 
milk interference was shown. Sensitivity was improved to 8 ng L-1 in milk (Figure 
4.23).    
 
Further work was performed to substitute the fragile antibody used in the sensing 
layer for a robust synthetic peptide receptor. Initially a virtual library of synthetic 
peptides was created using de novo design techniques in silico.  Further 
computational techniques were performed to determine the best peptide from the 
library. This peptide had a sequence of PVGPRP. From literature a peptide (LLAR) 
was reported with affinity for aflatoxin B1. This sequence along with the de novo 
design peptide was synthesised and tested using a host of techniques and 
immobilisation chemistries such as optical waveguide lightmode spectroscopy 
(OWLS), BIAcore and enzymatic techniques using EDC/NHS, glutaraldehyde and 
BS3 cross linking methods. The affinity of both peptides to aflatoxin M1 was 
demonstrated however further work is required to quantify the affinity and to 
incorporate the peptides into the microelectrode array. 
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1.1. History of mycotoxins. 
The term mycotoxin is applied to a group of toxic secondary metabolites produced 
by fungi. The word mycotoxin is derived from the Greek language where mekes 
translates to mushroom and toxikon for toxic (Waring, 2002) or poison (Rustom, 
1997). Since Roman times the knowledge that some fungal products can cause 
illness (mycotoxicoses) has been known. 
 
One of the first recorded cases of mycotoxicoses occurred in 1722 when a large 
Russian army was gathered on the delta of the river Volga at Astrakhan under the 
direction of Peter the Great. During the armies formation the men were given rye 
flour and the horses were fed on grain and hay. Within a short period of time after 
consumption, the men and horses were struck by paralysis and suffered a ‘fiery 
itch.’ Thousands of men died before reaching battle with the Turkish armies. The 
mould Claviceps purpurea was the cause of the symptoms now named St. 
Anthony’s fire or Holy Fire (Farrer, 1987). 
 
In 1960 there was significant research into the causes of mycotoxicoses due to a 
mysterious new disease that swept through England which killed over one hundred 
thousand turkeys. This occurrence was given the name turkey ‘X’ disease 
(Bradburn et al., 1994; Sargeant, 1961). The fatalities were not limited to turkeys; 
also ducklings and young pheasants were affected. After extensive investigation 
into the deaths, a link was observed that the feed had come from the same 
shipment of peanut meal from Brazil (Daly et al., 2000) which had become mouldy 
during transport. Further investigations showed that the peanut meal was heavily 
contaminated with the organism ‘Aspergillus flavus’ hence the name Aflatoxin 
(Sargeant, 1961) and that the poultry died from liver cancer since the aflatoxins 
were highly carcinogenic. 
The detection method used was thin layer chromatography (TLC). During analysis 
of the peanut meal four dots would appear on the paper, when illuminated with an 
ultra violet light, two dots would emit a blue light and two would emit a green light, 
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hence the structures of the aflatoxins are known as B1, B2 and G1, G2. In 1966 it 
was observed that cows that were fed on a diet contaminated with aflatoxin B1 and 
B2 would produce milk contaminated with new aflatoxins M1 and M2, denoted M for 
milk (Holzapfel & Steyn, 1966). 
 
The connection with aflatoxin and poultry gave concerns into human consumption 
of mouldy foods. Investigations were made into the high levels of liver cancer found 
in Uganda and Swaziland (South Africa). When measuring the aflatoxin levels of 
about 500 samples of local food the levels found were about 100 µg Kg-1 (current 
European Commission limits for total aflatoxin are between 4 and 10 µg Kg-1 
depending on the foodstuff). Later a study in Thailand showed similar levels for 
aflatoxins in normal foods but levels of 3,000 µg Kg-1 and 12,000 µg Kg-1 were 
found in corn and peanuts respectively (Waring, 2002).  
 
In northwest India further information was discovered about the onset of 
Aspergillus flavus. During the summer of 1974 there had been chronic drought 
conditions affecting the maize crop, in the harvest time unseasonable rains 
occurred resulting in the corn being stored at high humidity. Upon consumption of 
the corn it was reported that nearly 400 people suffered from fevers and jaundice 
and 108 people died. The suspicions that the corn had caused the disease were 
verified by the village dogs similarly suffering with the same symptoms. Analysis of 
the corn showed that the levels of aflatoxin being consumed were between 2,500 
µg Kg-1 and 15,600 µg Kg-1 whereas a survey of the following year’s crop showed 
levels of less than 100 µg Kg-1 (Waring, 2002). 
 
Another episode occurred in Kenya in 1981 where again chronic drought 
conditions and then early rains hampered the maize crop, 20 people complained of 
light fever and abdominal discomfort. They were admitted to hospital with jaundice 
and were feeling very weak. It was diagnosed that their livers were very tender. 
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Only 8 people made a recovery. As in India the dogs also became ill as well as the 
woodland birds.  
 
1.2 The Mycotoxin family. 
Over 190 moulds have been found to be able to produce toxins. In some cases 
more than one mould can produce the same toxin (Gilbert, 2002; Moreau, 1979). 
The main moulds families of concern are; 
Fusarium, Aspergillus, Penicillium, and Alternaria. Table 1.1 shows the mycotoxins 
that these moulds produce. 
 
Table 1.1: Moulds responsible for producing mycotoxins. 
  
Mycotoxin Mould 
Aflatoxin Aspergillus 
Ochratoxin  Penicillium 
 
Aspergillus 
Patulin Penicillium 
 
Aspergillus 
 
Byssochylamys 
Trichothecenes Fusarium 
Zearalenol Fusarium 
Fumonisins Fusarium 
AAL  Alternaria 
 
1.2.1 Ochratoxin. 
Ochratoxin can be produced by Aspergillus ochraceus, Aspergillus ostianius and 
Penicillium verrucosum. Generally Aspergillus occurs in warmer climates where as 
Penicillium occurs in cooler climates. Ochratoxin mainly contaminates grains such 
as barley, corn, wheat, rye and oats and therefore products manufactured from 
grain, for example beer. Ochratoxin can also be found in beans, figs, olives, nuts, 
coffee and spices as well as grapes and grape based products such as wine. 
Ochratoxin A (Figure 1.1) is the main form of this toxin and has a molecular weight 
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of 403.8 Daltons. Ochratoxin B also exists, however it is rarer and at least one 
order of magnitude less toxic (Petzinger & Zeigler, 2000). Ochratoxin A has an 
unusually long serum half-life resulting in a high occurrence in human serum. Its 
half-life is 840 hours; hence from a single uptake, Ochratoxin A would still be 
detectable for 280 days. The European Commission maximum permissible limits 
for this toxin are between 1 and 10 µg Kg-1 depending on the foodstuff (EMAN, 
2000).  
N
O
O
OH
Cl
CH3
H
COOH
 
Figure 1.1: Structure of Ochratoxin A. 
 
1.2.2 Patulin. 
Patulin (Figure 1.2) is produced mainly from Penicillium expansum however some 
60 species of mould can produce patulin (Lai et al., 2000). It is mainly found in 
apple products although pears, peaches and berries can also be affected. The 
toxicity of patulin affects bacteria, fungi, plants and animals. It also has 
mutagenicity towards Saccharomyces cerevisiae, a yeast used in brewing. The EU 
maximum limits for this toxin are between 10 and 50 µg Kg-1. When raising 
antibodies towards this toxin, patulin has to be coupled to a protein carrier to 
increase its immunogenicity due to its small size (154.1 Daltons), however when 
using these antibodies greater preference is found for the protein carrier than 
patulin hence resulting in poor specificity (Sheu et al., 1999; McElroy and Weiss, 
1993). 
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Figure 1.2: Structure of Patulin. 
 
1.2.3 Trichothecenes. 
Trichothecenes, zearalenone and fumonisins are all formed by the Fusaria mould. 
This mould has one major difference to the other mycotoxin moulds since it grows 
in the field whereas most moulds grow during storage. Figure 1.3 shows the basic 
structure of the trichothecenes. There are two groups of trichothecenes, A and B. 
Group A consists of T-2 and HT-2 toxin whereas group B contains fusarenon X, 
deoxynivalenol (DON) and nivalenol. The mycotoxins of interest in this group are 
deoxynivalenol and T-2. Neither deoxynivalenol nor T-2 have shown strong 
evidence that they are carcinogenic (Wijnands & van Leusden, 2000). 
 
Deoxynivalenol is a concern because it is frequently found in grains however T-2 is 
not so common although it has a much higher toxicity. Fusaria graminearum is 
chiefly responsible for the production of deoxynivalenol. Animal feed contaminated 
with deoxynivalenol results in a loss of appetite and vomiting, this has given 
deoxynivalenol the synonym vomitoxin.  
 
The main producer of T-2 toxin is Fusaria sporothrichioides, which occurs in cooler 
climates and grows on crops which are left over the winter in the field. The most 
significant effect of T-2 is its immunosuppressive activity. The European 
Commission limits for these compounds are; deoxynivalenol 100-1500 µg Kg-1, T-2 
50-500 µg Kg-1 (EMAN, 2000). 
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Figure 1.3: Basic structure of Trichothecenes. 
 
1.2.4 Zearalenone. 
Zearalenone (Figure 1.4) is another toxin produced by several Fusarium species 
but mainly Fusaria graminearum. It is a non-steroidal estrogenic mycotoxin which 
contaminates many cereals but mainly maize (EMAN, 2000; Wijnands & van 
Leusden, 2000). It is responsible for outbreaks of oestrogenic syndromes in farm 
animals. There is little evidence to show that zearalenone is carcinogenic for 
humans.  
 
O
O
OH
OH
O
CH3H
 
Figure 1.4: The structure of Zearalenone. 
1.2.5 Fumonisins. 
Fumonisins (Figure 1.5) are a relatively recent discovery having only been 
discovered in 1988 (EMAN, 2000). There have been six fumonisins isolated 
however only B1 is of interest due to its health risks. Alternaria alternata produces a 
toxin AAL that is structurally similar to Fumonisin B1 and has very similar toxic 
properties (Wijnands & van Leusden, 2000; Pinot et al., 1997). The main effects of 
fumonisin B1 are carcinogenic and growth problems, it accumulates in the liver and 
kidneys of animals so man could be exposed to the toxin upon the consumption of 
the animal. Fumonisins have been detected in milk (Barna-Vetró et al., 2000).  
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Figure 1.5: The general structure of Fumonisins. 
 
1.2.6 Aflatoxins.  
The discovery of aflatoxins has been previously discussed in Section 1.1. In this 
review the aflatoxin of interest is aflatoxin M1 or AFM1. From the reported 
outbreaks of aflatoxins it became clear that the mould Aspergillus was prevalent in 
the warmer climates. Optimum temperature for Aspergillus flavus has been 
determined at 30oC however it can grow in a range of temperatures from 10oC to 
45oC. It was also recognised that storage of the grain after heavy rains increased 
the chance of spoilage. In order for Aspergillus to grow a relative humidity of 80% 
is required (Moreau, 1979) hence aflatoxin production is more of a concern in 
humid tropical regions, such as Brazil, Uganda, Nigeria and India, when grain is 
not stored within the correct parameters (Janardhana et al., 1999; D’Mello & mac 
Donald, 1997). 
 
High aflatoxin levels are associated with stresses such as; drought, temperature, 
nutrients, insects and weeds, hence reducing aflatoxin contamination by plant 
breeding or genetic manipulations is a difficult task due to the number of sources of 
stress (Moreno & Kang, 1999). Aflatoxin B1 is known to be found on grains, 
however it also contaminates nuts such as cashew, hazel, peanuts, walnuts, 
pistachios and almonds (Leszcynska et al., 2000; Mahoney & Rodriguez, 1996; 
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Steiner et al., 1992) also figs, spices (chilli and cayenne pepper) (Vahl & 
Jorgensen, 1998) as well as rice and pulses (Begum & Samajpati, 2000).  
 
Out of all the mycotoxins, aflatoxin causes the greatest amount of management 
costs and the most losses in the USA, due to its high toxicity per unit basis and 
long history of strict legislations. Furthermore monitoring and research of 
mycotoxins in the USA is estimated to cost between 0.5 and 1.5 billion dollars a 
year (Robens & Cardwell, 2003). Potentially 1.3 billion tonnes (Stroka & Anklam, 
2002) or 25% (Moreno & Kang, 1999) of crops world wide are contaminated with 
aflatoxins. The toxic effects of aflatoxins have resulted in them being used in 
biological weapon programmes (Zilinskas, 1997; Presidential Advisory Committee 
on Gulf War Veterans' Illnesses, 1996).  
 
Aflatoxin B1 is not a primary toxin. Upon digestion of the Aflatoxin B1 the body’s 
response is to activate a microsomal cytochrome P450. This cytochrome is a 
general response to detoxification of foreign substances or ‘xenobiotic compounds’ 
(Stryer, 1988). In the removal of aflatoxins the enzymes emitted from the 
cytochrome are CYP1A2 and CYP3A4.  Evidence shows that the CYP1A2 enzyme 
is responsible for the conversion to aflatoxin M1 whereas CYP3A4 causes the 
production of an epoxide of the AFB1. Figure 1.6 summarises these reaction 
routes. The chemically unstable epoxide then reacts with DNA, RNA and proteins 
(Kuilman et al., 2000) in particular the epoxide seems to attack the guanine sites 
on the DNA.  
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Figure 1.6: The mechanisms for DNA attack. The structural changes from aflatoxin 
B1 are highlighted. 
 
Similar to the trends found between liver cancer and aflatoxin B1 levels in Uganda, 
a trend was noticed connecting levels of liver cancer and hepatitis A where 
aflatoxin B1 exposure also occurred. It has been suggested that the metabolism of 
aflatoxin B1 changes with people infected with hepatitis A and the occurrence of 
liver cancer is increased. Upon immunisation to hepatitis A the number of cases of 
liver cancer decreases (Henry et al., 1997).  
 
There are many conflicting reports about the conversion of aflatoxin B1 into M1. 
Reports vary between 0.003% (Rodricks and Stoloff, 1976) and the generally 
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accepted value of around 5% of digested aflatoxin B1 turns into aflatoxin M1 in milk 
produced by dairy cows. It should be noted however that the low ratio reported by 
Rodricks and Stoloff, (1976) was early work where the detection was not as 
precise as later reports. The conversion takes between 12 to 72 hours after 
consumption of feed contaminated with aflatoxin B1 (Martins & Martins, 2004; 
Lopez et al., 2003; van Egmond, 1983). Levels of aflatoxin M1 are seasonal due to 
dairy cows being fed stored feed during winter or grazing naturally on fresh grass 
during summer (Lopez et al., 2003; Bakirci 2001; Henry et al., 1997). It is proposed 
that the production of aflatoxin M1 is a detoxification process since the 
carcinogenicity is one tenth of aflatoxin B1 (Neal et al., 1998) and the genotoxicity 
is estimated between one tenth (Neal et al., 1998) and one third (Henry et al., 
1997). Aflatoxins are mutagenic, teratogenic and also act as immunosuppression 
agents.  
 
Aflatoxin M1 was first discovered to exist in urine when trying to elucidate the 
aetiology of liver cancer from aflatoxin B1 (Campbell et al., 1970). Aflatoxin P1 and 
Q1 have been recorded as homologues of aflatoxin M1 and have also been isolated 
in human urine (Moreau, 1979). Figure 1.7 shows the structural differences 
between P1 and Q1 as well as other known aflatoxins. Aflatoxin Q1 is found in 
greater concentrations in human urine than M1 (Kussak, 1994) however the 
opposite has been reported for monkeys and dogs (Bingham, 2004; Hsieh, 1974). 
The conversion of ingested aflatoxin B1 to excreted urinary aflatoxin M1 is reported 
to be in the region of 1.3 to 1.5 % (Zhu, 1987).  
 
In a study of 300 young Chinese males, Mykkänen et al., (2005) reported that 50% 
of the subjects produced detectable aflatoxin M1 in urine (>8 ng L-1) with the mean 
concentration of 80 µg L-1 furthermore the concentration of Q1 was 60 times that of 
M1 in urine and faeces.  A study in Sierra Leone showed aflatoxin M1 levels in the 
urine of 50 % of school children (n=334) with concentrations as high as 374 µg L-1 
with a mean value of 7.1 µg L-1 (Jonsyn-Ellis, 2000a,b), similarly a study by Nyathi 
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et al., (1987) in Zimbabwe reported that aflatoxin M1 levels were detected only in 
4.4% of human subjects (n=1228), however the mean concentration was similar to 
Sierra Leone at 4.2 µg L-1 and maximum detected sample of 120 µg L-1.  The 
percentage detected values between Zimbabwe and Sierra Leone cannot be 
analytically compared since there is no detail in the reports of the level that is 
classified as ‘detectable’.  
 
Coulter et al., (1986) reported levels in Sudanese children (n=584) with positive 
detection in 39% and a mean level of 490 ng L-1.  A study in Lagos, Nigeria 
reported aflatoxin M1 detectable in 8.7% of the population (n=161) with the average 
concentration being much lower than other studies at 8.9 ng L-1 (Bean et al., 1989).  
This data shows that there is significant consumption of aflatoxin M1 contaminated 
food in Africa. No literature reports were found other than Mykkänen et al., (2005) 
where aflatoxin M1 in bodily fluids had been surveyed in a non-African country. 
 
There are no limits set for aflatoxin P and aflatoxin Q, presumably since it does not 
reach the food chain and they are of lower toxicity than M1 (Fan, 1984). Q1 can be 
identified by TLC where aflatoxin Q1 is separated out between aflatoxin M1 and 
aflatoxin B1 and emits green light under fluorescence (Hsieh, 1974). 
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Figure 1.7: The different homologues of aflatoxin. Highlights show the differences 
from aflatoxin B1. 
 
Aflatoxin M1 has been detected in human breast milk samples and this acts as a 
good biomarker for human intake for aflatoxin B1. Table 1.2 shows reported levels 
of aflatoxin M1 in human breast milk. 
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Table 1.2: Worldwide reported levels of aflatoxin M1 in human breast milk (all 
values in ng Kg-1). 
Location  Percentage 
detection 
Maximum  Minimum Mean Number 
of tests 
References 
Victoria, 
Australia 
15 % 1031 28 71 73 El-Nezami et 
al., 1995 
Qalyubiyah, 
Egypt 
35.5 % 5000 5 13.5 388 Polychronaki 
et al., 2006 
São Paulo, 
Brazil 
2 % 20 20 20 50 Navas et al., 
2005 
Lombardy, 
Italy 
<1 % 194 194 194 231 Turconi et 
al., 2004 
Adu Dhabi, 
UAE 
99.5 % 3000‡ 2 187 445 Saad et al., 
1995 
Northern 
Zimbabwe  
11 % 14.1 49.3 ~ 54 Wild et al., 
1987 
Khartoum, 
Sudan 
37 % 3.0 19.0 64.0 99 Coulter et 
al., 1984 
Liverpool, 
UK 
0 % 0 0 0 10 Coulter et 
al., 1984 
Accra, 
Ghana 
34 % 1815 20 377 264 Lamplugh et 
al., 1988 
Accra, 
Ghana 
32 % 1379 5.0 445 501 Maxwell et 
al., 1989 
Al Ain, UAE 92 % 3400 7.0 560 140 Abdulrazzaq 
et al., 2003 
‡ Samples were taken from mixed nationalities residing in Adu Dhabi.  
 
More concerning is the fact that aflatoxin M1 is detectable in neonatal cord blood, 
demonstrating that aflatoxin M1 passes through the placenta thus reaching the 
foetus. Aflatoxin M1 levels as high as 7320 ng L-1 has been detected in neonatal 
cord blood (Lamplugh et al., 1988). 
Due to the fact than the milk intake of infants is high, and when young they are 
very vulnerable to toxins, a low limit was introduced by the European Union in 1999 
of maximum levels of aflatoxin M1 in milk 0.05 µg L-1 and 0.025 µg Kg-1 for infant 
formulae (Henry et al., 2001). This level is now enforced by Commission regulation 
(EC) no. 472/2002 (Gilbert and Vargas, 2003). The FDA (The US Food and Drug 
Administration) have set levels higher than the European Commission at 0.5 µg L-1 
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whereas Switzerland and Austria have set limits at 0.01 µg L-1. These limits have 
been set by the ALARA process, As Low As Reasonable Achievable rather than 
medically determined (Rastogi et al., 2004).   
Aflatoxin M1 has also been found in other dairy based products such as cheese 
and yoghurt (Martins & Martins, 2004; Sharman et al., 1989; van Egmond, 1983). 
Aflatoxin M1 has been reported in the muscle tissues of animals (Stubblefield et al., 
1983; Rodricks and Stoloff, 1976). It was found that when cows were fed on 
aflatoxin B1 contaminated feed, then aflatoxin M1 was detected in the brain, 
gallbladder, heart, intestines, kidneys, liver, lung, mammary glands, spleen and 
tongue, of which the kidneys, mammary glands and liver were the highest with 
levels at 57.9, 25.1 and 13.2 µg L-1 respectively. When studying swine, although 
their digestive system is completely different, the highest aflatoxin levels were 
again found in the kidneys (Stubblefield et al., 1983). In a more recent study 
aflatoxin M1 has been detected as high as 1.05 µg kg-1 in the livers of swine 
(Chiavaro et al., 2005). The kidneys of chickens have also been shown to contain 
aflatoxin M1 if the chicken is given aflatoxin B1 contaminated feed (Trucksess et al., 
1983).   
 
Eggs of laying hens have been shown to contain aflatoxin M1 (Kuilman et al., 2000; 
Wolzak et al., 1985). The main observation when hens were fed an aflatoxin B1 
contaminated feed was a reduction of the weight of the eggs. After being fed for 
four weeks the eggs had reduced in weight to 39%. The aflatoxin M1 levels 
recorded were a maximum of 0.03 µg L-1. Other authors have reported no aflatoxin 
M1 in eggs, however there is dispute in the extraction methods (Trucksess et al., 
1983). 
 
1.3 Aflatoxin M1 and Milk. 
As previously discussed the aflatoxin M1 is a detoxification product from aflatoxin 
B1.  Aflatoxin M2 is a detoxification product of aflatoxin B2, however aflatoxin M2 is 
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rarer than M1 and not as toxic so it receives little interest. Aflatoxin M1 has also 
been isolated on highly contaminated corn samples where it occurs 1000 times 
lower concentration than aflatoxin B1 (Shotwell et al., 1976). Much less research 
has been done on aflatoxin M1 compared to the parent aflatoxin B1.   
 
Aflatoxin M1 has the full chemical name of; Cyclopenta (C) furo (3’, 2’:4,5) furo 
(2,3-H) (1) benzopyran-1,11-dione, 2,3, 6A, 9A tetrahydro-9°-hydroxy-4-methoxy 
and its CAS number is 6795-23-9. Its chemical formula is C17H12O7 hence it 
molecular weight is 328.3 Daltons. As with all aflatoxins it is a highly oxygenated 
heterocyclic compound. Aflatoxin M1 is chemically stable, it is not destroyed under 
domestic conditions such as microwave or oven heating however the stability of 
aflatoxin M1 during pasteurization is in debate. Bakirci, (2001) and  Henry et al., 
(1997) report that pasteurization has no effect whereas Deveci and Sezgin (2006) 
suggests that pasteurization causes a 16% decrease, hypothesising that the 
decrease is due to heat treatment causing casein decomposition.  
 
Many methodologies have been researched to remove aflatoxin M1 from milk by 
adsorption using bentonite, applying ultra-violet radiation (Henry et al.,1998), humic 
acids (van Rensburg et al., 2006), polyvinylpolypyrrolidone and synthetic zeolites 
(Keçeci, et al., 1998) although little is known about the changes in biological safety 
or nutritional value these processes cause (Henry et al., 1997). Additionally it is 
suggested that binders may aid mycotoxin management but other methods would 
be required for complete control (van Rensburg et al., 2006). Since it is difficult to 
eradicate aflatoxin M1 in milk, greater monitoring of aflatoxin B1 must be preformed 
so that aflatoxin B1 is prevented from entering cattle feed (van Egmond, 1983). 
Many studies have shown that aflatoxin B1 binds reversibly with the polysaccharide 
surface of lactic acid bacteria (Haskard et al., 2001; Peltonen et al., 2001; Haskard 
et al., 2000).  
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Chemically aflatoxin M1 is hydrophobic; studies have shown that aflatoxin M1 in 
milk resides in the hydrophobic cavities of the protein casein. Therefore, casein 
rich foods such as cheese have a 3 to 6 fold increase in aflatoxin M1 compared to 
low protein products (Bakirci, 2001; van Egmond, 1983; Brackett and Marth, 1982).  
 
The casein content of cows milk is about 2.5% (compared to 0.4% found in human 
milk). Casein consists of about 200 amino acid residues.  It occurs in a structure 
similar to denatured globular proteins due to the high number of proline residues 
(about 10% proline); this in turn causes a hydrophobic surface of the protein 
making it insoluble in water and attractive to the aflatoxin M1 molecule (Henry et 
al., 1997). Frequently in clean-up procedures for analysis, proteins are removed by 
denaturing with trichloroacetic acid and then filtered or centrifuged, however in the 
case of aflatoxin M1 the trichloroacetic acid derivatizes the molecule thus causing 
low recovery rates. Another unfavourable property of milk with respect to analysis 
is the fat content. Fats can cause blocking of the active sites in clean up 
techniques, thus ideally fats are removed in an early stage of analysis. Milk also 
contains about 5% sugar in the form of lactose.  
 
Due to the high solid content of milk, direct analysis can cause blockages in narrow 
fluid channels found in some analytical equipment (Sibanda et al., 1999).  
 
Figure 1.8 and Table 1.3 shows the levels of aflatoxin M1 reported in literature 
where it is observable that the highest levels reported come from hotter climates 
and the lowest levels from cooler climates.  
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Figure 1.8: Levels of aflatoxin M1 reported in literature for the world. 
A) excluding Europe. B) Europe only. Logarithmic scale for aflatoxin M1 (ng L-1). 
Data obtained from Table 1.3. 
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Table 1.3: Reported levels of aflatoxin M1. Table is ordered by maximum aflatoxin 
M1 levels. All aflatoxin M1 values reported as ng L-1. 
Country/ 
State 
Number of 
samples 
 
Method 
 
Min 
 
Max 
 
Mean 
 
Matrix 
 
References 
UK, 
Nationwide  
 ~ HPLC-immuno 10 21  ~ Raw and 
pasteurized milk 
FSA, 2001 
Spain, 
Leon  
92 ELISA & HPLC 14 25 20.5 Raw milk Rodriguez 
Velasco, 2003 
Japan, 
Nationwide  
208 HPLC-immuno 1 29 9 Milk Nakajima et al., 
2004 
Argentina, 
Nationwide 
77 Ridascreen <10 30 13 Milk López et al., 
2003 
Greece, 
Nationwide  
297 HPLC-immuno <5 >50 ~ Milk Roussi et al., 
2002 
Italy, 
Nationwide  
373 HPLC-immuno <1 >50 13.6 Milk, yogurt Galvano et al., 
2001 
Portugal, 
Lisbon  
101 HPLC-immuno 5 >50  ~ Raw and UHT milk Martins & 
Martins, 2000 
Turkey, 
Ankara 
27 HPLC-immuno <10 51 22.3 UHT and 
pasteurized 
Gürbay et al., 
2006 
Portugal, 
Lisbon 
96 HPLC-immuno <10 98 48 Yogurt Martins & 
Martins, 2004 
Iran, 
Tehran 
328 Ridascreen 31 113 72.2 Pasteurized milk Oveisi et al., 
2007 
Morocco, 
Rabat  
54 HPLC -immuno 10 117 18 Pasteurized milk Zinedine et al., 
2006 
Turkey, 
Van 
province  
90 TLC 12.5 123 29 Raw milk Bakirci, 2001 
Kuwait, 
Nationwide  
54 HPLC-immuno 20 210 ~ Milk, yogurt, infant 
formula 
Srivastava et al., 
2001 
Colombia, 
Bogota  
 ~ HPLC-immuno 10.7 213  ~ Pasteurized milk Diaz et al., 2004 
Turkey, 
Ankara  
223 Ridascreen <1 >250  ~ Cheese and butter Aycicek et al., 
2005 
Iran, Sarab 
city  
111 TLC 15 280 24 Raw milk Kamkar, 2005 
Korea, 
Seoul  
180 HPLC & ELISA 10 & 
2 
342 49 Milk, yogurt, fnfant 
formula 
Kim et al., 2000 
Brazil, 
Campinas  
204 TLC 73 370  ~ Milk, cheese, 
yoghurt 
de Sylos et al., 
1996 
Brazil, São 
Paulo  
139 HPLC- Silica <15 500 ~ UHT and 
pasteurized milk 
Garrido et al., 
2003 
Turkey, 
Anatolia  
129 Ridascreen 0 543 108.17 UHT milk Unusan, 2006 
Turkey, 
Nationwide  
600 ELISA 100 800 269 Cheese Yaroglu et al., 
2005 
Turkey, 
Ankara  
400 Ridascreen <50 >800  ~ Cheese Sarimehmetoglu 
et al., 2004 
India, 
Lucknow  
87 Ridascreen 28 1012 299 Milk and infant 
food 
Rastogi et al., 
2004 
Brazil, São 
Paulo  
150 TLC 100 1680 ~ Milk Sabino et al., 
1989 
Brazil, 
Paraná 
state  
42 Ridascreen-Fast <245 1975 ~ Raw milk Sassahara et al., 
2005 
Libya, 
Northwest 
69 HPLC-immuno 30 3130 347 Milk, cheese Elgerbi et al., 
2004 
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Other members of the Bovine family apart from cows also produce aflatoxin M1 
contaminated milk. Paul et al., (1976) reported the occurrence of aflatoxin 
originating in buffalo milk from India with contamination levels similar to that of 
cows.   
 
Not only Bovine milk is affected, Oliveira & Ferraz (2005) reported the natural 
occurrence of aflatoxin M1 in goats milk. Goat milk has a 1% market share of the 
consumption in Brazil where 69% of the samples were positive with values ranging 
from 11 to 161 ng L-1 (n=36) however these values are lower than those from local 
bovine milk studies. In addition to goat and cow, milk from ewes is susceptible to 
aflatoxin M1 contamination with the conversion ratio of ingested aflatoxin B1 
transformed into aflatoxin M1 being nearly identical to that of cows (Allcroft et al., 
1968; Naybey et al., 1967).  
 
Kaniou-Grigoriadou et al., (2005) observed that from 54 samples taken from 
Thessaloniki Greece, no samples were above EU maximum permissible limits. 
Furthermore from Sicily 240 samples were analysed and only 3 were above EU 
maximum permissible limits (Bognanno et al., 2006). The results from the Ovine 
samples are not significantly high; however the studies were performed 
geographically where incidents of aflatoxin M1 contamination in Bovine milk are not 
high (1% of samples above 50 ng L-1 reported by Roussi et al., (2002) from 
Greece; 0% above 50 ng L-1 reported by Galvano et al., (2001) from Italy). This 
data suggests that not only Bovine milk should be routinely monitored, but also 
Ovine and goat milk.  It should be observed that when comparing geographical 
data, the analysis of supermarket milk gives a good indication of the levels of 
consumed milk.  However this does not necessary give a good indication of the 
aflatoxin M1 levels produced by the lactating cattle at that strict location, since at 
the dairies, contaminated milk is blended with non contaminated milk to comply 
with the maximum permissible limits (de Sylos et al., 1996; Sabino et al., 1989). 
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1.4 Analysis techniques.  
The generally accepted method for the analysis of aflatoxin in milk is by high 
performance liquid chromatography (HPLC) (Henry et al., 2001). Many other 
methods exist; if these methods show a positive result then HPLC is used for 
confirmation. For the analysis of aflatoxin B1 the greatest source of error is due to 
sampling. With pistachios for example, one single heavily contaminated nut can 
cause a 5 Kg sample to be rejected (Mahoney & Rodriguez, 1996) hence it is very 
important to get a representative sample of the bulk material.  
 
For the analysis of milk the sampling errors are reduced dramatically since the milk 
is assumed to be a homogeneous matrix (van Egmond, 1983) even so the FDA 
has guidelines stating that ten portions should be taken from a 5 Kg sample and 
the European Commission state that the sample size should be 10 Kg (Henry et 
al., 1997). Analysing for aflatoxin B1 to European Commission legislations is no 
longer an analytical challenge due to state of the art instrumentation and methods, 
however due to capacity problems in many countries only 5-25% of imported foods 
are screened for mycotoxins (Stroka et al., 2000).    
 
HPLC is an expensive technique to perform mainly due to the cost of the 
instrumentation and the cost of employment of technical operators. Unfortunately 
the regions of the world which are most affected by aflatoxin contamination tends 
to be the poorer areas. In India, a recent survey found that 87.3% of the milk based 
samples analysed were contaminated, of those 99% were outside European 
Commission limits. This is a major concern considering that India is the largest 
producer of milk in the world (Rastogi et al., 2004). In conclusion a direct quote 
from United Nation states (Proctor, 1994) ‘There is an urgent need for simple, 
robust, low-cost analysis methods, for the major mycotoxins, which can be 
routinely used in developing country laboratories.’ 
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1.4.1 HPLC (High Performance Liquid Chromatography). 
This is a very versatile method and during the 1980’s popularity for HPLC 
increased and the analysis moved away from TLC (Henry et al., 1997). As 
previously discussed, milk is a difficult matrix to analyse. Many different clean up 
techniques have been reported. Some of these are; C18 SPE columns (Carisano & 
Torre, 1986; Bijl & van Peteghem, 1985; Takeda 1984; Winterlin, 1979), silica 
columns (Qian et al., 1984; Chambon et al., 1983; Fremy & Boursier, 1981) 
precipitation by zinc hydroxide (Chambon et al., 1983) and precipitation by 
concentrated hydrochloric acid and sodium hydroxide (Gauch 1979), however the 
latter has shown that alkaline extracts reduce the recovery of aflatoxin M1 
(Shepherd et al., 1986).   
 
The first draft Association of Analytical Communities method (AOAC) used 
trifluoroacetic acid to intentionally derivatize the aflatoxin M1 to M2a which has six 
times greater fluorescence
 
(Orti et al., 1989; Carisano & Torre,1986; Hisada et al., 
1984). This reaction is shown in Figure 1.9. 
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Figure 1.9: The reaction scheme for the conversion of aflatoxin M1 to the more 
fluorescent M2a. (Carisano & Torre,1986). 
 
A silica SPE cartridge was used to clean up the sample and then normal phase 
chromatography was used for the separation. The method was revised to use 
reverse phase HPLC using a C18 column and acetonitrile : water as an eluent, 
thus reducing the amount of waste solvent and analysis time (Beebe & Takahashi, 
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1980). It became the AOAC method in 1986. Currently the AOAC method uses 
immunoaffinity columns containing monoclonal antibodies specifically for aflatoxin 
M1 which are supported on Sepharose® packing material (AOAC, 1996). The 
following literature was among the first to implement immunoaffinity columns for 
aflatoxin M1 determination; Martins and Martins, (2000); Stroka et al., (2000); 
Farjam et al., (1992); Mortimer et al., (1987). In all methods the detection method is 
fluorescence.  Recently the use of HPLC with tandem mass spectroscopy has 
been applied to the detection of aflatoxin M1. Chen et al., (2005) has reported 
impressive limits of detection to 0.59 ng L-1, some 100 times lower than the current 
EU maximum permissible limits.  
 
Aflatoxins have been detected using electrochemical detection. Holak et al. (1997) 
reported the use of a voltammetric detector for detecting aflatoxins. Voltammetry 
alone cannot distinguish between aflatoxins B1, B2, G1 and G2 since they all give a 
response at -1.25V vs Ag/AgCl so by coupling a hanging drop mercury electrode 
(HDME) to a HPLC system it was reported that it is feasible to detect aflatoxin B1 
levels down to 2.5 µg L-1. Holak et al., (1997) also speculated that by switching to a 
gold/mercury electrode then lower limits of detection could be achieved. Elizalde-
Gonzalez et al., (1998) continued this work and showed that sensitivity was 
improved using a glassy carbon electrode rather than a gold or platinum electrode. 
 
1.4.2 TLC (Thin Layer Chromatography). 
This method is older than HPLC and has many advantages. It is far cheaper than 
HPLC methods and it does not require extensively trained operators, however it is 
less accurate than HPLC (Gilbert and Anklam, 2002). Original extraction methods 
detailed were laborious involving a 6 hour Soxhlet extraction using acetone, 
chloroform and water followed by treatment with lead acetate and then petroleum 
ether before being spotted onto TLC plates (Goldblatt, 1969). 
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Subsequently the method has improved using a two dimensional development 
technique (Beebe & Takahashi, 1980). The milk is extracted with chloroform and 
spotted onto silica plates, first toluene : ethyl acetate : formic acid is used then 
diethyl ether : methanol : water (Henry et al., 2001; Wood & Mann, 1989). In order 
to improve accuracy, techniques are being implemented to incorporate 
densitometric equipment such as a computer scanner to electronically quantify the 
dots rather than by visual inspection (Henry et al., 2001). All these methods used 
long wave ultra-violet light for the detection where aflatoxin M1 fluoresces blue. 
 
In developing countries TLC is the preferred detection technique due to the low 
cost and ease of use.   
 
1.4.3 ELISA (Enzyme Linked ImmunoSorbant Assay). 
The majority of recent papers reviewed who have used ELISA as a method of 
detection have all used the kit made by R-Biopharm for example; Rastogi et al., 
(2004); Sarimehmetoglu et al., (2004); Lopez et al., (2003); Rodriguez Velasco et 
al., (2003). The kit is part of the RIDASCREEN® range of diagnosis. Many authors 
have developed themselves an ELISA protocol. Table 1.4 lists the differences in 
these self developed methods. 
 
Table 1.4: The different ELISA protocols developed for aflatoxin by various 
authors. 
Enzyme 
marker 
Enzyme 
substrate 
Immobilised 
component 
Limit of 
detection  
Reference 
(main author) 
HRP TMB Aflatoxin B1-BSA 30 ng L-1 Wild, 1987  
HRP TMB Aflatoxin B1-BSA 5 ng L-1 El-Nezami, 1995  
HRP TMB Antibody 5 ng L-1 Kim, 2000 
AP pNPP Antibody 10 ng L-1 Thirumala Devi, 2002 
HRP luminol Aflatoxin M1-BSA 0.25 ng L-1 Magliulo, 2005 
HRP, horseradish peroxidase; AP, alkaline phosphatase; TMB, 3,3′,5,5′-
Tetramethylbenzidine; pNPP, 4-Nitrophenyl phosphate.  
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Commonly the principle of the analysis is to incorporate a monoclonal antibody 
which is specific to aflatoxin M1 only. Either standards of known value or sample is 
added to immobilized antibodies. An additional secondary antibody with an 
attached enzyme or an enzyme conjugated analyte then binds to any surplus 
antibody sites and the excess secondary antibody with enzyme is then washed 
away. For the RIDASCREEN method, urea peroxide acting as an enzyme 
substrate is added with a chromogen and the enzyme will break down the urea 
peroxide and the by-product will cause a colour reaction with the chromogen from 
a blue colour to a yellow colour, which is then measured at 450nm (Ridascreen®, 
2001). The absorbance is proportional to the amount of enzyme conjugate bound, 
which is therefore inversely proportional to the amount of aflatoxin M1. This 
reaction process is classified as a competitive enzyme immunoassay.  
 
Competitive assays have the disadvantage to non-competitive assays since the 
amount of unbound sites are measured, resulting in difficulties to distinguish low 
levels of analyte from a zero level i.e. blank value (Giraudi et al., 1999b). A more 
reliable method is the non competitive sandwich technique where one antibody is 
bound to a fixed surface and the analyte is added, then a different antibody is 
added and this also binds to the analyte. Thus the detection method is directly 
proportional to the concentration of analyte. This method is unsuitable for small 
analytes such as the aflatoxins since the molecule is not large enough for two 
antibodies to bind to it, and therefore can not be applied to mycotoxin analysis.  
 
The advantages of the ELISA technique is the ease of use and the cost of the 
equipment required. A semi-automated version of this method is available from 
Charm Scientific Inc. (Massachusetts, USA), however at 0.25 µg L-1 the detection 
limits are insufficient for European Commission legislations. With all ELISA 
techniques a positive result needs to be verified by HPLC since no ELISA method 
has been given AOAC approval (Henry et al., 2001).  Frequently ELISA methods 
yield results which are higher than those obtained by HPLC; it is believed the 
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reason for this misalignment is due to the antibodies in the ELISA procedure cross-
reacting with molecules of similar structure to the analyte of interest in the sample 
(Kulisek & Hazebroek, 2000).  
 
In 1999 a paper was published by Sibanda et al., (1999) detailing a portable field 
assay for the detection of aflatoxin M1. This used a cell which contained antibodies 
and reagents, so that the milk sample could be detected by a visible colour 
development, as with the standard ELISA test the colour development was 
inversely proportional to the concentration. This idea has been invested in and a 
company called Idexx Laboratories Inc. (Maine, USA) have produced a working 
commercial kit. Unlike the original paper by Sibanda which required clean up using 
immunoaffinity columns, this method requires no pre-treatment of the milk and a 
positive or negative result is known within 15 minutes. Like the Charm instrument 
the limits of detection are insufficient for European Commission legislations (0.50 
µg L-1). Again a positive test needs to be verified by HPLC, but this is the first signs 
of aflatoxin M1 analysis can be performed away from the laboratory. 
 
Another interesting application using antibodies is the use of a dipstick similar to a 
home pregnancy test. Two references of this technology have been reported for 
mycotoxin analysis. Delmulle et al., (2005) have reported the development of a 
lateral flow dipstick for the detection of aflatoxin B1 in pig feed. In the test they used 
monoclonal antibodies conjugated to colloidal gold particles which upon the 
reaction with immobilised aflatoxin B1 – BSA yielded a visual pink band on the 
dipstick. Although this technology can only give a false/positive result, the reported 
detection limit of 5 µg kg-1 is sufficient to meet the maximum permissible limit set 
by the European Union for pig feed, the accuracy of the test was reported at 90% 
(n=88).  The other reported use of dipstick technology for mycotoxin detection was 
for fumonisins in corn based foods (Schneider et al., 1995). The dipstick provides a 
positive/negative result within 60 minutes for qualitative measurement.    
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1.4.4 Bilayer Lipid Membranes (BLM). 
Bilayer lipid membranes are classified as a non immunochemical technique and 
can provide rapid results (Siontorou et al., 2000; Andreous & Nikolelis, 1998). 
Briefly, upon the interaction of aflatoxin M1 and a lipid, channels in the lipid open up 
and allow the eluent to pass through. The eluent is an ionic solution so that 
changes in ion concentration can be monitored using an electrochemical detector 
(see Figure 1.10). The method has very fast analysis time (response time of 15 
seconds) and the lipid membranes can be used many times. The cost of the 
equipment is much lower than HPLC and by altering the flow rates, protein 
interferences from the milk can be eliminated.  
 
 
Figure 1.10: Schematic diagram of a Bilayer lipid membrane. (Reproduced from 
Sugawara et al., 2002). 
 
Initially detection limits were only 750 µg L-1 but these limits were improved by 
stabilising the system. Most recently single strands of DNA oligomers were 
incorporated into the membranes to modify the surface electrostatic properties and 
thus provided a system with better stability and 0.016 µg L-1 as a limit of detection 
(Gilbert and Vargas, 2002; Siontorou et al., 2000). 
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1.4.5 Summary of conventional methods.   
Figure 1.11 shows the frequency of a sample of literature published detailing the 
detection of aflatoxin M1. 
1965 1970 1975 1980 1985 1990 1995 2000 2005 2010
Year of publication
BLM
ELISA
HPLC
TLC
 
Figure 1.11: Detection of aflatoxin M1 timeline. The x-axis states the date of 
publication for each method and therefore the frequency of each method and when 
the method was first reported.  
 
The timeline in Figure 1.11 is compiled from; Holzapfel & Steyn,1966; Tuinstra & 
Bronsgeest, 1975; Paul et al., 1976; Shotwell et al., 1976; Gauch 1979, Winterlin 
1979; Beebe & Takahashi,1980: Chambon et al., 1983; van Egmond, 1983; Qian 
et al., 1984; Takeda, 1984; Bijl & van Peteghem,1985; Carisano & Torre, 1985; 
Shepherd et al., 1986; Mortimer et al., 1987; Sharman et al., 1989; Farjam et al., 
1991; Diaz et al., 1995; El-Nezami et al., 1995; de Sylos et al., 1996;  Andreou & 
Nikolelis, 1997, Andreou & Nikolelis,1998; Sibanda et al., 1999; Simon et al., 1998; 
Kim et al., 2000; Martins et al., 2000; Siontorou et al., 2000; Stroka et al., 2000; 
Bakirci, 2001; Galvano et al., 2001; Lopez et al., 2001; Srivastava et al., 2001; 
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Martins & Martins, 2002; Garrido et al., 2003; Lopez et al., 2003; Diaz et al., 2004; 
Elgerbi et al., 2004; Martins & Martins, 2004; Nakajima et al., 2004; Rastogi et al., 
2004;  Sarimehmetoglu et al., 2004; Aycicek et al., 2005; Sassahara et al., 2005; 
Tekinşen & Tekinşen, 2005; Yaroglu et al., 2005; Gürbay et al., 2006; Oveisi et al., 
2006; Unusan et al., 2006; Zinedine et al., 2006). 
 
As discussed, the first identification of aflatoxin M1 as a product of milk was in 1966 
using TLC. In the late 1970’s HPLC technology received much interest and more 
recently the use of ELISA and BLM’s have been reported. TLC is still being used in 
developing countries. 
 
An interesting observation when reviewing the literature for this thesis was that 
Mass Spectroscopy (MS) as a detection technique is used rarely, presumably due 
to the highly fluorescent properties of the aflatoxins (sufficient limits of detection 
are reached with fluorescence). Mass spectroscopy was used by van Egmond 
(1983) for verification of TLC and more recently it has been employed by Chen et 
al., (2005) with HPLC for aflatoxin M1 determination in milk and milk powders and 
by Kokkonen et al., (2005) again with HPLC but for aflatoxin M1 determination in 
Cheese. Chen et al. achieved a limit of detection to 0.59 ng kg-1 solely looking at 
aflatoxin M1 whereas Kokkonen et al., utilized the multianalysis advantages of 
MS/MS by observing 9 mycotoxins including aflatoxin B1, B1, G1, G2, M1, ochratoxin 
A aswell as roquefortine C, a common mycotoxin found in roquefortine cheeses. 
Considering the potential sensitivity of MS/MS the detection limit for aflatoxin M1 
was a high level at 0.3 µg kg-1, insufficient for the maximum permissible limits 
imposed by the European Union and almost 3 orders of magnitude worse than the 
work of Chen et al., (2005). 
 
1.5  Biosensors. 
The term biosensor is used for a device where a biological component attracts an 
analyte of interest and the reaction between the biological component and analyte 
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produces an electrical signal. The official IUPAC definition states "A biosensor is a 
self-contained integrated device, which is capable of providing specific quantitative 
or semi-quantitative analytical information using a biological recognition element 
(biochemical receptor) which is retained in direct spatial contact with an 
transduction element.” (Thévenot et al., 1999.) 
 
If the biological component is an antibody or antibody fragment then the term 
immunosensor is employed. Biosensors have the advantages over traditional 
techniques of; rapid analysis, continuous monitoring and reusable sensor 
elements. There are five classes of biosensor detection; electrochemical, optical, 
calorimetric, magnetic and mass (Tothill and Turner, 2003). 
 
Many biosensors have been reported for aflatoxin B1 however aflatoxin M1 has 
received less interest. Table 1.5 summarises this area of research.  
 
Table 1.5: Reported limits of detection from aflatoxin biosensors. 
Aflatoxin Matrix Sensing 
method 
Limits of 
detection 
Reference 
B1 Maize Optical Not Reported Boiarski et al., 1996 
B1 Nut Optical 4 µg Kg-1 Strachan et al., 
1997 
B1 Maize Optical 2 µg Kg-1 Maragos & 
Thompson, 1999 
B1 None Optical 1 µg L-1 Carlson, 2000 
B1 Maize, 
Sorgum, Nut 
Optical 5 µg Kg-1 Nasir & Jolley, 2002 
B1 Nut, Oat Optical 0.2 µg Kg-1 Gaag et al., 2003 
B1 Barley Electrochemical 0.03 µg Kg-1 Ammida et al., 
2004* 
M1 Milk Electrochemical  0.02 µg L-1 Badea et al., 2004* 
M1 Liver Optical 1 µg Kg-1 Chiavaro et al., 
2005 
M1 Milk Electrochemical 0.05 µg L-1 Micheli et al., 2005* 
* Authors from the same research group at Universitá di Roma Tor Vergata. 
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1.5.1 Optical Biosensors. 
Surface plasmon resonance (SPR) was first suggested as a detection method for 
biological interactions in 1990, however, the phenomenon was first described by 
Kretschmann in 1971 (Kurihara & Suzuki, 2002; Sarkar & Somasundaran, 2002; 
Kretschmann, 1971). 
SPR is an increasingly popular technique for the detection of biological reactions 
since detection requires either substances with a high refractive index or greater 
than 10 kDa (Gaag et al., 2003; Tudos et al., 2003). SPR measures the change in 
mass concentration on a thin gold surface (Sarkar & Somasundaran, 2002; Mullett 
et al., 1998). At a specific angle of incidence and wavelength, the evanescent wave 
component of the light will be adsorbed by the free electrons in the gold (total 
internal reflection) (Tudos et al., 2003) therefore the amount of light being reflected 
will decrease.  The angle at which this occurs (the critical angle) is dependant on 
the refractive index of the material under investigation. Figure 1.12 displays a 
simplified diagram of the SPR detection process.  
 
 
Figure 1.12: Schematic diagram of the detecting unit of the Biacore instrument. 
Diagram from Biacore AB (Uppsala, Sweden). 
 
In practice a mycotoxin could be immobilized onto the sensor chip surface, the test 
sample would be mixed with a known excess amount of antibody and the sample 
would pass over the sensor surface. The non-complexed antibody would be 
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attached to the mycotoxin immobilized on the sensor surface and thus the mass 
concentration on the surface would change, hence the refractive index would 
change. By monitoring the change in the angle of incidence required to achieve 
total internal reflection then the concentration of non-complexed antibody is known, 
thus the amount of mycotoxin in our original sample can be back calculated. This 
technique is known as an inhibition assay and has been reported by Gaag et al., 
(2003). In order to immobilise aflatoxin directly onto the sensor surface, the 
aflatoxin has to be carboxylated. The interactions with the antibody and mycotoxin 
are non-covalent therefore the sensor surface can be regenerated many times.  
 
Mullett et al., (1998) has reported the use of a homemade SPR biosensor for the 
detection of fumonisin B1 with a detection limit of 50 µg kg-1. In opposite to Gaag et 
al., (2003) a polyclonal antibody was immobilized onto the surface rather than the 
analyte, and the detection relied upon the direct detection of fumonisin B1 (712 
daltons). 
 
The Biacore instrumentation is automated so that the analysis and regeneration is 
computer controlled. The sensor chip contains four channels; hence four different 
interactions can be studied simultaneously or one of the four channels can be used 
to measure a sample of known value to act as an internal control. Commonly light 
in the visible region is used which results in a field of detection 200 to 300 nm away 
from the sensor surface, hence turbid solution can be analysed.  
 
Mobile SPR instruments have been developed such as the SPREETA range by 
Texas Instruments, although not as sensitive as the larger instruments its small 
size of 1.5 x 0.7 x 3 cm and weighing only 7 grams means that SPR can be applied 
in portable instrumentation (Chinowsky et al., 2003; Weimar, 2000). 
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Figure 1.13: Schematic diagram of the Spreeta 2000, showing the internal 
components. Reproduced from Chinowsky et al., (2003). 
 
In order to regenerate the sensor an antibody only of moderate affinity should be 
chosen since antibodies can have very strong affinity and when used with SPR the 
regeneration of the temporarily complexed analyte may not be released or require 
a drastic regeneration solution which would destroy the antibody (Daly et al., 2000; 
Diamond, 1998). Optical biosensors have the disadvantage that they contain 
expensive optical components (Tothill and Turner, 2003). 
 
The theory of evanescent waves has been used in handheld fibre-optic devices for 
the detection of aflatoxin B1 (Maragos & Thompson, 1999). Using fibre-optics has 
great potential for hand held devices since they can be easily miniaturised.  An 
additional optical biosensor has been reported by Nasir & Jolley (2002) which uses 
a different optical method of fluorescence polarization. The fluorescence 
polarization method will not be discussed here, but its potential should be 
highlighted since the instrumentation is portable and can be powered from a laptop 
battery.  
 
The biosensor reported by Boiarski et al., (1996) is similar to the method reported 
by Gaag (2003). An aflatoxin antibody is attached to a sensor surface and the 
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sample is added, the aflatoxin in the sample binds to the antibody, then an excess 
of aflatoxin labelled with horseradish peroxidase (HRP) is added. The change in 
mass concentration due to the HRP is recorded and the amount of aflatoxin in the 
sample can be back calculated. Instead of SPR, Boiarski et al., (1996) used an 
optical waveguide based interferometric device which can be classed as optical 
waveguide lightmode spectroscopy or OWLS. This device is very similar to SPR 
however a fixed grating diffuses the light into a waveguide rather than a prism and 
the detectors are perpendicular to the sample, this latter difference means that the 
OWLS instrumentation cannot be miniaturised (Vörös et al., 2002).  A 
comprehensive review of OWLS and SPR is given by Ramsden (1997).   
 
Optical biosensors which don’t require SPR or OWLS have been reported. Carlson 
et al., (2000) reported the use of immunoaffinity columns to separate the aflatoxins 
from the impurities, and then the aflatoxin is eluted from the column and detected 
by fluorescence without any further separation. The detection range for the sensor 
was 0.1 to 50 µg Kg-1. The same protocol has been adopted by Chiavaro et al., 
(2005) for the detection of aflatoxins B1 and M1 in pigs liver where a detection limit 
of 1 µg Kg-1 was reported.  
Cucci et al., (2006) reported a fluorometer for the detection of aflatoxin M1. The 
detection relied upon the monitoring of fluorescence using a small, portable 
fluorometer with a very sensitive PMT detector. For pure solutions of aflatoxin M1 
the fluorescence could be monitored to 50 ng L-1. With no pre-treatment the 
detection method cannot be classed as a biosensor since no biological element is 
incorporated. Although a detection limit of 50 ng L-1 was achieved, this was only 
semi-quantitative and furthermore only applicable with pure solutions. Due to the 
fact that milk causes light scattering this sensor is not currently applicable to real 
samples.  
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1.5.2  Amperometric devices. 
A large number of biosensors use amperometry as their detection technique. The 
first sensors were based on the oxygen electrode developed by Clark in 1973. 
Typically glucose and oxygen would react with glucose oxidase to produce 
hydrogen peroxide and gluconic acid. The electrode detected oxygen by applying a 
high positive potential to reduce oxygen from O2 to O2-, thus the amount of glucose 
could be calculated. This principle has evolved into the commercially very 
successful glucose monitor for diabetics. With no optical system the amperometric 
biosensor is robust and makes it ideal for using in the field at the point of source. 
This is a very useful concept with regards to aflatoxin M1 detection since much of 
the highly contaminated milk which is consumed originates from village dairies with 
1 or 2 cows rather than large scale producers (Suzangar et al., 1976).  
 
Only a few electrochemical biosensors have been reported for mycotoxin 
detection. A report by Moressi et al., (1999) demonstrated the detection of 
mycotoxins produced by Alternaria. Moressi et al., (1999) incorporated a 
polyphenol oxidase enzyme found in mushrooms (also found in pears, peaches 
and potatoes) to a carbon paste electrode. Mushroom tyrosinase, a member of the 
polyphenol oxidase family, reduces the high potential required for the detection of 
the alternaria mycotoxins and therefore gains specificity. The author concluded that 
further research was required. 
 
Much work has been carried out at the Dipartimento di Scienze e Tecnologie 
Chimiche, Universita di Roma Tor Vergata on the electrochemical detection of 
aflatoxins. Ammidia et al., (2004) reported the development of an electrochemical 
screen printed device for the detection of aflatoxin B1 in barley. This device used 
alkaline phosphatase as the enzyme label with a detection limit of 30 ng kg-1 in 
barley. Badea et al., (2004) also reported a flow injection system with 
electrochemical detection. In an uncommon format, free aflatoxin M1 and aflatoxin 
M1 – HRP competes for an anti-aflatoxin M1 antibody; however the complexed anti-
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aflatoxin M1 and aflatoxin M1–HRP is retained on a protein G column and the 
eluted aflatoxin M1–HRP is detected electrochemically. The protocol reached a 
limit of detection of 11 ng L-1 in pure buffer conditions although the presence of 
milk required the deactivation of indigenous lactoperoxidase through heat 
treatment and dilution. The resulting sensor had a detection limit of 20 ng L-1, 
however, the sensor was confined to the laboratory and not portable.  
 
As previously stated in Section 1.3, milk is a difficult matrix to analyse. There have 
been some reports published on biosensors designed for analytes in milk such as 
Pellegrini, (2003) and Pemberton et al., (1999). Pemberton et al. used an alkaline 
phosphatase based ELISA to detect progesterone in milk. By using alkaline 
phosphatase the products (4-aminophenol or 1-naphthol) can be detected by 
amperometric methods operating below +400mV. This voltage is low enough so 
that electro-active interfering species, such as fructose and lactose, from the milk 
are not activated (Mayer et al., 1996). It was concluded by Pemberton et al. when 
using 1-naphthol phosphate as the enzyme substrate rather than 4-aminophenyl 
phosphate, better correlation with existing methods were observed.  
 
1.6  Sensing receptors.  
There are a range of different receptors that can be used as sensing layers in 
sensor systems. This section describes the most relevant types for this work. 
 
1.6.1  Antibodies. 
Antibodies are glycoproteins produced in response to foreign molecules or 
organisms in the body. Mostly they are produced by plasma cells and transported 
around the body by the blood system where they bind to the antigen. The affinity of 
the antibody towards the antigen is very high. To produce specific antibodies, a 
specific antigen is injected into a laboratory animal and serum samples containing 
the specific antibodies are collected and purified. Usually the animal will produce 
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many different antibodies each with different binding capabilities towards the 
antigen.  Hence the term polyclonal is used.  
 
Monoclonal antibodies were first synthesised in 1975 (Milstein 2000; Harlow & 
Lane, 1999; Kohler & Milstein, 1975). These are produced by isolating precursors 
of plasma cells (myeloma) and fusing them with B-cells (lymphocytes) to produce 
hybridoma cells (B lymphocytes). Normal B-cells have a finite lifetime; however by 
using them to produce hybridoma cells they become immortalised (Diamond, 
1998). 
 
In order to produce monoclonal antibodies towards a specific antigen, lymphocytes 
which are expected to yield specific antibodies are screened and fused with 
myeloma cells and then continuously produced in vitro.  Monoclonal antibodies 
have much higher specificity towards the antigen than polyclonal antibodies 
(Chandrashekar & Bandyopadhyay, 2000). 
 
Commonly when considering antibody binding, the immunoglobulin G (IgG) 
molecules are used since the IgG molecules have the simplest structure, a Y 
shape (Figure 1.14). The arms of the Y interact with the antigen and are called the 
Fab domain (antigen binding) whereas the base or tail interact with macrophages 
for transportation and is called the Fc domain (fragment that crystallises.)  
 
Figure 1.14: Diagram of IgG molecule. 
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The IgG molecule contains four polypeptides, two are called the heavy chains 
which consist of about 440 amino acids hence 55,000 Daltons and two are called 
the light chain consisting of 220 amino acids thus 25,000 Daltons. The chains are 
held together by disulphide bridges.  
 
The binding of the antibody to the antigen consists of non-covalent interactions 
such as; van de Waals forces, coulombic interactions, hydrophobic interactions 
and hydrogen bonding (Harlow & Lane, 1999). This collection of interactions can 
make the antigen-antibody binding very specific, for instance, if two very similar 
antigens are present A and B, where A has an additional hydrogen bond which B 
does not. The strength of the interaction of A to the antigen compared to B can be 
1,000 greater. Due to this great specificity shown by antibodies several techniques 
now employ this binding such as ELISA and immunoaffinity clean-up columns for 
HPLC.  
 
1.6.2 MIPS (Molecularly Imprinted Polymers). 
Molecularly imprinted polymers (MIP) have recently been researched to replace 
antibodies in analysis. Basically they are produced by forming a highly cross-linked 
organic polymer around the molecule of interest (target) then removing the target 
to leave a void. Figure 1.15 summaries this process. Unlike size exclusion 
techniques MIPs interact similarly to antibodies with the target through non-
covalent bonding (Batra & Shea, 2003). MIPs have great potential since they are 
very robust as they are made in essence of plastic. However MIPs can suffer from 
either leaching of the target due to insufficient cleaning during synthesis or that 
they are poorly specific for one molecule from a series of homologues (Ye & 
Mosbach, 2001). 
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MIP’s require a very pure analyte as a template, any impurities will obviously 
produce impure affinity media (Tozzi et al., 2003a; Tozzi et al., 2003b) and MIPs 
are currently only operational in non aqueous environments.   
 
Attempts have been made to use the MIP procedure but using amino acids as the 
monomers (Giraudi et al., 2003). As with MIP protocols the target is surrounded by 
amino acid monomers and then cross linked to produce peptides with memory for 
the target. The binding affinity for the peptide was deduced by adding the peptides 
to an immunoassay where the antibody was immobilised. With the addition of the 
peptide the concentration of antibody / antigen (target) complexes decreased.  The 
results show that there is an advantage from MIPS that these amino acid polymers 
can be used in an aqueous media, however there are two distinct disadvantages, 
there is doubt over their stability and they cannot be fixed to a solid surface. 
 
Figure 1.15: A schematic diagram showing formation of MIP. 
A) Template and monomers are added together, B) assembly of monomers with 
the template, C) polymerisation and D removal of template.   
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MIPS for mycotoxin removal has been reported for zearalenone and ochratoxin A. 
Urraca et al., (2006) reported the use of a zearalenone mimic for MIP production 
since the aromatic ring in zearalenone becomes incorporated into the polymer 
during polymerization, thus blocking the binding sites and rendering the polymer 
with poor recognition (Urraca et al., 2006; Weiss, 2003). This raises concerns 
about the applicability of MIP technology for the development of receptors towards 
aflatoxins due to their highly electron rich ring structure.  For ochratoxin A, Yu and 
Lai (2005) has reported on a MIP layer integrated onto a SPR gold surface for the 
detection of ochratoxin A. Unfortunately the report does not include affinity data but 
the sensor was capable for detecting a concentration range of 0.05 to 0.5 mg L-1. 
Mailer et al., (2004) has reported on the use of a MIP as a solid phase packing 
material for the separation and clean-up of ochratoxin A in red wine determination. 
Although the MIP recognised ochratoxin A, the recovery rate was <66% due to 
polar acidic compounds in red wine. Upon the pre-treatment of red wine with a 
conventional C18 column the recovery increased to >90% showing that MIP 
technology can aid extraction techniques but cannot be solely employed. Maier et 
al. (2004) used a template mimic perhaps causing the low selectivity. MIPS have 
been developed and designed by computer molecular modelling methods by 
Cranfield University. Turner (2004) reported the development of MIPS for 
Ochratoxin A analysis, however with detection levels at 50 – 100 µg L-1, further 
work needed to be carried out on the monomers employed to be able to detect the 
EU maximium permissible limits of 1 µg L-1.  
 
1.6.3 Peptides. 
Peptides are compounds made from arrangements of 10 or less amino acids. 
There are over 500 amino acids in nature however only 20 amino acids are 
observed in all species, hence there are a vast number of peptides (Berg et al., 
2006). As previously stated the biologically active site of the antibody is a 
polypeptide. Thus it is possible to recreate the affinity of the antibody by using a 
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peptide sequence (Welling et al., 1990). There are many documented reports were 
peptides have been specifically synthesised to react with molecules of interest 
such as; nucleic acids (Gutte et al., 1979), DDT (Moser et al., 1983), estradiol 
(Giraudi et al., 2003; Giraudi et al., 1999a), estrogen (Tozzi et al., 2002) and 
aflatoxins (Tozzi et al., 2003b).  
 
None of these studies have used anything other than the 20 common amino acids 
hence by additionally incorporating other amino acids, the peptide’s affinity and 
stability may be improved. There is a great interest into the use of unnatural amino 
acids in the pharmaceutical industry. These unnatural amino acids are divided into 
two groups α and β. α amino acids have been used more than the β unnatural 
amino acids in order to improve availability and dynamics, and also used to reduce 
conformational flexibility (Ma, 2003). Recently there is increasing interest into the 
use of the β unnatural amino acids. 
 
Potentially there are many advantages for using peptides rather than antibodies. 
For nature to remove the antibody once the antibody is attached to the antigen 
many other interactions have to occur (Fc interactions). It is possible that these 
other functions on the antibody causes a decrease in the specificity of the antibody 
to the antigen (Welling et al., 1990).   
 
With the current method of producing antibodies, variations in the quality and 
concentration of the antibodies occur between each batch (Tozzi et al., 2003a) 
whereas since the peptide is synthesised completely by instrumentation the 
reproducibility will be increased as well as being prepared faster than antibodies. 
Peptides are also more stable than antibodies, and immunity against low molecular 
weight analytes such as patulin are difficult to produce (Nakamura et al., 2001).  
 
Peptides should have an advantage over MIPs as molecular receptors since they 
are more flexible than MIPs. 
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In the work by Tozzi et al., (2003b) they used only eight different amino acids. They 
created a combinatorial library by placing the eight different amino acids in the 
wells on a micro titre plate in rows and then they added a second amino acid in 
columns in order to produce 64 different combinations. Each dipeptide was 
screened for the best binding properties towards the aflatoxin. To evolve the 
peptide further the best binding dipeptide (Leu Leu) was added to each well on the 
micro titre plate and then the plate was filled again with each of the eight amino 
acids in row and columns to form another 64 different combinations this time 
consisting of tetrapeptides. It was reported that the best tetrapeptide was Leu Leu 
Ala Arg, which had selectivity equal to the commercial antibody.  
 
Katayama (2000) has reported using peptides as ion channel mimics. Although no 
application towards the aflatoxin has yet been reported, it is an area worth 
reviewing. A gold electrode is coated with a peptide and placed into an anionic 
solution. Upon the addition of the analyte of interest (cyclic AMP) the analyte binds 
to the peptide which in turns blocks the surface of the electrode to the anionic 
solution.  This blocking action causes a change in the response on the electrode. 
Figure 1.16 shows this principle. 
 
Figure 1.16: Schematic diagram of a ligand gated ion channel or ‘Ion Channel 
Mimic’ (Reproduced from Katayama, 2000). 
1.7 Receptor design using computational methods. 
Molecular modelling or computational chemistry is a technique which is becoming 
more popular. The cost of the technique is decreasing as computers are becoming 
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cheaper and more powerful and in turn the programs have evolved with simpler 
user interfaces allowing chemists access to such tools rather than computer 
specialists. 
 
Since the 1980’s many de novo design computer programs have been employed 
within the pharmaceutical industry to aid drug design. Drugs for HIV-1 protease 
inhibitors, for example, have been successfully designed and now marketed 
(Wlodawer & Vondrasek, 1998). 
1.7.1 Peptide design using computational methods. 
In this project, a peptide is to be designed and computationally tested. The peptide 
will be created from a minimum of twenty different amino acids and will be at least 
six residues in length. The number of different combinations thus is 206. Using the 
data from Abagyan and Totov (2001) this would suggest that in order to dock all 
the possible combinations of peptide then it would take about 120 years to screen. 
Subsequently Zsoldos et al., (2003) has suggested a new docking method which 
can dock 10000 ligands in 16459 seconds. Using this rate the library would take 
3.3 years, however there is still concern over the validity scoring function, 
furthermore this example suggests use of only twenty different amino acids, to 
improve interaction and stability, unnatural amino acids may be incorporated into 
the design.  
 
A function called genetic search algorithm can screen through the library in an 
‘intelligent’ approach. Leapfrog (Tripos) utilises this principle.  
 
Leapfrog is a ‘de novo’ ligand design program which creates ligands in the active 
site of the receptor (Bertelli et al., 2001).  First a program called GRID (Goodford, 
1985; Moon and Howe, 1991) searches the receptor for interaction sites by using a 
small probe of; methyl, hydroxyl or carbonyl-oxygen.  This data is then used to 
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describe the desirable orientations of the methyl, hydroxyl or carbonyl groups of 
the ligand (Goodman, 1998). 
 
Then the ligand is built by placing fragments and linking together. The genetic 
algorithm calculates a binding score of the total of the contributions from steric, 
electrostatic and hydrogen bonding interactions, and records the score. A slight 
variation of the ligand is produced and the ligand is scored again, if the new ligand 
has a more favourable interaction than the parent then the parent is dismissed and 
the sibling is stored (Payne and Glen, 1993). 
 
This principle of preservation or the survival of the fittest is likened to Darwin’s 
natural selection (1872). In summary Darwin stated, ‘it leads to the improvement of 
each creature in relation to its organic and inorganic conditions of life; and 
consequently, in most cases, to what must be regarded as advancement in 
organisation.’ Genetic algorithms are frequently employed in docking programs, 
such as Flexidock (Tripos) (Bertilli, et al., 2001; Payne and Glen, 1993).  
 
There are disadvantages of genetic algorithms. Again the scoring function 
frequently stores a significant number of false positive structures and some of the 
structures produced by de novo programs are synthetically difficult to produce 
(Schneider and Böhm, 2002; Bohacek et al., 1997). 
 
From an extensive literature search only one author has been discovered whom 
has used computational modelling for sensor development. Mascini et al. in 2004 
published a report on a 5 residue peptide optimised using the de novo program 
leapfrog to act as a receptor for the detection of dioxins. It should be noted 
however that 4 residues of the peptide had already been discovered to have affinity 
by Kobayashi et al., (1999) by analysing dioxins affinity in biological systems, 
therefore the sequence was not truly prepared from first principles by the leapfrog 
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program. Additionally the peptide developed was covalently attached at both ends, 
therefore not projecting into solution but activating as a reactive surface. 
1.7.2 Previous Molecular Modelling Work. 
Previous molecular mechanics work has been done on aflatoxin M1 to produce a 
better understanding of the ideal attachment of the aflatoxin to the protein to form a 
specific antibody towards aflatoxin M1 (Holtzapple et al., 1996). It was concluded 
that the aflatoxins can be split into three conformational/chemical groups. Group 
one consists of aflatoxin M1, B1 and G1, although chemically different, the rings B, 
C, D and E are all in the same plane with ring A at 102O from the plane. The 
presence of the hydroxide group does not change the bond angle. Figure 1.17 
shows the structure of aflatoxin M1 and the labelling of the rings. 
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Figure 1.17: Labelling the rings of aflatoxin M1 and the idealistic point of 
attachment for covalent bonding to a protein for production of an immunogen.  
 
Group two contains aflatoxin M2, B2 and G2, these again have rings B, C, D and E 
in the same plane and ring A at the same angle however with the loss of the 
double bond in ring A, a bend or kink is formed in the ring which is not present in 
group one. 
 
The third group consists of the derivatives B2α and G2α, where rings B, C, D and E 
are still in the same plane, ring A is significantly altered due to the loss of the 
double bond and the insertion of a hydroxide group. From these observations it is 
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clear to see that the conformation of ring A changes the most throughout the 
groups, thus this ring should be furthest from the point of attachment when 
producing an antibody. In addition, when comparing the chemical structure of 
aflatoxins B and M the only difference is the extra hydroxide group on ring A. 
1.8 Aims and Objectives.  
The work carried out in this project was part of a European Union collaborative 
project, GOODFOOD (FP6-IST-1-508744-IP) which is an integrated project with 
aims at developing a new generation of analytical methods based on micro and 
nanotechnology solutions for the safety and quality assurance along the food chain 
in the agrofood industry.  
The GOODFOOD project was split into 8 workgroups in which this project was part 
of the WP3 workgroup. Workgroup 3 was founded with the aim to develop 
microsystems technology solutions for the rapid detection of toxigenic fungi and 
mycotoxins by natural bioreceptors, artificial receptors technology and nano-
electrode devices.  
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The attention of this thesis has been focused on the development of artificial and 
bioreceptors for the rapid detection of the mycotoxin aflatoxin M1. The objectives of 
this project were: 
 
• Sourcing a commercially available antibody and verifying its affinity to 
aflatoxin M1 through development of an indirect ELISA protocol. 
• Production in-house of screen printed electrode and characterisation of the 
sensors towards use as an immunosensor. 
• Development of the screen printed immunosensor for aflatoxin M1 utilising 
the developed ELISA protocol as a foundation. 
• Optimisation of the screen printed immunosensor for detection of aflatoxin 
M1 to meet the maximum permissible limits imposed by the European Union 
foods standards committee.  
• The analysis of real milk samples with the developed immunosensor and the 
determination of pre-treatment strategies. 
• Transfer of the screen printed electrode immunosensor protocol to 
microelectrodes to achieve high detection senstivity. 
• Development of synthetic peptide receptors through computational 
chemistry by building a virtual receptor library. Screening the library for 
peptides with high affinity towards aflatoxin M1 using computational docking 
programs. 
• Validating the affinity of the synthetic peptides using laboratory 
instrumentation.  
• Substitution of the bioreceptor used in the sensor for the synthetic receptor.   
An outline of the different stages undertaken in this thesis to meet the aims and 
objectives is shown in the flowchart below (Figure 1.18). 
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Sourcing a commercially available antibody and verifying its affinity to aflatoxin 
M1 through development of an indirect ELISA protocol.
Introduction
Production in-house of screen printed electrode and characterisation of the 
sensors towards use as an immunosensor.
Development of the screen printed immunosensor for aflatoxin M1 utilising the 
developed ELISA protocol as a foundation.
Optimisation of the screen printed immunosensor for detection of aflatoxin M1 to 
meet the maximum permissible limits imposed by the European Union foods 
standards committee. 
The analysis of real milk samples with the developed immunosensor and the 
determination of pre-treatment strategies.
Transfer of the screen printed electrode immunosensor protocol to 
microelectrodes.
Development of synthetic peptide receptors through computational chemistry by 
building a virtual receptor library.
Screening the library for peptides with high affinity towards aflatoxin M1 using 
computational docking programs.
Validating the affinity of the synthetic peptides using laboratory instrumentation.
Substitution of the bioreceptor used in the sensor for the synthetic receptor.  
Further Conclusions
Further work
References and appendix
 
Figure 1.18: Flowchart detailing the different stages of the work in this thesis. 
2. Development of ELISA. 
 
 
 
CHAPTER 2 
 
DEVELOPMENT OF THE ELISA PROTOCOL AND  
VALIDATION OF THE ANTIBODY. 
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2.1 Introduction. 
The initial stage of the project was to source and test an antibody for use as a 
sensing receptor in the electrochemical affinity sensor. The antibody’s suitability 
was validated by designing and optimising an ELISA protocol using the antibody 
with spectrophotometric methods. Once the antibody was validated it was then 
implemented in the electrochemical sensor.  
 
A heterogeneous indirect immunoassay format was chosen for the assay 
configuration since this is a common format for the analysis of small analytes, 
when the more common sandwich format is not suitable due to the small size of 
the analyte.  
 
Initially the work published by Ammida et al. (2004) was used as a foundation, 
however the system was optimised for the antibodies being used, by changing the 
concentration and time of incubation. Furthermore the blocking agent was 
optimised and compared to other agents available. Lastly milk was studied in the 
system to determine whether there would be any matrix effects and how to 
overcome these problems.  
 
2.2  Materials and Methods. 
2.2.1 Materials. 
A search was carried out to find an antibody with affinity towards aflatoxin M1. 
Abcam Ltd. (Cambridge, UK) produces a rat monoclonal antibody raised against 
aflatoxin M1 – BSA as the immunogen. Upon delivery of the antibody solution (1 
mg mL-1) the contents were split into 5 µL aliquots and stored at -18oC to avoid 
repeat thaw – freeze cycles which reduces the antibody activity. A secondary 
antibody with alkaline phosphatase (polyclonal goat) enzyme was also obtained 
from Abcam Ltd (1 mg mL-1). 
2. Development of ELISA. 
 
 51 
Aflatoxin M1 was obtained from Alexis Biochemicals (Nottingham, UK), made up in 
methanol and split into aliquots and stored under nitrogen at -18oC. Working 
standards were made from the stock using 1% methanol in 10 mM PBS. Aflatoxin 
M1- BSA from Sigma-Aldrich Co. Ltd. (Gillingham, UK) was diluted in carbonate 
buffer (pH 9.6) and stored as aliquots at -18oC. Aflatoxin M1 RIDASCREEN assay 
kit was purchased from R-Biopharm (Glasgow, UK). 
Blocking agents, polyvinyl alcohol 50,000 Da (PVA) and polyvinyl pyrrolidone 
360,000 Da (PVPP), p-nitrophenyl phosphate (pNPP) enzyme substrate for the 
alkaline phosphatase enzyme, 10% sodium hypochlorite for aflatoxin M1 
decontamination and all other general chemicals were obtained from Sigma-Aldrich 
Co. Ltd. (Gillingham, UK). 
 
ELISA experiments were measured using a BMG Fluorstar galaxy ELISA plate 
reader (Aylesbury, UK). The micro well plates were Nunc Immuno plates supplied 
by Fisher Scientific (Loughborough, UK). 
2.2.2 General protocol for ELISA. 
Optimisation experiments used the checkerboard design as detailed by Crowther 
(2001). Initially the concentrations of antibodies and buffers, incubation times and 
blocking agents described by Ammida et al. (2004) were used and then each 
component of the system was optimised further. Table 2.1 shows the parameters 
which were altered. Additionally, the time of the blocking was also investigated 
using the checkerboard design. This was altered from 2 hours to 15 minutes. 
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Table 2.1: The different reagent concentrations used to optimise the ELISA 
system. 
Component Concentration range 
 
Anti-aflatoxin M1 antibody 4 to 0.05 µg mL-1 
Alkaline phosphatase labelled 
antibody 
4 to 0.2 µg mL-1 
Aflatoxin M1 – BSA 200 to 2.5 ng per well 
Blocking buffers (PVA and PVPP) 2 % to 0.25% 
 
The ELISA system was also optimised by producing calibration charts using a 
series of standards of aflatoxin M1 ranging from 10,000 ng L-1 to 20 ng L-1 in 1% 
methanol, 99% PBS. Three experiments were carried out; the concentration of 
anti-aflatoxin M1 was varied from 4 to 0.05 µg mL-1, the concentration of alkaline 
phosphatase labelled antibody was varied from 2 µg mL-1 to 1 µg mL-1 and the time 
of the incubation for the anti-aflatoxin M1 was varied from 2 hours to 30 minutes. 
  
Throughout the investigation the antibodies were diluted in 10 mM PBS (phosphate 
buffered saline) pH 7.4 buffer and the aflatoxin M1 - BSA was diluted in a 0.1 M 
carbonate buffer pH 9.6.  
 
With the exception of washing before the addition of pNPP substrate, the washing 
solution used was 0.05% Tween in 10 mM PBS buffer (pH 7.4). For the washing 
before the addition of pNPP, a 0.05 M Tris buffer was used at pH 7.5 since 
phosphate based buffers inhibit alkaline phosphatase.  
 
Polyvinyl alcohol and polyvinyl pyrrolidone blocking solutions were made using 
cold reverse osmosis water.  
 
The coating of the micro well plate was done at 4oC overnight. All other incubations 
were performed at 25oC. During the incubation of the antibodies, the plate was 
shaken using a Labsystems iMES plate incubator at 400 rpm, 25oC. The plate was 
measured at 405 nm, 45 minutes after the addition of pNPP. 
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Calculations of analytical sensitivity were determined as described by Ammidia et 
al., (2004) and Draisci et al., (2001) as the amount of aflatoxin M1 required to 
reduce the signal change by 25%. 
 
All glassware and consumables were decontaminated from aflatoxin M1 by soaking 
in 10% sodium hypochlorite for 48 hours. Then an equal amount of 5% aqueous 
acetone was added and left for three hours. The mixture was disposed of as 
general hazardous waste. This procedure is recommended by AOAC (Association 
Of Analytical Communities) official methods of analysis (AOAC, 1996). 
 
The developed ELISA method was performed as follows. A 50 µl aliquot of 0.2 mg 
L-1 aflatoxin M1 – BSA solution in 0.1 M, pH 9.6 carbonate buffer was added to the 
bottom of a microwell and stored at 4oC overnight. After washing twice with 0.05 % 
Tween 20 in 10 mM PBS (pH 7.4) and once with reverse osmosis water, 50 µl of 
1% PVPP in water was added and incubated at room temperature for 90 minutes. 
After washing again with Tween 20 and water as previously described, 25 µl of 
sample or standard was added to the well and incubated for 5 minutes at room 
temperature before the addition of 25 µl of the anti-aflatoxin M1 antibody diluted in 
PBS to 1.0 µg ml-1. The microwell plate was shaken during incubation, and after 90 
minutes was washed again as previously described with Tween 20 and water. After 
washing, 50 µL of 2.0 µg ml-1 alkaline phosphatase labelled antibody diluted in 10 
mM PBS, pH 7.4 was added to the plate and shaken at room temperature for 60 
minutes. After washing with Tween 20 twice and once with 0.05 M Tris buffer, pH 
7.5, pNPP substrate system was added to the microwell plate and was allowed to 
develop for 45 minutes at room temperature before measurement at 405 nm with a 
BMG Fluorstar galaxy ELISA plate reader.  
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2.3 Results and Discussions from ELISA development. 
2.3.1 Investigating the sources of anti-aflatoxin M1 antibody. 
A search was performed to find suppliers of an anti-aflatoxin M1 antibody. Also a 
literature search was executed to locate where previous authors had sourced their 
antibodies.  
 
Of the reported ELISA methods for aflatoxin M1, the authors had either used the 
commercial kit from R-biopharm or had produced their own supplies. No other 
report could be found where an ELISA system had been developed using a 
commercial antibody. Abcam Ltd (Cambridge, UK) was found to supply a 
monoclonal antibody for aflatoxin M1 and therefore this antibody was used 
throughout this investigation.  
 
2.3.2  Development of ELISA method without using free aflatoxin M1. 
The first studies were undertaken to optimise the system so that the maximum 
signal would be obtained with the absence of free aflatoxin M1. Using a 
checkerboard experiment design, as described by Crowther (2001), different 
concentrations of the BSA-aflatoxin M1 conjugate (from 250 ng per well to 2.5 ng 
per well) were added to the ELISA plate with each column containing a different 
concentration. Figure 2.1 shows a schematic of the micro well plate and 
concentrations used in this work. 
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Figure 2.1: Schematic diagram showing the principle of the checkerboard design 
used to develop and optimise the ELISA test. 
 
After incubation and blocking, different concentrations of the anti-aflatoxin M1 
antibody were used (from 4 µg mL-1  to 0.4 µg mL-1) and added in rows. Thus each 
well had a different permutation of the amount of anti-aflatoxin M1 and BSA-
aflatoxin conjugate. The results obtained are shown in Figures 2.2, 2.3 and 2.4. 
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Figure 2.2: Optimisation of the signal by varying the anti-aflatoxin antibody 
concentration (all data shown).  
 
The graph in Figure 2.2 was obtained by varying the aflatoxin M1 - BSA 
concentration from 0 to 200 ng L-1 and varying the anti-aflatoxin M1 antibody from 
0.2 to 2 µg mL-1. Alkaline phosphatase labelled antibody concentration was 1 µg 
mL-1. Aflatoxin M1 – BSA was immobilised at pH 9.6 overnight at 4oC. PVA 
blocking (1% PVA) was carried out at room temperature for 1 hour as were both 
antibody incubations. pNPP substrate system was added to the system and 
allowed to develop for 45 minutes.  
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Figure 2.3: Optimisation of the signal by varying the anti-aflatoxin antibody 
concentration (mean only shown).  
 
For the data shown in Figure 2.2 each plot contains the results for a different 
concentration of aflatoxin M1 - BSA, however the change in dilution of anti-aflatoxin 
M1 antibody is common to all the plots. Therefore, the mean of the value for the 
dilution of anti-aflatoxin M1 antibody is shown in Figure 2.3 but standard deviations 
cannot be produced since the experiment is not repeated exactly, and hence error 
bars are not shown. This approach of development was recommended by 
Crowther (2001). The data from Figure 2.3 shows a significant difference between 
2 µg mL-1 and 1 µg mL-1 dilution is observed; hence subsequent experiments used 
a concentration of 1 µg mL-1.  
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Figure 2.4: Optimisation of the signal by varying the amount of aflatoxin M1 - BSA 
coated per well.   
 
Figure 2.4 was obtained from the same run as Figures 2.2 and 2.3. Figure 2.4 
shows that there is a plateau in the signal from 25 ng per well and above. 
Therefore the binding capacity of the surface for aflatoxin M1 - BSA is 25 ng per 
well or 39.7 ng cm-2 (surface area of well for 50 µL is 0.63cm2). For further 
experiments a slightly higher concentration of 50 ng was used to allow for some 
errors in reproducibility and degradation of the protein. A 50 ng per well 
concentration was also used by De Boevere and Peteghem (1993). The use of 
carbonate buffer as an immobilisation buffer was recommended by Crowther 
(2001) as a standard method of immobilisation and was also followed by Magliulo 
et al. (2005). 
 
This method of immobilisation using absorption is common to all authors who have 
developed ELISA systems for the aflatoxins with the exception of Pestka et al., 
(1980) where they immobilised the BSA conjugate using covalent attachment 
through glutaraldehyde, dried using compressed air and storing the plates in a 
desiccator for two weeks. The immobilisation performed by Pestka et al. (1980) 
allows the plates to be stored at room temperature whereas other authors (El-
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Nezami et al., 1995; Wild et al., 1987) require refrigerated storage of plates. In this 
project storage of plates was not considered since the ELISA development was 
only to characterise the antibody.  
 
In the second experiment the amount of alkaline phosphatase labelled antibody 
was optimised whilst changing the anti-aflatoxin antibody by again using the 
checkerboard procedure. Figures 2.5 and 2.6 show the results achieved. 
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Figure 2.5: The optimisation of the alkaline phosphatase labelled antibody applied 
in the test.  
 
Figure 2.5 was obtained by varying the alkaline phosphatase labelled antibody 
concentration from 0.2 to 2.0 µg mL-1. Aflatoxin M1 - BSA concentration was 50 ng 
per well and anti-aflatoxin M1 antibody concentration was 1.0 µg mL-1. Aflatoxin M1 
– BSA was immobilised at pH 9.6 overnight at 4oC. PVA blocking (1% PVA) was 
carried out at room temperature for 1 hour as were both antibody incubations. 
pNPP substrate system was added to the system and allowed to develop for 45 
minutes.  
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The trend in Figure 2.5 is expected since the more labelled enzyme present, the 
greater the signal produced. In order to keep costs down but still give a respectable 
signal a dilution of 1 µg mL-1 was chosen during optimisation of incubation times. 
However, as with the anti-aflatoxin M1 antibody, the optimum concentration was re-
evaluated using a competition assay.  
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Figure 2.6: Optimisation of the ELISA by varying the amount of anti-aflatoxin M1 
antibody.  
 
Figure 2.6 was obtained by varying the anti-aflatoxin M1 antibody concentration 
from 0.05 to 4.00 µg mL-1. Aflatoxin M1 - BSA concentration was 50 ng per well and 
Alkaline phosphatase labelled antibody concentration was 1.00 µg mL-1. Aflatoxin 
M1 – BSA was immobilised at pH 9.6 overnight at 4oC. PVA blocking (1% PVA) 
was carried out at room temperature for 1 hour as were both antibody incubations. 
pNPP substrate system was added to the system and allowed to develop for 45 
minutes. 
 
Figure 2.6 is a repeat and extension of Figure 2.3 to determine the point of 
inflection of the higher plateau. It is shown that the more anti-aflatoxin M1 antibody 
used the higher the signal. However due to the cost of the antibody the plateau 
could not be determined. A concentration of 2 µg mL-1 was used for further 
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experiments since this level is about 80% of the highest signal. However if this 
level did not meet the required limits of detection, then the anti-aflatoxin M1 
antibody levels could be re-evaluated.  
 
Following the work of Ammida et al. (2004) a PVA blocking agent was used. The 
immunogen used for the anti-aflatoxin M1 antibody was aflatoxin M1-BSA. BSA is a 
common blocking agent. It is a component of the immunogen for the Abcam anti-
aflatoxin M1 antibody, therefore non-specific binding could be observed resulting in 
high background noise. BSA can also contain Bovine IgG, causing interferences 
(Crowther, 2001), therefore the use of BSA was avoided. Another frequently used 
blocking agent is casein. Casein is a milk protein and studies have shown that 
aflatoxin M1 resides in the hydrophobic cavities of this protein, therefore the use of 
casein has also been avoided (Bakirci, 2001). Fish gelatine has been used in the 
past as a blocking agent (Lee et al., 2004; Crowther, 2001). However, since the 
end product is required to be robust, polymers were investigated as the blocking 
agent due to their stability rather than proteinaceous blocking agents.  
 
The use of polymers as ELISA blocking agents is an increasing area of research 
(Micheli et al. 2005; Ammida et al, 2004). Work carried out by Studentsov et al., 
(2002) compared using PVA against using PVPP. The results showed that PVPP 
provided better sensitivity limits. Thus the two polymers were compared against 
each other in the next experiment. Different concentrations of PVPP and PVA were 
used as well as varying the time allowed for the blocking. Figures 2.7 and 2.8 show 
the results.  
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Figure 2.7: The determination of the best blocking agent and concentration for use 
as a blocking buffer.  
 
Figure 2.7 was obtained by varying the PVA and PVPP concentrations from 0.25 to 
2.0 % (weight by weight). Blocking was carried out at room temperature for 5 
minutes to 2 hours. Aflatoxin M1 - BSA concentration was 50 ng per well and anti-
aflatoxin M1 antibody concentration was 2.0 µg mL-1. Alkaline phosphatase labelled 
antibody concentration was 1.0 µg mL-1. Aflatoxin M1 – BSA was immobilised at 
pH 9.6 overnight at 4oC. Both antibody incubations were performed at room 
temperature for 1 hour. pNPP substrate system was added to the system and 
allowed to develop for 45 minutes. 
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Figure 2.8: Optimising the incubation time required to achieve blocking. 
 
Figure 2.8 was obtained using the same data as Figure 2.7. 
From both Figures 2.7 and 2.8, it can be seen that a better signal response is 
observed using PVPP rather than PVA. From Figure 2.7, little difference is 
observed when using different concentrations of PVPP, so a value of 1% was used 
to give tolerance and allow for any decrease in concentration which may occur due 
to polymerisation of the blocking solution during storage, which was observed 
during use.   
2.3.3 Optimisation of the ELISA system using the free aflatoxin M1. 
After optimising the ELISA reagents and assay procedure, the method was used to 
test the analyte (aflatoxin M1) in buffer solutions. The first experiment with free 
aflatoxin M1 was to perform a calibration curve experiment from 10,000 ng L-1 
(parts per trillion) to 20 ng L-1. The free aflatoxin M1 and the anti-aflatoxin M1 
antibody were premixed in an Eppendorf tube, in triplicate, and then added to the 
ELISA plate. The transfer procedure involving 36 Eppendorf tubes took a 
substantial amount of time to perform and with the incubation time for the anti-
aflatoxin M1 antibody being just 60 minutes, a considerable error occurred hence a 
high standard deviation can be seen when plotting the graph with error bars. This 
is shown in Figure 2.9. 
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Figure 2.9: The first attempt at a calibration graph using the developed ELISA 
method.  
 
Figure 2.9 was obtained with an aflatoxin M1 - BSA concentration at 50 ng per well 
and anti-aflatoxin M1 antibody at 2.0 µg mL-1. Alkaline phosphatase labelled 
antibody concentration was 1.0 µg mL-1. Aflatoxin M1 – BSA was immobilised at 
pH 9.6 overnight at 4oC. Both antibody incubations were performed at room 
temperature for 1 hour. Blocking with either PVA or PVPP (1%) was performed at 
room temperature for 90 minutes. pNPP substrate system was added to the 
system and allowed to develop for 45 minutes. (Error bars show standard 
deviations, n=3). 
 
Again it can be seen that PVPP gives a better response than PVA, so PVPP was 
used for all subsequent experiments. 
 
To improve the reproducibility the experiment was repeated, however, the free 
aflatoxin M1 was first placed into the micro wells on the ELISA plate then the anti-
aflatoxin M1 antibody was added. Previously, the free aflatoxin M1 and anti-
aflatoxin M1 was pre-mixed to gain sensitivity. This reduced the amount of transfer 
time and improved the repeatability as shown in Figure 2.10. 
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Figure 2.10: Repeat of the calibration performed by ELISA.  
 
Figure 2.10 was obtained using an aflatoxin M1 - BSA concentration of 50 ng per 
well and anti-aflatoxin M1 antibody of 2.0 µg mL-1. Alkaline phosphatase labelled 
antibody concentration was 1.0 µg mL-1. Aflatoxin M1 – BSA was immobilised at 
pH 9.6 overnight at 4oC. Both antibody incubations were performed at room 
temperature for 1 hour. Blocking with PVPP (1%) was performed at room 
temperature for 90 minutes. pNPP substrate system was added to the system and 
allowed to develop for 45 minutes. (Error bars show standard deviations, n=3). 
 
It can be seen from Figure 2.10 that at the lower aflatoxin M1 concentrations there 
is little difference between each concentration so this procedure reduced the assay 
sensitivity.  
  
The European Commission maximum permissible limit for aflatoxin M1 in milk is 50 
ng L-1. Additional work was done to try and ‘fine tune’ the assay so that the 
dynamic range included this level.  
 
The concentration of the anti-aflatoxin antibody was reviewed, on the basis of the 
understanding that a lower amount of antibody may cause a greater competition 
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between the free aflatoxin and the BSA-aflatoxin conjugate as observed by El-
Nezami (1995). Figure 2.11 shows the results.  
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Figure 2.11: Optimising the concentration of the anti-aflatoxin M1 antibody in the 
presence of the free aflatoxin M1.  
 
Figure 2.11 was obtained using various anti-aflatoxin M1 antibody concentration 
from 0.5 to 2.0 µg mL-1. Aflatoxin M1 - BSA concentration was 50 ng per well. 
Alkaline phosphatase labelled antibody concentration was 1.0 µg mL-1. Aflatoxin 
M1 – BSA was immobilised at pH 9.6 overnight at 4oC. Both antibody incubations 
were performed at room temperature for 1 hour. Blocking with PVPP (1%) was 
performed at room temperature for 90 minutes. pNPP substrate system was added 
to the system and allowed to develop for 45 minutes. (Error bars show standard 
deviations, n=3). 
 
To be able to detect 50 ng L1, the standard curve must be able to distinguish 
between 50 ng L-1 and lower concentrations. The 0.5 µL L-1 plot does this, 
however, the signal is low. The 2 µL L-1 plot has the levels at 100 and 75 ng L-1 
significantly higher than the lower concentrations; hence the use of a 1 µL L-1 
dilution was investigated further. 
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The incubation time of the anti-aflatoxin M1 antibody had not been studied.  Figure 
2.12 shows the effects of increasing the incubation time on the signal and 
specificity.  
-9 -8 -7 -6 -5
0.0
0.5
1.0
1.5
2.0
2.5
90
60
30
45
Concentration of af latoxin M1 (Log g L-1)
A
v
er
ag
e 
ab
so
rb
an
ce
 
(40
5n
m
)
 
Figure 2.12: The effect of different incubation times of the anti-aflatoxin M1 
antibody and the sample on the ELISA signal.  
 
Figure 2.12 was obtained using an anti-aflatoxin M1 antibody concentration of 1.0 
µL g-1 and the time of incubation was varied from 30 to 90 minutes at room 
temperature. Aflatoxin M1 - BSA concentration was 50 ng per well. Alkaline 
phosphatase labelled antibody concentration was 1.0 µL g-1 and incubated at room 
temperature for 1 hour. Aflatoxin M1 – BSA was immobilised at pH 9.6 overnight at 
4oC. Blocking PVPP (1%) was performed at room temperature for 90 minutes. 
pNPP substrate system was added to the system and allowed to develop for 45 
minutes. 
 
Figure 2.12, shows the maximum signal is obtained with the longest incubation 
time; however the noise has increased with increasing the incubation time. The 
data for 30, 45 and 60 minutes shows that there is a detectable difference between 
50 ng L-1 and lower concentrations, however for these values the signal is low, 
hence the difference is slight. As an experiment 90 minutes was chosen.    
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The concentration of the alkaline phosphatase labelled antibody was checked. If 
there is not enough of this antibody in the assay, then this might be a cause of why 
the lower end reached a plateau. Figure 2.13 shows the results from this 
investigation.  
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Figure 2.13: The effect of changing the concentration of the alkaline phosphate 
labelled antibody.  
 
Figure 2.13 was obtained by varying the alkaline phosphatase labelled antibody 
concentration from 1.0 to 2.0 µg mL-1 and performed at room temperature for 1 
hour. Anti-aflatoxin M1 antibody concentration was 1.0 µg mL-1 and the time of 
incubation was 90 minutes at room temperature. Aflatoxin M1- BSA concentration 
was 50 ng per well. Aflatoxin M1 – BSA was immobilised at pH 9.6 overnight at 
4oC. Blocking with PVPP (1%) was performed at room temperature for 90 minutes. 
pNPP substrate system was added to the system and allowed to develop for 45 
minutes. 
 
Figure 2.13, shows that there is an improvement with increasing the concentration 
of the alkaline phosphatase labelled antibody.  Furthermore all three lines show 
there is a detectable difference between 50 ng L-1 and lower concentrations. Using 
a concentration of 2 µL L-1 for the antibody would seem preferential. Figure 2.14 
shows a repeat of this concentration with an r2 value of 0.96 and an analytical 
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sensitivity of 50 ng L-1 as determined by Ammidia et al., (2004) and Draisci et al., 
(2001) as the amount of aflatoxin M1 required to reduce the signal by 25%. 
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Figure 2.14: Calibration graph for aflatoxin M1 after complete optimisation of the 
ELISA system.  
 
Figure 2.14 was obtained using an aflatoxin M1 - BSA concentration was 50 ng per 
well. Aflatoxin M1 – BSA was immobilised at pH 9.6 overnight at 4oC. Blocking with 
PVPP (1%) was performed at room temperature for 90 minutes. Anti-aflatoxin M1 
antibody concentration was 1.0 µg mL-1 and the time of incubation was 90 minutes 
at room temperature. Alkaline phosphatase labelled antibody concentration was 
2.0 µg mL-1 and incubated at room temperature for 1 hour. pNPP substrate system 
was added to the system and allowed to develop for 45 minutes. (Error bars show 
standard deviations, n=3). 
 
2.3.4  Determination of the interference from the milk matrix. 
An initial investigation was carried out on the matrix effects which may occur from 
milk. Milk samples complying with British standards were purchased daily from 
Tesco’s supermarket (Flitwick, UK). Three samples were examined; a 
homogenised full fat milk, a semi skimmed milk and a skimmed milk sample. Table 
2.2 lists the nutritional information given for each product.   
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Table 2.2: The nutritional information for the three milk samples examined in this 
investigation.  
 Full Fat (g) Semi Skimmed (g) Skimmed (g) 
 
Protein 3.2 3.3 3.3 
Carbohydrate 4.7 5.0 5.0 
    Of which are sugars 4.7 5.0 5.0 
Fat 3.6 1.6 0.1 
    Of which is saturated 2.2 1.1 0.1 
 
Each milk sample (25 µL) was taken with 25µL standard (1% methanol in 10 mM 
PBS, pH7.4) and placed into the micro well of the ELISA plate and shaken for 5 
minutes using a Labsystems iMES plate incubator at 400 rpm, 25oC. The anti-
aflatoxin M1 antibody was then added and the plate was shaken for 90 minutes. 
Figure 2.15 shows the more fat there is then the greater the signal. 
 
-9 -8 -7 -6 -5
0.0
0.5
1.0
1.5
2.0
Skimmed
Full fat
Semi skimmed
Concentration of af latoxin M1 (Log g L-1)
A
v
er
ag
e 
ab
so
rb
an
ce
 
(40
5n
m
)
 
Figure 2.15: The effect of the milk matrix on the ELISA response.  
 
Figure 2.15 was obtained using an aflatoxin M1 - BSA concentration at 50 ng per 
well. Aflatoxin M1 – BSA was immobilised at pH 9.6 overnight at 4oC. Blocking with 
PVPP (1%) was performed at room temperature for 90 minutes. Anti-aflatoxin M1 
antibody concentration was 1.0 µg mL-1 and the time of incubation was 90 minutes 
at room temperature. Alkaline phosphatase labelled antibody concentration was 
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2.0 µg mL-1 and performed at room temperature for 1 hour. pNPP substrate 
system was added to the system and allowed to develop for 45 minutes. 
 
The presence of milk caused the loss of resolution at low aflatoxin M1 
concentrations and poorer detection limits.  
Further work was carried out to clarify the milk such as the Carrez technique, to 
remove high molecular weight compounds such as proteins and fats (Gökmen and 
enyuva, 2006; Rufián-Henares and Morales, 2006), deproteinate using lead 
acetate (Goldblatt, 1969) or to remove the fats in the milk using solvents (Thomas 
et al., 1998; Delgado Zamarreño et al., 1992) to reduce the differences between 
each type of milk and to determine whether fat or protein causes the interferences 
observed. 
The results of milk sample pre-treatment was not successful. Defatting the milk 
using hexane caused no detectable signal. Thomas et al., (1998) used hexane to 
remove the fat from milk samples, for fat content and polychlorinated biphenyls 
analysis. It was noted by Thomas et al. (1998) that milk with hexane caused a 
suspension that became difficult to separate. The defatted sample in our tests had 
a hexane aroma which indicates residual hexane may be present in the sample 
and caused the loss of binding. This would have not caused a problem for Thomas 
et al. (1998) since the hexane extracts were used for HPLC analysis where the 
presence of solvents is not a concern. 
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Deproteination failed to work since the lead acetate used to denatured the protein 
in the milk sample, may also had the same effect on the antibody and BSA 
conjugate in the test. This denaturing of the test components may have been the 
cause of the zero signal when utilising Carrez clarification.  
 
The pre-treatment techniques stated for the RIDASCREEN kit did not remove the 
matrix effects. The pre-treatment was to chill the sample to 4oC and centrifuge at 
10,000 rpm for 10 minutes and aliquots were taken from below the fat layer. 
 
Upon reviewing the literature reports for self-developed ELISA methods there is 
little consensus whether milk causes interferences. Magliulo et al. (2005) reports 
that milk causes ‘significant’ interference, and commercial dried non fat milk diluted 
in buffer could only be used. El-Nezami et al., (1995) reported that extraction is 
‘essential’ and recommends freeze drying, solvent extraction, solid phase 
extraction and reconstitution in buffer.  Micheli et al., (2005) reports that milk that 
has only been mildly centrifuged does not cause any interference and Thirumala-
Devi et al., (2002) reports that milk only required mild centrifugation followed by 
filtration through standard filter paper. It can only be postulated that milk does form 
some interference in the aspect of antibody binding. However, either different 
authors have obtained antibodies with different affinities or geographically the milk 
is different in its composition. Unfortunately the authors do not give data on the 
milk composition. From reviewing the geographical location of the authors (Table 
2.3) it cannot be concluded that location is the prime cause of the sporadic 
interferences, However the provenance of the interference also is influencing the 
results in this project. 
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Table 2.3: Geographical location of authors for aflatoxin M1 ELISA development. 
Main author Interference Geographical location 
El-Nezami (1995) Yes Australia and Thailand 
Magliulo (2005) Yes Central Italy 
Micheli (2005) No Central/Western Italy 
Thirumla-Devi (2002) No Rural India 
  
Before further investigation could be carried out supplies of aflatoxin M1 – BSA 
could not be obtained from Sigma Aldrich so work was transferred to the 
electrochemical sensor where the assay format was then modified.  
 
2.4 Conclusions to the ELISA development. 
The purpose of the ELISA development was to investigate whether a commercially 
available antibody was suitable for the application in sensor development. The 
detection of aflatoxin M1 in the region of the required detection range demonstrates 
that the antibody from Abcam Ltd is suitable for use in the immunosensor. 
A schematic flow diagram of the final method developed in this chapter is shown in 
Figure 2.20.  
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Figure 2.16: The developed ELISA scheme.  
The scheme is split into two stages. First (marked with orange arrows) is the 
preparation of the microwell plate; immobilisation of the aflatoxin – BSA conjugate 
onto the microwell plate and blocking. Second is the analysis (shown in green) i.e. 
competition reaction and detection.  
 
The analysis stages require about 3.5 hours to perform which is comparable to the 
commercial ELISA kit which requires 3 hours.  
Traditional clean-up protocols stemming from TLC and HPLC methods have been 
demonstrated to be inadequate and not appropriate since the components 
employed for deproteination also have some effect on the antibody and 
immobilised BSA conjugate, as both are proteinaceous in nature. Techniques such 
as solid phase extraction (SPE) and immunoaffinity columns (IAC) are also not 
suitable since they require the use of solvents and are laborious techniques. 
Further work using the ELISA had to be suspended due to a shortage of aflatoxin 
M1 - BSA supplies. To produce the aflatoxin – BSA conjugate a reactive group for 
the coupling reaction is first produced by preparing an aflatoxin M1-1-(O-
carboxymethyl) oxime before coupling can be performed (Chu et al., 1977). This is 
a complicated procedure outside the scope of this project for in-house production. 
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CHAPTER 3 
 
DEVELOPMENT OF THE IMMUNOSENSOR FOR  
AFLATOXIN M1 USING SCREEN PRINTED ELECTRODES 
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3.1 Introduction.  
The aim of this chapter is to describe the coupling of the antibody receptor, 
optimised by ELISA, to an electrochemical interface. Thick film technology was 
utilised for the fabrication of screen printed carbon electrodes, which were then 
characterised by cyclic voltammetry and used as the transducer for the 
electrochemical immunosensor. A new immunochemical format was chosen for the 
development of the immunosensor due to the difficulty in acquiring aflatoxin M1 – 
BSA. However the new format incurred many advantages such as the reduction of 
assay time, fewer steps and the number of components involved in the test for the 
final user. Initially the work described by Micheli et al., (2005) was used as a 
foundation for the immunosensor construction. However, upon reviewing the 
literature the initial protocol was modified and improved. 
  
The effect of milk was reviewed with the immunosensor and through cross 
examining reported literature the responsible compounds for the interferences in 
the test were elucidated and the matrix interferences were reduced. Lastly the 
causes of poor reproducibility were investigated and the immunosensor was 
compared to other existing technologies.   
  
3.2 Materials and methods. 
3.2.1  Fabrication of electrodes. 
The screen printed electrodes were manufactured in house at Cranfield university 
by a multistage deposition process using a DEK 248-screen printer and stencils 
(DEK, Weymouth, UK). The electrodes were printed using 250 µm thick polyester 
Melinex sheets (CMS acoustics, Colchester, UK).  The print parameters were set 
so that the squeegee pressure was 4 psi, a carriage speed of 50 mm sec-1 and a 
print gap of 2.5 mm. For the fabrication, the basal tracks were printed first using 
Electrodag 423-SS graphite ink (Acheson industries, Plymouth, UK). The auxiliary 
electrode layer was printed using the same ink but with a different screen. The 
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reference electrode was printed using Electrodag 6038-SS silver / silver chloride 
ink and printed over the graphite basal track (left track). The blue epoxy insulating 
layer was printed last using 242-SB protective polymer (ESL electroscience 
products, Reading, UK).  
Between each layer the sheets were allowed to dry for 2 hours at 60oC. After the 
insulating layer the sheets were cured at 120oC for two hours. Figure 3.1 shows a 
schematic diagram of the fabrication procedure.  
 
 
Figure 3.1: The fabrication of the sensor. A) the initial basal tracks are laid, B) the 
auxiliary electrode is added, C) the silver/silver chloride reference electrode is then 
printed and finally D) the epoxy insulating layer is placed onto the sensor. 
 
3.2.2  Methods and parameters for the electrochemical procedures. 
For the electrochemical procedures a computer controlled four channel Eco 
Chemie Autolab electrochemical analyser multipotentiostat (Eco Chemie, The 
Netherlands) was used throughout, which allows the simultaneous detection of four 
electrodes. Data capture was through the supplied GPES version 4.9 software to a 
PC. 
 
The screen printed electrodes were connected to the Autolab using an in-house 
fabricated connector from a PCB edged IDC socket, ribbon cable and 4mm cable 
sockets.  Figure 3.2 shows a photo of the instrumental components.  
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Figure 3.2: The Autolab instrumentation from Eco chemie used for the 
electrochemical measurement.  
 
The parameters for the cyclic voltammetry (C.V.) scans are shown in Table 3.1 
 
Table 3.1: The settings used for cyclic voltammetry using the Autolab instrument. 
Number of cycles 5 
Start potential -1.0 V 
First vertex potential +1.0 V 
Second vertex potential -1.0 V 
Step rate 0.00274 V 
Scan rate 0.1 V/s (unless stated) 
 
For the cyclic voltammetry experiments 100 µl of sample was used and the 
electrode was replaced after each scan. Characterisation of the electrodes was 
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carried out by recording cyclic voltammetry scans of potassium hexacyanoferrate 
(III) whilst varying the scan rate from 10 to 100 mV s-1.  
 
For the immunosensor construction all reagents and chemicals were obtained and 
diluted as optimised by the ELISA protocol described in Chapter 2 with some 
additional steps included. In general 8 µl of 96 µg mL-1 anti-primary antibody 
(capture antibody; Pierce, Cramlington, UK) with carbonate buffer pH 9.6, 0.1 M 
was added to the working electrode, placed into a humid environment to avoid 
drying and stored overnight at 4oC.  The sensor was then washed twice with 0.05% 
Tween 20 in 10 mM PBS buffer and once with 10 mM PBS (pH 7.4), ensuring that 
the spray from the wash bottle did not impact directly on the working electrode but 
the flow washed over the working electrode. The electrode was shaken dry to 
remove most of the surplus buffer.  
 
The anti-aflatoxin M1 antibody (8 µl, 40 µg mL-1) was added to the working 
electrode and incubated for 2 hours at 37oC for the reaction of the immobilized 
antibody to the anti-aflatoxin M1 antibody. To block the surface the sensors were 
dipped into 1% PVA in PBS for 2 hours at 37oC then washed and dried using the 
same protocol as before. To the sensor 6 µl of a mixture of aflatoxin M1 standard 
(in either 1% methanol PBS buffer or 1:1 dilution of milk with 1% methanol PBS) 
and a equal volume of 1:10 dilution of the aflatoxin M1 - HRP conjugate from the 
Ridascreen kit from R-Biopharm, Glasgow, UK (diluted using 1% PVA in PBS) was 
added to the working electrode and incubated at 37oC for 2 hours. The sensor was 
again washed, dried and 100 µl of 0.5 mM 3,3′,5,5′-Tetramethylbenzidine (TMB) in 
0.1 M citrate buffer (pH 5.2) with 1 mM hydrogen peroxide was added to the 
sensor, ensuring all three electrodes were covered. The Autolab running in 
chronoamperometry mode was started and the data collected for 10 minutes. 
During measurement the sensors were stored within an aluminium chassis case 
connected to the Autolab’s earth point to reduce the electrical interferences from 
neighbouring apparatus such as computers, gas chromatographs and air 
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conditioning units and in turn stored the sensors away from light during 
measurement due to the TMB being light reactive.  
 
Calculations of analytical sensitivity was determined as described by Ammidia et 
al., (2004) and Draisci et al., (2001) as the amount of aflatoxin M1 required to 
reduce the signal change by 25%. 
 
The settings for the chronoamperometry are listed in Table 3.2 
Table 3.2: Settings for the Autolab chronoamperometry measurments. 
Measurement interval Time 1s 
Standby voltage 0.0 V 
Preconditioning voltage for 20s 0.2 V 
Equilibration voltage for 5s 0.0 V 
Measuring potential for 600s 0.1 V 
 
Step amperometry experiments were performed in triplicate where a solution of 0.1 
M KCl in citrate buffer, 0.1 M pH 5.2 citrate buffer with 0.5 mM TMB and 1 mM 
H2O2 was added to the sensors with and without 20 U of peroxidase from Sigma 
Aldrich Ltd (Gillingham, UK). The peroxidase was added and an incubation time of 
30 minutes was allowed for the reaction with peroxide. Starting from 0 V and going 
towards -1 or 1 V incremental steps of 0.1 V were taken, scanning for 100 seconds 
each. The ratio of peroxidase versus blank (no added peroxidase) was calculated.   
 
For all the experiments the aflatoxin M1 was made up in methanol to a stock 
concentration of 1 mg L-1, aliquots were taken and stored at -18oC under nitrogen.  
Working aflatoxin M1 standards between 10 µg L-1 and 10 ng L-1 were made using 
1% methanol in 10 mM PBS (pH 7.4). 
 
Milk samples complying with British standards were purchased from Tesco 
supermarket (Flitwick, UK) and obtained on the day of analysis. 50 mL of milk 
sample was placed into a 100 mL volumetric flask, 10 mL of 100 mM PBS and 0.26 
g of CaCl2 was added and the sample was made up to 100 mL. The milk samples 
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were centrifuged using a Hettich D-78532 centrifuge, (Kirchlengern, Germany) at 
5000 rpm for 5 minutes. Initially only centrifugation was applied to milk samples.   
For all electrochemical experiments a supporting electrolyte of 0.1 M KCl was 
added to the scanning solution.  
  
All glassware and consumables were decontaminated from aflatoxin M1 by soaking 
in 10% sodium hypochlorite for 48 hours and then an equal amount of 5% aqueous 
acetone was added. The mixture was left for three hours and then disposed as 
general hazardous waste. This procedure is recommended by AOAC (Association 
Of Analytical Communities) official methods of analysis (AOAC, 1996). 
 
For testing the non-specific binding of the aflatoxin M1 to different blocking agents 
the assay for the screen printed electrode was transferred to an ELISA multiwell 
plate and the same concentrations of reagents were used. 50 µL of 96 µg mL-1 
anti-primary antibody (capture antibody; Pierce, Cramlington, UK) with carbonate 
buffer pH 9.6, 0.1 M was added to the plate in triplicate and incubated overnight at 
4oC. The plate was washed twice with 10 mM 0.05% PBS-T and once with 10 mM 
PBS. Following drying, 50 µL of 40 µg mL-1 anti-aflatoxin M1 antibody was added to 
the well and incubated for 2 hours at 37oC using a Lab systems multiwell plate 
incubator. The plate was washed again and 50 µL of either 1% PVPP, 1% PVA, 
0.5% BSA or 1% gelatine in 10 mM PBS buffer was added and incubated for 2 
hours at 37oC. Again washing of the plate was performed as before and 50 µL of 
aflatoxin M1 – HRP (1:10 dilution from Ridascreen Stock) was added and 
incubated for a final 2 hours at 37oC. The plate was then washed and 50 µL of 
Ultra TMB solution from Pierce (Cramlington, UK) was added to the wells and the 
plate was scanned using a BMG Fluorstar galaxy ELISA plate reader (Aylesbury, 
UK) at 450 nm after 30 minutes.  
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3.2.3  Calculation of indigenous lactoperoxidase.  
The levels of lactoperoxidase were estimated by the addition of 0.8 mL of 
untreated milk and 0.2 mL of water to 0.4 mL of TMB ultra peroxidase substrate 
solution from Pierce (Cramlington, UK). After 10 minutes incubation the sample 
was quenched with 10 µL of H2SO4 and centrifuged at 9000 rpm to yield a 
transparent solution. The resulting solution was spectrophotometrically recorded 
using the plate reader at 450 nm. Blank readings for the milk were calculated by 
pre-treating the milk with the addition of 0.2 mL, 1 M trichloroacetic acid to 0.8 mL 
of milk, stirring and then adding to the TMB solution. A corresponding calibration 
curve was produced by dissolving pure peroxidase enzyme into PBS buffer and 
treating the same as the milk sample.  
 
3.2.4 Optimisation of the electrochemical detection of TMB using the screen 
printed electrode.  
During the optimisation of the detection of TMB, three experiments were performed 
in a similar manner. For all the experiments the immobilisation of the capture 
antibody, anti-aflatoxin M1 antibody, blocking agent, aflatoxin M1 – HRP and TMB 
substrate addition were performed as previously described in Section 3.2.2. Firstly 
the identification of the optimum potential for TMB measurement was determined 
by preparing sensors in triplicate and scanning the TMB at +100 mV and -100 mV 
using chronoamperometry. Blank values were obtained by excluding aflatoxin M1 – 
HRP from the test. Secondly the effect of pre-conditioning the electrode with TMB 
before scanning was investigated by again producing sensors in triplicate and 
immediately prior to scanning either applying or not applying a potential at 200 mV 
for 5 seconds. A blank value was obtained by not including aflatoxin M1 – HRP in 
the test. Finally the effect of electrochemical pre-cleaning of the sensor was 
investigated by cleaning screen printed electrodes in triplicate with water, ethanol, 
water and then applying a potential of 2.0 V for 30 minutes to the electrodes. Once 
cleaning had been completed then sensors were produced using the cleaned 
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electrodes. A blank value was obtained by not including aflatoxin M1 – HRP in the 
test.  
3.2.5  Determination of the causes of electrochemical fouling from milk.  
For the elucidation of the causes of interference from milk on the electrochemical 
sensors several solutions of full fat commercial milk was spiked or treated. Initially 
milk was added to the test and a calibration was performed. This was done by 
mixing 1:1 full fat untreated milk with aflatoxin M1 standards (1% methanol in PBS) 
and no other pre-treatment.  
Further investigations were performed to determine the interfering factors. Firstly 
full fat milk was added 1:1 with 10 mM potassium hexacyanoferrate (III) and 0.2 M 
KCl to yield a test solution of 5 mM potassium hexacyanoferrate (III) in 0.1 M KCl. 
This solution was then analysed by cyclic voltammetry using the setting described 
in Table 3.1. Secondly for the investigation of lipids, a commercial milk sample was 
adjusted to pH 8.6 with NaOH whilst constantly stirring, to activate indigenous 
lipases, and then placed into an incubator set at 37oC for 24 hours. This sample 
and a sample of non-fat milk from Sigma Aldrich (Gillingham, UK) were added to 
potassium hexacyanoferrate (III) as described above and tested by cyclic 
voltammetry using the same settings. The non-fat milk was prepared as described 
by the manufactures instructions.  
The investigation into the effects of lactose was performed by producing solutions 
of 4.6% lactose in 0.1 M KCl with and without the presence of potassium 
hexacyanoferrate (III) and analysed by cyclic voltammetry as described by Table 
3.1. 
For the investigations into the removal of proteins three solutions were prepared for 
potassium hexacyanoferrate additions. 1) To a 100 mL commercial sample of milk 
the pH was adjusted to 4.6 and the sample was centrifuged at 4000 rpm, 4oC for 
10 minutes and the supernatent was poured out and an aliquot was mixed with 
potassium hexacyanoferrate (III) and tested by cyclic voltammetry. The remaining 
supernatent was further treated with 50 µL of 5.5 M trichloroacetic acid and stirred 
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for 10 minutes to allow coagulation. The sample was centrifuged again at 4000 
rpm, 4oC for 10 minutes to remove the whey proteins and tested again with 
potassium hexacyanoferrate. Finally a sample was produced by mixing a 50 mL 
commercial milk sample with 25 g finely ground (using a pestle and mortar) 
ammonium sulphate. The solution was incubated at 4oC for 48 hours before 
centrifuging at 4000 rpm and testing with potassium hexacyanoferrate (III) using 
cyclic voltammetry.  
 
3.2.6  The determination of urine on the alfatoxin M1 immunosensor.  
For the determination of aflatoxin M1 in urine, the general method for the 
determination of aflatoxin M1 in milk was followed with the exception of the addition 
of calcium chloride. Breifly, 8 µl of 96 µg mL-1 anti-primary antibody (capture 
antibody; Pierce, Cramlington, UK) with carbonate buffer pH 9.6, 0.1 M was added 
to the working electrode, placed into a humid environment to avoid drying and 
stored overnight at 4oC.  The sensor was then washed twice with 0.05% Tween 20 
in 10 mM PBS buffer and once with 10 mM PBS (pH 7.4), ensuring that the spray 
from the wash bottle did not impact directly on the working electrode, but the flow 
washed over the working electrode. The electrode was shaken dry to remove most 
of the surplus buffer.  
 
The anti-aflatoxin M1 antibody (8 µl, 40 µg mL-1) was added to the working 
electrode and incubated for 2 hours at 37oC, for the reaction of the immobilized 
antibody to the anti-aflatoxin M1 antibody. To block the surface the sensors were 
dipped into 1% PVA in PBS for 2 hours at 37oC, then washed and dried using the 
same protocol as before. To the sensor 3 µl of urine (diluted 1:1 with PBS buffer, 
spiked with aflatoxin M1 in methanol) and 3 µl of 1:10 dilution of the aflatoxin M1 - 
HRP conjugate from the Ridascreen kit from R-Biopharm, Glasgow, UK (diluted 
using 1% PVA in PBS) was added to the working electrode and incubated at 37oC 
for 2 hours. The sensor was again washed, dried and 100 µl of 0.5 mM 3,3′,5,5′-
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Tetramethylbenzidine (TMB) in 0.1 M citrate buffer (pH 5.2) with 1 mM hydrogen 
peroxide was added to the sensor, ensuring all three electrodes were covered. The 
Autolab running in chronoamperometry mode was started and the data collected 
for 10 minutes. 
 
3.2.7  The development and validation of the HPLC method.  
The HPLC determination was performed using a Waters 600E System Controller, a 
Waters 712 WISP Autosampler and a Waters 470 Scanning Fluorescence Detector 
set at an excitation wavelength of 360 nm and an emission wavelength of 430 nm. 
The Waters modules were computer controlled using Kromasystem 2000 software. 
A Phenomenex Luna 5u C18 analytical column was used throughout with a 
Security Guard TM  guard column. Aflatoxin M1 standards were made up 1% 
methanol, 49% PBS buffer and 50% milk and isolated using immunoaffinity 
columns as denoted by the manufactures R-Biopharm (Glasgow, UK). Briefly 50 ml 
of spiked milk was centrifuged at 3,000 RPM to isolate the fat and then passed 
through the immunoaffinity column at a rate of 1-2 drops per second. Once the 
sample had been passed then the column was washed with 2 aliquots of 10 ml 
H2O and eluted into a eppendorf tube with 1.25 ml of 2:3 methanol:acetonitrile 
followed by 1.25 ml of H2O. After mixing by vortex the sample was divided into 
three and placed into HPLC vials for triplicate analysis.  
 
3.3  Results and discussions for the electrochemical sensor. 
3.3.1  Production and characterisation of electrodes. 
The screen printed electrodes were produced as described in Section 3.2.1. Thick 
film technology was chosen initially as the fabrication method for the sensors due 
to the flexibility of design, choice of materials, easy of integration with electronic 
circuits, low cost and fast speed of manufacturing.   
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Thick film technology or screen printing is a procedure where a paste of dielectric 
or conductive materials is applied to a substrate material using a mask. The 
deposition is achieved by pressing the paste through a silk screen mask using a 
squeegee and then curing at raised temperatures. The deposited films have a 
typical thickness of 10 to 50 µm. There is a variety of materials available for 
printing the working electrode including gold and carbon inks, as well as silver 
based inks for the reference electrode. Carbon inks are attractive for sensing 
applications since they are inexpensive, have a wide potential range with a low 
current background. Additionally the adsorption capacity of carbon results in easy 
immobilisation through adsorption of antibodies to the carbon surface. Carbon inks 
contain graphite particles and a polymeric binder as well as other additives which 
are removed upon curing. This leaves a relatively rough surface and thus a high 
surface area.  
 
Sensors were printed in batches of 6000 (100 sheets) and the sensor to sensor 
reproducibility was quantified using cyclic voltammetry (C.V.) by varying the scan 
rate whilst observing the anodic to cathodic peak separation of potassium 
hexacyanoferrate (III) as shown in Figure 3.3.  
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Figure 3.3: Cyclic voltammetry scans of 5 mM potassium hexacyanoferrate (III) in 
0.1 M KCl whilst varying scan rate using the in-house fabricated screen printed 
sensors. Plots were obtained from the average of triplicate results. Fresh sensors 
were used after each scan.  
 
The redox reaction for potassium hexacyanoferrate is a classic reaction and 
therefore easily comparable to other electrode systems. As the potential is 
increased from -0.75 to 1 V in the forward scan the electrode becomes a strong 
oxidant and FeII(CN)63- is formed at the electrode. The current increases and forms 
an oxidation peak on the voltammogram until the vicinity of the electrode is 
depleted from FeIII(CN)64- and migration of the reactant to the surface through 
diffusion cannot be sustained, i.e. mass transport for the unstirred reaction is 
slower than the redox reaction, at which point the current decreases and the 
potential scan is reversed. When the potential scan is in the opposite direction and 
back towards the origin, the reduction reaction for the cathodic peak becomes 
FeII(CN)64-  FeIII(CN)63- + e-.  
 
It can be seen in Figure 3.3, that at a low scan rate of 20 mv s-1 the peak 
separation is 59 mV and thus the reaction is reversible as the electrical equilibrium 
is maintained at the electrode surface (Nicholson, 1965). Upon increasing the scan 
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rate then the oxidation peak potential (Epa) is shifted to a more positive potential 
and therefore demonstrates that the redox reaction is quasi-reversible because the 
rate of electron transfer is too slow to keep the FeII(CN)64- / FeIII(CN)63-  couple in 
equilibrium as the potential is changed.    
 
3.3.2 Characterisation of milk samples. 
Milk is a very complex solution consisting of over 100,000 compounds (Hui, 1992; 
Walstra, 1984). Within its constitution are electro-active species such as ascorbic 
acid, fructose and lactose (Mayer et al., 1996). Hence it is recommended to use 
low voltages for the electrochemical detection to avoid interference. Previous 
reports have stated that the detection of alkaline phosphatase or horseradish 
peroxidase at -100mV does not cause interferences (Pellegrinei et al., 2004; 
Pemberton et al., 1999). 
Additionally milk contains indigenous enzymes such as lacto-peroxidase and 
alkaline phosphatase which may cause false positive readings.  
  
3.3.2.1 Electrochemical interferences from electro-active compounds.  
To validate these concerns, a C.V. scan of full fat milk, with no laboratory pre-
treatment other than spiking with KCl was performed as shown in Figure 3.4. The 
C.V. scan doesn’t show any peaks at the voltage of -100mV, and therefore re-
enforces the observations of Pellegrinei et al., (2004) and Pemberton et al., (1999). 
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Figure 3.4: A C.V. scan of full fat milk with 1 M KCl (no other pre-treatment). The 
results shown are taken from the average of 4 sensors.  
 
3.3.2.2 The determination of indigenous lactoperoxidase.    
 
Marks et al., (2001) detailed a test using hydrogen peroxide strips for detecting the 
effectiveness of heat treatment during the packaging process by determining the 
lactoperoxidase activity. Furthermore reports from Badea et al., (2004) described 
an electrochemical system for the detection of aflatoxin M1 using flow injection 
where the indigenous lactoperoxidase interfered with the HRP marker in the test. 
To determine the lactoperoxidase content a test was done to quantify the levels 
using the Ultra TMB determination solution from Pierce. Briefly a sample of milk 
was added to the Ultra TMB solution and incubated for 10 minutes before 
quenching the reaction with trichloroacetic acid. The solution was centrifuged at 
high speed to yield a transparent solution and the absorbance was measured at 
450 nm. A blank reading was taken where the trichloroacetic acid was added to the 
milk before the addition of Ultra TMB. 
3. Development of screen printed immunosensor. 
 
 90 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
1.0E-06 1.0E-05 1.0E-04 1.0E-03 1.0E-02 1.0E-01 1.0E+00
Concentration of horseradish peroxidase (ng L-1)
A
bs
o
rb
an
ce
 
(45
0n
m
)
 
Figure 3.5: A calibration graph for the determination of peroxidase activity in milk 
using spectrophotometry at 450 nm. Error bars showing standard deviation (n=3). 
 
Using the calibration graph different milk samples were tested and the responses 
and respective concentrations are reported in Table 3.3. 
 
Table 3.3: The responses and concentrations of peroxidase found in different 
milks.  
Sample Dilution Response Concentration 
(ng L-1) 
UHT 1 0.428 ± 0.050 <1x10-4  
Dried 1 0.222 ± 0.012 <1x10-4  
Pasteurised 10 0.382 ± 0.011 <1x10-3  
Raw 10 0.709 ± 0.062 <1x10-3  
 
Table 3.3 is an estimate of the lactoperoxidase activity in the milk samples. It can 
clearly be seen that the enzyme concentrations are very low and 4 magnitudes 
lower than the maximum permissible levels of aflatoxin M1 in the milk.  
3.3.3  Development of the screen printed sensor. 
The aim of this project focuses on developing a sensor for aflatoxin M1. The ELISA 
method developed utilised an alkaline phosphatase enzyme marker as the method 
3. Development of screen printed immunosensor. 
 
 91 
of detection, however, for the electrochemical sensor it was chosen to substitute 
the alkaline phosphatase enzyme for horseradish peroxidase.  
 
Horseradish peroxidase has been extensively evaluated in the literature as an 
electrochemical marker. The enzymatic system monitors the consumption of 
hydrogen peroxide by the horseradish peroxidase enzyme, an enzyme with a high 
turnover rate. The electrochemical detection of hydrogen peroxide directly requires 
a high voltage and therefore subject to interference. In order to overcome this 
problem, mediators are employed. Upon undergoing a literature review for the 
electrochemical detection of HRP several mediators have been evaluated. The 
most common of these are; OPD (o-Phenylenediamine dihydrochloride), ABTS (2-
2'-azino-di-[3-ethylbenzthiazoline sulfonic acid]) and TMB (3,3’,5,5’-
Tetramethylbenzidine). Volpe et al., (1998) concludes that alkaline phosphatase 
generally has superior electrochemical activity over horseradish peroxidase, but, 
when using TMB this difference is negligible.  ABTS and OPD as mediators have 
shown to exhibit mutagenic or carcinogenic effects (Voogd et al., 1980), therefore 
the use of these mediators has been avoided. Alkaline phosphatase does have the 
drawback that there are concerns over its stability, particularly in alkaline 
environments. An additional disadvantage of using alkaline phosphatase is that the 
electrochemical product of the reaction of 4-aminophenolphosphate (p-NPP) is 4-
aminophenol, which is prone to fouling the electrode surface upon measurement. 
Hence the electrochemical scanning technique can only involve one reading rather 
than continuous measurement. It was chosen in this project to use 
chronoamperometry to allow real time observation of the enzyme kinetics to aid 
development. Thus the employment of alkaline phosphatase was not feasible.  
In a deviation to the ELISA system, the antibody has been immobilised onto the 
surface of the sensor, and an aflatoxin M1 – HRP conjugate is used in the test. 
These changes occurred due to the shortage of the commercially available 
aflatoxin M1- BSA conjugate, but also resulted in the sensor becoming much 
simpler for the end user since it will require fewer operator steps.  
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Upon immobilising the antibody onto the surface, much of the antibody is wasted 
due to the haphazard random orientation of the antibody during adsorption. This 
causes up to a 90% decrease in sensitivity (Malmsten et al., 1998). The anti-
aflatoxin M1 antibody is a monoclonal antibody and hence expensive. To reduce 
costs and to improve the affinity of the anti-aflatoxin M1 antibody, a cheap anti-rat 
polyclonal antibody from Abcam Ltd (Cambridge, UK) was immobilized onto the 
surface which has affinity for the Fc fragment (tail) of the anti-aflatoxin M1 antibody. 
This results in the anti-aflatoxin M1 antibody orientated in the correct position and 
therefore improves efficiency.  Figure 3.6 shows a schematic diagram of the 
immobilisation steps. 
 
Figure 3.6: A schematic diagram of the electrochemical sensor.  
 
Initially a polyclonal antibody with affinity for the Fc fragment (tail) of the anti-
aflatoxin M1 antibody is immobilised onto the carbon surface of the electrode 
(Figure 3.6 [1]). Secondly the anti-aflatoxin M1 antibody is added to the sensor [2] 
and using the polyclonal antibody the anti-aflatoxin M1 antibody is orientated into 
the solution and thereby improving sensitivity. The surface is then blocked with 
PVA [3] and for detection a competitive reaction occurs between free aflatoxin M1 
in the sample and HRP labelled aflatoxin M1 [4,5].         
 
Before using the new assay format on the screen printed electrode, the assay was 
performed using the ELISA method. This was employed to determine if this 
substitution improved the detection in the ELISA test. The results showed that 
horseradish peroxidase binds non-specifically to the PVPP blocking agent and 
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causes significant interference when PVPP is used as the blocking agent, as 
shown in Figure 3.7. 
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Figure 3.7: Testing the new method design using ELISA. Different concentrations 
of anti-aflatoxin M1 antibody (2.0, 1.0, 0.5, 0.1 µg L-1) was applied in the test with 
PVPP used as the blocking agent.  
 
Little observational difference can be seen due to non-specific binding of the HRP 
enzyme for the PVPP blocking layer. A study was then done to show, whether, 
horseradish peroxidase has affinity for PVPP alone or other blocking agents. 
PVPP, PVA, BSA and gelatine were used as blocking agents, and background 
readings were obtained for each agent. Table 3.4 shows these results.  
 
Table 3.4: Investigation of the non-specific binding from horseradish peroxidase 
secondary antibody with different blocking agents.  
 
Blocking Agent Average Absorbance (450nm)  
1% PVA 0.33 
1% PVPP 2.32 
0.5% BSA 0.58 
1% Gelatine 1.20 
 
From the results PVPP gave high non-specific binding and thus high interference, 
followed by gelatine, BSA and PVA. From this evidence PVA was used as the 
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blocking agent with horseradish peroxidase. The use of PVA should stabilise the 
system for long time periods since traditional protineacous blocking agents such as 
gelatine and BSA could denature upon storage.  
3.3.4  Electrochemical detection of TMB. 
Before implementing the immuno-components onto the sensor the detection of the 
TMB was verified. Pure unconjugated horseradish peroxidase enzyme (Sigma 
Aldrich, Gillingham, UK) was immobilised onto the sensor surface (1 µL L-1 to 
1,000,000 µL L-1) through adsorption and measured using chronoamperometry 
(measuring potential -100 mV) with TMB (0.5 mM) and hydrogen peroxide (1 mM) 
in 0.1 M citrate phosphate buffer, pH 5.2, as described by Micheli et al., (2005). In 
addition to the parameters reported by Micheli et al., (2005) 0.1 M KCl was added 
additionally as a supporting electrolyte to the citrate buffer to repress the migration 
of electro-active species from the electrode surface (Evans et al., 1983).  The 
results are shown in Figure 3.8. 
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Figure 3.8: Electrochemical detection of immobilising peroxidase onto the 
electrode surface using TMB and H2O2 solution.  
 
The data in Figure 3.8 was obtained using chronoamperometry (-100 mV) with 
TMB (0.5 mM) and hydrogen peroxide (1 mM) in 0.1 M citrate phosphate buffer, pH 
5.2.  Error bars denote standard deviations (n=3). 
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It can clearly be seen that the parameters were able to detect horseradish 
peroxidase with good reproducibility.  
The oxidation of TMB is a two step reaction. Firstly the addition of hydrogen 
peroxide to the heme group containing HRP enzyme reduces the HRP to form an 
intermediate (compound 1) involving a 2 electron process changing the heme 
(Fe3+) group into a ferryl oxo iron (Fe4+=O) and a porphyrin (P) cation radical. Upon 
the addition of TMB, 2 molecules of TMB are oxidised by compound 1 to form a 
blue coloured product. Upon the release of H2O the peroxidase returns to the 
native state via a further intermediate, leaving the TMB in an oxidized state. 
Commonly sulphuric acid is added to the oxidised TMB to develop a stable yellow 
diiamine product that is measured at 450nm and can be measured 
electrochemically (Tanaka et al., 2003; Frey et al., 2000; Ruzgas et al., 1996; 
Josephy et al., 1982). Figure 3.9 shows a summary of the TMB reduction reaction. 
CH3
CH3 CH3
NH
CH3
NH
CH3
CH3 CH3
NH2
CH3
NH2
+ 2 H+ + 2 e-
TMB (Ox) TMB (Red)
 
Figure 3.9: The electrochemical reaction of TMB.   
 
3.3.5 Optimisation of anti-aflatoxin M1 antibody concentration.  
To develop the system a variety of concentrations for the anti-aflatoxin M1 antibody 
was tested without the addition of the free aflatoxin M1 on the screen printed 
electrode sensor surface as shown in Figure 3.10.  
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Figure 3.10: The effect of different primary antibody (anti-aflatoxin M1) 
concentrations using chronoamperometry (-100 mV) for 10 minutes.  
 
Figure 3.10 was obtained with TMB (0.5 mM) and hydrogen peroxide (1 mM) in 
0.1M citrate phosphate buffer pH 5.2.  Error bars denote standard deviations (n=3). 
  
From Figure 3.10 it can be seen that the baseline response is proportional to the 
amount of anti-aflatoxin M1 antibody, this is to be expected. The graph shows that 
a concentration of 100 µg mL-1 (1:10 dilution of the stock solution) yields the 
greatest response, however, this would incur a high cost for the sensor, hence a 
lower dilution of 40 µg mL-1 was trialled and if this had not given suitable results 
then a higher dilution would have been used. It was demonstrated during the 
ELISA development that the concentration yielding the highest signal was not 
required and a lower concentration could be used in order to reduce antibody 
consumption and hence costs.   
 
From Micheli et al., (2005) an initial concentration of 96 µg mL-1 (1:25 dilution of the 
stock) of capture (anti-anti-aflatoxin M1 antibody) antibody was used, if this level 
was not sufficient then we would expect a plateau of the graph in Figure 3.10 at the 
highest concentrations. Therefore a concentration of 96 µg mL-1 is sufficient. In 
deviation from the reports of Micheli et al., (2005) all incubations were done in a 
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humid environment at 37oC. This change is due to the observations during the 
development of single and multi-analyte affinity sensors for the rapid detection of 
androgen residues in live and post mortem animals (European commission 
contract QLK1-2001-01670). A humid environment was required to avoid the 
sensor from drying during incubations.  
 
Using these adjustments, a calibration graph was obtained on the screen printed 
electrode to determine the limits of detection. Figure 3.11, shows the results 
obtained from the sensor.     
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Figure 3.11: Initial results from the electrochemical sensor using 
chronoamperometry (-0.100 mV) for 10 minutes.  
 
Figure 3.11 was obtained using TMB (0.5 mM) and hydrogen peroxide (1 mM) in 
0.1 M citrate phosphate buffer, pH 5.2. Error bars denote standard deviations 
(n=3). 
 
The calibration procedure was reproduced a different day and the same trend was 
obtained, although the limits of detection seem surprisingly low. Concerns were 
raised and the test was repeated however with the practical order of the standards 
reversed. Figure 3.12 shows the results for this test.  
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Figure 3.12: Conclusive results showing errors in the system using 
chronoamperometry (-100 mV) for 10 minutes.  
 
Figure 3.12 was obtained using TMB (1 mM) and hydrogen peroxide (5 mM) in 0.1 
M citrate phosphate buffer pH 5.2. Error bars denote standard deviations (n=3). 
 
When reversing the order of analysis for the standards, the opposite trend was 
observed. This result was invalid. Each standard was analysed in triplicate with the 
electrochemical measurement taking 30 minutes to analyse. From the beginning of 
the run of all the standards to completion the electrochemical measurement took 3 
hours. During this time the TMB mediator was found to be precipitating out of 
solution. This is assumed to be the reason for the decrease of electrochemical 
signal with time, which gave a plot similar to that expected from a sigmoidal curve 
seen from antibody based systems. Additionally hydrogen peroxide does cause 
some spontaneous oxidation with TMB, this has been quantified by Volpe et al., 
(1998) as causing a 4 nA current change after 15 minutes although it should be 
noted that the TMB/H2O2 system is more stable than other systems with regards to 
oxidation such as hydroquinone.  
 
With concerns about the solubility stability of the TMB mediator in the citrate buffer, 
different buffer solutions were tested. The TMB appeared stable in ultrapure water 
so the TMB was tested in a 1:10 dilution (10 mM) of the original citrate buffer 
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solution (100 mM) to investigate whether if the high ionic strength of the citrate 
buffer was the cause of the TMB instability.  
The previous work was repeated but with the TMB solution prepared just before 
each measurement and using a diluted citrate buffer solution. A 1:10 dilution of the 
original citrate buffer was used (10 mM). This produced an expected sigmodial 
curve as shown in Figure 3.13. 
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Figure 3.13: A standard curve of the optimised procedure for the electrochemical 
sensor using chronoamperometry (-100 mV) for 20 minutes.  
 
Figure 3.13 was obtained using TMB (0.5 mM) and hydrogen peroxide (1 mM) in 
10 mM citrate phosphate buffer pH 5.2. Error bars denote standard deviations 
(n=3). 
 
  
The EU maximum permissible limit for aflatoxin M1 is 50 ng L-1. The calibration 
curve in Figure 3.13 fails to meets the requirements for the EU maximum 
permissible limits. Therefore further experimentation was carried out to increase 
the sensitivity of the sensor.  
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The initial immunosensor protocol was adopted from Micheli et al., (2005) and was 
either validated or evolved to maximise the signal response and improve 
sensitivity. Firstly upon performing a literature review there are discrepancies into 
the optimum potential for electrochemical detection of TMB. 
Micheli et al., (2005) reported the detection of TMB at -100 mV versus Ag/AgCl 
whereas Butler et al., (2006), Fanjul-Bolado et al., (2005) Badea et al., (2004), and 
Volpe et al., (1998) suggest a voltage at +100 mV versus Ag/AgCl. To elucidate 
the correct potential initially step amperommetry was performed as shown in Figure 
3.14.  
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Figure 3.14: The determination of the optimum potential for horseradish 
peroxidase detection using TMB as the mediator.  
 
In Figure 3.14 the ratio of the signal current to background current is plotted using 
step amperometry of 0.5 mM TMB / 1 mM H2O2 with the addition of peroxidase in 
pH 5.2 10 mM citrate buffer with 0.1 M KCl. The data is a result from an average of 
4 electrodes.  
 
No previous literature reports could be found where the preferential voltage for 
TMB detection had been discussed. All reports were either using the reduction 
peak or the oxidation peak at +100 mV (Butler et al., 2006, Fanjul-Bolado et al., 
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2005 Badea et al., 2004, Volpe et al., 1998) and -100 mV (Micheli et al., 2005), 
respectively, therefore a range of voltages from -900 mV to +900 mV was 
investigated. It is shown in Figure 3.14 that the best potential for monitoring the 
reduction was -100 mV and for the oxidation +100 mV. The step amperometry in 
Figure 3.14 suggested that +100 mV would yield a stronger signal than -100 mV 
therefore an additional more accurate experiment was preformed to validate this 
observation.  
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Figure 3.15: The comparison of different sensing potentials for horseradish 
peroxidase detection using TMB as the mediator.  
 
In Figure 3.15 the blank comprised of the complete sensor system without the 
addition of aflatoxin M1 – HRP conjugate. The buffer contained 0.5 mM TMB / 1 
mM H2O2 in pH 5.2, 10 mM citrate buffer with 0.1 M KCl. Error bars denote 
standard deviation (n=3). 
 
From Figure 3.15 although the reduction signal gave a greater signal than the 
oxidation signal, the reduction signal also incurred a high blank signal, hence for 
the development of the sensor the oxidation signal was monitored. The +100 mV 
did yield some background signal; this is to be expected since TMB with hydrogen 
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peroxide undergoes limited spontaneous reaction producing a small signal (Volpe 
et al., 1998). 
 
Work completed in a previous EU project on the development of single and multi-
analyte affinity sensors for the rapid detection of androgen residues in live and post 
mortem animals (European commission contract (QLK1-2001-01670) used  
electrochemical preconditioning of the electrode for TMB as the mediator for 
horseradish peroxidase (Conneely et al., 2007; Lu et al., 2006). No other literature 
reports could be discovered where a preconditioning potential was applied before 
detection of TMB.  For the chronoamperometric detection a preconditioning 
potential of +200 mV for 20 s was applied before the scanning potential of +100 
mV was set.  Figure 3.16 shows the gain in detection signal when applying a 
preconditioning potential.  
-5
5
15
25
35
45
55
65
75
Normal blank Normal signal Pre-conditioned blank Pre-conditioned signal
Cu
rr
en
t (n
A)
 
 
Figure 3.16: A study into the use electrode preconditioning for maximizing the 
signal for aflatoxin M1 detection.  
 
In Figure 3.16 the blank comprised of the complete sensor system without any 
addition of HRP- aflatoxin M1.  For preconditioning a potential of +200 mV was 
applied for 20 seconds followed by a 5 second equilibration stage before the data 
collection at an applied of potential of +100 mV. The blank comprised of the 
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complete sensor system without the addition of aflatoxin M1 – HRP conjugate. The 
buffer contained 0.5 mM TMB / 1 mM H2O2 in pH 5.2, 10 mM citrate buffer with 0.1 
M KCl. Error bars denote standard deviation (n=4). 
 
Figure 3.16 shows although there is little advantage with respect to the background 
levels between applying a preconditioning potential or not. However there is a 
significant gain in signal by preconditioning the sensor before data collection.  
 
Further electrode treatment was investigated to depolarise the electrode surface 
before antibody immobilization. Grennan et al., (2000); Espinosa et al., (1999) and 
Wang et al., (1996) advocate the use of electrode pre-treatment. Summarising the 
reports, the use of a potential of 2.0 V from 30 seconds to 10 minutes was applied 
to increase protein immobilization capacity and electron transfer rates of the 
working electrode, in turn increasing the signal and reproducibility. The same 
treatment was performed for the in house produced electrodes to determine if this 
treatment would increase the signal or improve reproducibility. 
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Figure 3.17: The effect of pre-cleaning of the electrodes before immobilisation of 
the antibodies.  
 
In Figure 3.17 the electrodes were pre-cleaned by cleaning with water, ethanol and 
then applying a potential of 2.0 V for 30 minutes with the electrode covered with 
PBS before the application of the anti-primary antibody. The blank comprised of 
the complete sensor system without the addition of aflatoxin M1 – HRP conjugate. 
The buffer contained 0.5 mM TMB / 1 mM H2O2 in pH 5.2, 10 mM citrate buffer with 
0.1 M KCl. Error bars denote standard deviation (n=4). 
 
As shown in Figure 3.17 although the depolarisation did produce a greater signal, 
the difference is not significant. Additionally the cleaning resulted in a high 
standard deviation. Considering the additional time incurred from depolarisation the 
electrodes it was deemed that this step was not fundamental to increasing the 
sensors performance. 
 
The work of Micheli et al., (2005) described the use of PVA as a blocking buffer. 
The use of different blocking buffers with a range of different chemistries was 
investigated to ensure that for electrochemical detection PVA is the most suitable 
blocking agent (Figure 3.18).  
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Figure 3.18: The effect of different blocking buffers on the signal.  
 
In Figure 3.18 he different blocking buffers were made up in PBS buffer at a 
concentration of 1% and allowed to adsorb for 30 minutes at room temperature. 
The figure shows the ratio of the signal current and blank current where the blank 
signal was obtained using the complete sensor without the addition of aflatoxin M1 
– HRP. For all graphs error bars indicate the standard deviation (n=4). The buffer 
contained 0.5 mM TMB / 1 mM H2O2 in pH 5.2, 10 mM citrate buffer with 0.1 M 
KCl. 
 
Traditional proteinaceous blocking agents such as gelatine and BSA did not 
perform as well as the PVA. Interestingly the signal for BSA was lower than that for 
gelatine; the reverse could have been postulated considering that aflatoxin M1 - 
BSA was used as the immunogen for the antibody, thus demonstrating the high 
specificity of the monoclonal antibody. 
 
With the signal ameliorated a calibration was performed in pure buffer undertaking 
the factors from the optimisation. The dynamic range from 1 to 10,000 ng L-1 
possessed a linear r2 value of 0.95 as shown in Figure 3.19. 
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Figure 3.19: Standard curve for the detection of aflatoxin M1 using the 
electrochemical sensor after optimisation.  
 
Figure 3.19 was obtained using electrochemical preconditioning and data collection 
at a potential of +100 mV for 10 minutes. Error bars indicate the standard deviation 
(n=4) The buffer contained 0.5 mM TMB / 1 mM H2O2 in pH 5.2, 10 mM citrate 
buffer with 0.1M KCl.  
  
With the system working well a calibration was performed in a milk sample with no 
pre-treatment other than centrifugation. The correlation between concentration of 
aflatoxin M1 and current was not clear. 
Milk was added to the system to determine what effects that may have. Figure 3.20 
shows the calibration obtained with the presence of milk.  
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Figure 3.20: Calibration graph for aflatoxin M1 in milk using chronoamperometry.  
 
Figure 3.20 was obtained using TMB (0.5 mM) and hydrogen peroxide (1 mM) in 
10 mM citrate phosphate buffer, pH 5.2. Error bars from standard deviations (n=4). 
 
The milk sample selected was skimmed milk containing approximately 0% fat and 
was further centrifuged at 2000 g for 30 minutes. Figure 3.20 shows that there is 
significant interference caused by the presence of milk. Some sample treatment 
would be required, although the sample pre-treatment should be kept to a 
minimum so that the test can be carried out in the field at the point of source.  
 
3.3.6 Electrochemical characterisation milk. 
Previous reports from Pemberton et al., (1999) states that electro-active species 
can interfere with the detection of progesterone in milk. Mayer et al., (1996) have 
reported that milk can cause electrode fouling without pre-treatment, upon dialysis 
with a 12000-19000 molecular size cut off membranes the matrix effects are 
removed. To establish the cause of the interference several chemical clean up 
strategies were employed and tested by monitoring the electrochemical quenching 
effects of the cleanup sample to 5 mM potassium hexacyanoferrate in 0.1 M KCl.  
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Firstly potassium hexacyanoferrate was added to untreated milk (Figure 3.21). 
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Figure 3.21: Demonstration of the quenching effect of milk on the detection of 5 
mM potassium hexacyanoferrate in 0.1 M KCl. Plotted scans are from the average 
of 4 sensors. 
 
To ascertain the effects of fats to the system two samples were spiked with 
potassium hexacyanoferrate to a concentration of 5 mM and 0.1 M KCl. Firstly a 
sample of milk was adjusted to pH 8.6 and incubated at 37oC for 24h to activate 
the natural lipases in the milk and thus breaking down the fats into fatty acids (Hui, 
1993). In a second sample, non-fat milk from Sigma - Aldrich (M7409) was also 
analysed. The resulting voltammograms are shown in Figure 3.22. 
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Figure 3.22: The cyclic voltammogram of 5 mM potassium hexacyanoferrate (III) in 
0.1 M KCl with and without the presence of non-fat milk or milk subjected to natural 
activated lipases. Plotted scans are from the average of 4 sensors. 
 
Both of these samples quenched the electrochemical signal from potassium 
hexacyanoferrate suggesting that fats are not the cause of the electrochemical 
interference and another component of the milk is still affecting the signal.  
 
Mayer et al., (1996) reported that lactose was an interfering compound for their 
milk based biosensor. Furthermore the electro-active nature of lactose is taken 
advantage of as a method of detection for ion chromatography (Hanko and Rohrer, 
2000). To determine the electrochemical effects of lactose, potassium 
hexacyanoferrate was spiked with 4.6% lactose to replicate the natural 
concentration in milk (Schrimshaw, 1988).  
 
From Figure 3.23 it can clearly be seen that lactose is not responsible for the 
quenching effects seen from milk. This is to be expected since lactose is below the 
molecular weight which Mayer et al., (1996) reported as being responsible for 
electrode fouling.   
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Figure 3.23: The cyclic voltammogram of 5 mM potassium hexacyanoferrate (III) in 
0.1 M KCl with and without the presence of 4.6% lactose. Plotted scans are from 
the average of 4 sensors. 
 
A third major component of milk is proteins. Milk was fractionated into a casein free 
sample by the addition of HCl until a pH of 4.6 was obtained (Hui, 1993; Walstra, 
1984) and a fraction free from both casein and whey using HCl and trichloroacetic 
acid using the methods described by Vernozy-Rozand et al., (2004). Potassium 
hexacyanoferrate was added to all fractions and voltammograms were taken as 
shown in Figure 3.24.  
 
 
3. Development of screen printed immunosensor. 
 
 111 
-50
-40
-30
-20
-10
0
10
20
30
40
-1 -0.5 0 0.5 1
Potential (V)
Cu
rr
en
t (
µµ µµA
)
HCl and TCA deproteination HCl deproteination Potassium hexacyanoferrate
 
Figure 3.24: The cyclic voltammogram of potassium hexacyanoferrate (III) in 0.1 M 
KCl with and without the presence of milk liquor subjected to deproteination with 
HCl for casein removal and HCl and TCA for casein and whey protein removal. 
Plotted scans are from the average of 4 sensors. 
 
The fraction from the casein only free sample still shows quenching of the signal 
from potassium hexacyanoferrate. Therefore the casein proteins alone are not the 
cause of the matrix interference.  
It can be seen that although the peak height is not identical for the casein and 
whey free fraction, the peak separation however is similar. It should be considered 
that the voltammograms would not be truly identical due to the samples consisting 
of different ionic strengths. This does show that whey proteins are the cause of the 
matrix interference.  
 
In a test to substantiate the findings from protein removal the proteins were 
removed in a milk sample through precipitation by saturating a milk sample with 
finely ground ammonium sulphate and allowing the milk proteins to completely 
precipitate for 48 hours at 4oC. The corresponding cyclic voltammogram is shown 
in Figure 3.25. 
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Figure 3.25: The cyclic voltammogram of potassium hexacyanoferrate (III) in 0.1 M 
KCl with and without the presence of deproteinated milk saturated with ammonium 
sulphate. Plotted scans are from the average of 4 sensors. 
  
The pre-treatment with ammonium sulphate certainly removed all traces of the 
interference (the induced pH shift from ammonium sulphate is the cause of the 
sharper peaks) confirming that the electrochemical interference from milk is due to 
a proteinaceous compound. 
 
Whey proteins otherwise known as ‘milk serum’ proteins are a group containing; β-
lactoglobulin (18,363 Daltons), α-lactalbumin (14,176 Daltons) and bovine serum 
albumin (66,267 Daltons) additionally the groups also contains immunoglobins and 
small molecular weight peptides (Walstra, 1984). The molecular weight of β-
lactoglobulin, bovine serum albumin and α-lactalbumin correlates with the reports 
of Mayer et al., (1996) that the electrode fouling was eradicated by the use of 
dialysis membranes at 12,000 – 19,000 daltons. Cosman et al., (2005) reinforces 
this observation. In a method utilising TLC as the detection method, Diaz et al., 
(1993) suggested the use of dialysis membranes for the clean-up of milk with 
membranes at 8,000 to 15,000 Daltons. 
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Cosman et al., (2005) reported on the adsorption of the milk whey proteins holo-α-
lactalbumin and β-casein onto stainless steel surfaces. It was detailed that holo-α-
lactalbumin spontaneously adsorbs onto the surface and thus causes fouling to the 
surfaces of pasteurisation elements, a phenomena known as ‘milk stone’. During 
the adsorption the protein goes through dramatic conformational change as it is 
denatured resulting in the loss of centrally bound calcium ions. Considering that the 
adsorption capacity for carbon is far greater than stainless steel it is possible that a 
similar fouling of the surface is arising from this protein.  
 
In an experiment the calibration procedure was repeated however calcium chloride 
was added to the milk sample and washing buffers at a concentration of 18 mM 
based on the theory that through denaturation calcium is lost, then an increase in 
calcium ions may make it less energetically favourable for the protein to denature. 
The results are shown in Figure 3.26.  
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Figure 3.26: Calibration graph for aflatoxin M1 in real milk samples using calcium 
chloride as pre-treatment. Error bars taken from standard deviations (n=3). 
  
By spiking the milk sample with calcium chloride produced a working calibration 
graph with analytical sensitivity at 39 ng L-1. Analytical sensitivity is determined as 
the amount of aflatoxin M1 required to reduce the signal change by 25% (Ammidia 
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et al., 2004; Draisci et al., 2001). The concentration of 18 mM CaCl2 was chosen to 
mimic the concentration of calcium chloride in PBS suggested by Dulbecco et al., 
(1954) upon the work with the isolation of viruses. The recipe later became known 
as Dulbecco’s PBS and is a standard buffer for maintaining the structure of 
mammalian cells. However it is shown to work with antibodies. Therefore fears that 
an addition of calcium chloride could increase the ionic strength and affect the 
antibodies activity are unfounded.    
Although the detection at 50 ng L-1 is possible, the error bars are significant and 
therefore accuracy with the measurement is low. To improve the accuracy, causes 
of the poor reproducibility was investigated.   
 
3.3.7: Investigations into the errors associated with the screen printed 
sensor. 
The sensors in use had been manufactured 18 months before Figure 3.26 was 
obtained. A new batch of sensors was produced and the calibration was repeated 
as shown in Figure 3.27.  
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Figure 3.27: A calibration using calcium chloride for milk pre-treatment and fresh 
sensors. Error bars taken from standard deviations (n=3). 
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The relative standard deviation for the 10 ng L-1 point for the old electrodes is 9.5 
% whereas for the new electrodes it was 7.8 % therefore showing that fresh 
electrodes improved the reproducibility however the error bars are still significant. 
Additionally the signal improved from Figure 3.26 with the working range greater 
than 30 nA compared to less than 20 nA, suggesting that the new electrodes had 
lower resistance than the old electrodes again possibly due to surface 
contamination. With these improvements it should be noted, however, that the 
analytical sensitivity became worse from 39 ng L-1 in Figure 3.26 to 42 ng L-1 for 
Figure 3.27, although this change is not significant. 
 
To try to elucidate the variability between electrodes a fresh sheet of new 
electrodes was taken and the resistance from the carbon connector to the working 
electrode was taken for every sensor on the sheet (60 electrodes). The results are 
shown in Figure 3.28.  
 
Figure 3.28: A 3D graph showing the resistance changes across a sheet of screen 
printed electrodes (%CV = 21%).  
  
Figure 3.28 shows that about 60% of the sheet had unilateral resistance. However 
towards the top of the sheet there is a reduction in the resistance. Therefore this 
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would incur poor repeatability, if these sensors were used in the test, since upon 
measuring current at a fixed potential then the resistance must also be fixed within 
a test. The cause of the variation in the resistance is most probably due to two 
issues. Firstly if the tension varies around the printing screen during electrode 
production then different thicknesses of carbon ink will be deposited on the screen 
and thus different resistances will arise. Secondly, placement in the oven during 
drying can affect the thicknesses of the carbon ink, and thus the resistances, if hot 
air from the oven fans are directed over one part of the screen during drying 
(Gilleo, 1996). These issues are inherent with screen printing technology, 
particularly if the fabrication machine is old. In order to overcome this variability a 
new screen printer is required to replace the existing printer since the printing 
registration can affect the quality of the sensors. Also the number of sensors 
printed on each sheet need to be reduced from 60 per sheet to 5 or 10 sensors.  
A further cause of reproducibility errors could derive from sampling and sample 
pre-treatment. Van Egmond (1983) stated that although the greatest source of 
error in analytical measurement is through sampling, for milk this error is negligible 
since milk is assumed to be a homogeneous matrix. 
   
The developed pre-treatment technique with calcium chloride from the screen 
printed method was compared to existing technology.  
 
Spiked milk samples prepared using the method developed for the immunosensor 
were analysed using the Ridascreen ELISA kit along with the standards in the kit. 
As shown in Figure 3.29 the calcium chloride pre-treatment did not fully isolate the 
aflatoxin M1. Therefore although the calcium chloride pre-treatment is a very clean 
pre-treatment there is some underestimation.  
 
Mendonça and Venâncio (2005) and Dosako et al. (1980) suggest that aflatoxin M1 
has affinity for casein proteins and whey proteins. The binding of aflatoxin M1 with 
casein is due to the hydrophobic pockets formed by the high number of proline 
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residues in casein (Bakirci, 2001; Henry, et al., 1997). It could be postulated that by 
increasing the ionic strength of the milk by adding calcium chloride then the 
aflatoxin M1 has increased affinity for the casein through hydrophobic interaction 
and thus remains partially bound during analysis. The underestimation requires 
that all samples and calibration standards need to be treated the same for this bias 
to be uniform and thus accountable.  
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Figure 3.29: Comparison of the calcium chloride pre-treatment method with 
existing ELISA standards obtained with the Ridascreen kit. Error bars denote 
standard deviations (n=3). 
 
More critical is the fact that the standard deviations for the laboratory prepared 
samples using calcium chloride are higher than those obtained using the kits and 
therefore more work is required to improve the repeatability of the extraction.  
 
3.3.8 Further application of the aflatoxin M1 immunosensor.  
As detailed in Chapter 1, aflatoxin M1 can be found in the urine, where it acts as an 
important biomarker for aflatoxin consumption. The reviews of Jonsyn-Ellis 
(2000a,b) Nyathi et al., (1987) and Coulter et al., (1986) reported levels of aflatoxin 
M1 as high as 374 µg L-1 and mean levels between 490 ng L-1 to 7.1 µg L-1.  With 
the immunosensor successfully designed and optimised for aflatoxin M1 detection 
in milk to 50 ng L-1, initial work was done to investigate the matrix effects of urine 
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on the sensor. Using the same procedure as the immunosensor for milk, however 
without the addition of calcium chloride to the sample, a calibration graph was 
obtained. The data is shown in Figure 3.30. 
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Figure 3.30: The effect of urine on the immunosensor.  
 
Figure 3.30 was obtained using TMB (1mM) and hydrogen peroxide (5mM) in 
citrate phosphate buffer pH 5.2. Error bars denote the standard deviation (n=3). 
 
Figure 3.30 clearly shows that the immunosensor is applicable for the detection of 
aflatoxin M1 in urine with an analytical sensitivity of 25 ng L-1. The levels of aflatoxin 
M1 reported with means in the region of 490 ng L-1 to 7.1 µg L-1 lie midway in the 
dynamic region of the plot. Further work should be carried out to ensure that the 
results are reproducible. However early results are encouraging, especially since 
there is no reported evidence of a sensor for aflatoxin M1 detection in urine. 
Furthermore this analysis provides key information on aflatoxin consumption in 
rural areas of Africa. In Zimbabwe 20,000 deaths per year are attributed to 
aflatoxin consumption (Nyathi et al.,1987) and the worldwide figure is estimated at 
over 200,000 deaths per year (Groopman et al., 1993). 
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3.4 Comparison of the developed immunosensor to other 
technologies.  
With the immunosensor fully functioning, comparisons were made against other 
technologies with regards to performance and cost. The immunosensor was 
compared to the Ridascreen ELISA kit and a developed HPLC method.  
3.4.1  The development and validation of the HPLC method.   
Originally the determination of aflatoxin M1 was performed using the standard 
method for the Waters HPLC equipment which was for the determination of 
Ochratoxin A. The resulting chromatogram showed the elution of the aflatoxin M1 
at the start of the chromatogram and thus prone to interference from non-retained 
components from the sample and also interference from the solvent peak. A 
literature search was performed to deem the most suitable ratio of acetonitrile to 
water which would yield good peak separation. Table 3.5 shows the composition of 
the mobile phases.  
 
Table 3.5: Literature reports for the determination of aflatoxin M1 using a C18 
analytical column.  
 
Main author % Acetonitrile % Methanol % Water 
Winterlin et al., (1979) 28 0 72 
Chambon et al., (1983) 20 5 75 
Takeda (1984) 15 15 70 
Farjam et al., (1992) 20 5 75 
Saad et al., (1995) 25 0 75 
Martins & Martins (2000) 25 0 75 
Kim et al., (2000) 30 50 20 
Galvano et al.,  (2001) 28 0 72 
Roussi et al., (2004) 25 0 75 
Elgerbi et al., (2004) 20 20 60 
Martins & Martins (2004) 25 0 75 
Gürbay et al., (2006) 16 22 62 
Bognanno et al., (2006) 25 25 50 
 
The original mobile phase was 57% acetonitrile, 41 % H2O and 2% acetic acid. 
With the aflatoxin M1 peak eluting early on the C18 column, the mobile p
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therefore required to be more polar by consisting of a greater percentage of water. 
Upon reviewing table 3.5 this is clearly seen that the majority of authors use a 
higher water ratio thus confirming that the polarity of the mobile phase was too low. 
The most common composition of mobile phase is of 25% acetonitrile and 75% 
water. Upon running this mobile phase the elution of aflatoxin M1 occurred at 11 
minutes rather than 2 minutes and thus isolating aflatoxin M1 from the non-retained 
compounds. Figure 3.31 shows an example chromatogram.  
 
Figure 3.31: The chromatogram from the determination of aflatoxin M1 using the 
Waters HPLC system.  
 
In Figure 3.31 the aflatoxin M1 peak has a retention time of 10.5 minutes and is 
clearly resolved from other interfering compounds.  
 
Using these parameters a calibration graph was performed as shown in Figure 
3.32. 
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Figure 3.32: A calibration graph for aflatoxin M1 standards extracted from milk 
using immunoaffinity columns. Error bars plotted from the standard deviations from 
triplicate injections. 
 
The calibration from the immunoaffinity columns produced an r2 value of 0.994 
showing that the method is valid. Using the accepted definition of the limit of 
detection is equilivent to 3 times the standard deviation of the zero value, the limit 
of detection for aflatoxin M1 by immunoaffinity SPE- HPLC is less than 10 ng L-1. 
 
3.4.2  The comparison of HPLC, ELISA and the immunosensor with 
respect to performance and cost.  
Milk samples were prepared using calcium chloride pre-treatment and the same 
sample were analysed by all three methods. Figure 3.33 shows the calibration 
graphs for all three methods.  
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Figure 3.33: Comparison between the developed screen printed immunosensor 
with the developed HPLC method using immunoaffinity pre-treatment and the 
commercial Ridascreen ELISA kit.  
 
In Figure 3.33 the same samples were used for all three methods and performed 
on the same day of analysis. For comparison the scale has been normalised to the 
highest signal for each method. Error bars denote standard deviations (n=3). 
 
The plots in Figure 3.33 show the success of the immunosensor development. 
Compared to the ELISA method, the immunosensor has similar limits of detection 
and comparable repeatability although the working range of the immunosensor is 
far greater than the ELISA method.  
Comparing the HPLC data to the immunosensor data, the HPLC and 
immunosensor has arguably similar sensitivity. However, at low concentrations the 
reproducibility of the HPLC is superior to the immunosensor. The HPLC and the 
immunosensor have similar dynamic ranges from 0 to 1000 ng L-1, although at high 
concentrations the immunosensor has marginally superior repeatability. With 
similar performance between the HPLC and immunosensor the cost of analysis 
was reviewed. Figure 3.34 shows predicted costs of using the three technologies 
with respect to cost of purchasing the instrumentation and running the analysis 
(derivation of the costs are detailed in Section 8.2).  
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Figure 3.34: The comparison of the start-up costs and analysis costs for three 
different methods in terms of number of samples analysed.   
 
All three methods rely on antibodies in the analysis. HPLC utilises antibodies in the 
form of immunoaffinity column pre-treatment, ELISA requires antibodies to be 
immobilised onto the surface of the microwell plate and the immunosensor requires 
antibodies on the surface of the electrode. It is this component of the analysis 
which is the main cost inherent to all methods. The ELISA and immunosensor 
methods require the same amount of financial investment. However, the cost per 
analysis is much cheaper for the immunosensor compared to the ELISA, which 
makes the former cheaper overall. The analysis cost of the HPLC and the ELISA 
are virtually the same as can be seen by the gradients in Figure 3.34. The main 
drawback of the HPLC with regards to cost is the higher start-up costs involved in 
purchasing the instrumentation.  
 
The main advantage with the immunosensor is the portability of the equipment, 
which is difficult to quantify, but using the PalmsensTM (a handheld, battery 
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operated electrochemical potentiostat from the Netherlands) the immunoassay can 
be performed away from the laboratory. Both the HPLC and ELISA methods 
require optical measurement which is fragile technology and cannot be miniturised. 
Therefore in terms of robustness the immunosensors boasts superior robustness 
compared to the HPLC and ELISA methods and increased portability.  
 
The results obtained from this project shows that screen printed technology 
answers the criteria of a simple, robust, low-cost analysis methods for aflatoxin M1 
analysis in milk. 
 
3.5 Conclusions to electrochemical immunosensor development.  
Starting with the components from the ELISA development the system was 
transferred to screen printed electrodes. Initially the system was not capable for 
detection of aflatoxin M1 at 50 ng L-1 but upon optimising the system with regards to 
measurement potential as well as other factors limits of detection improved. The 
final method scheme is detailed in Figure 3.35.  
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Immobilisation of capture antibody
Addition of anti-aflatoxin M1 antibody
Blocking of electrode with PVA
Addition of sample and aflatoxin M1 - HRP conjugate
Addition of TMB and H2O2
Measurement of electrochemical signal
40C, Overnight
37o, 120 minutes
37o, 120 minutes
37o, 120 minutes
RT, 10 minutes
 
Figure 3.35: The developed immunosensor scheme.  
 
The scheme in Figure 3.35 is split into to stages. First (marked with orange arrows) 
is the preparation of the sensor; immobilisation of the antibodies and blocking the 
working electrode surface. Second is the analysis (shown in green) i.e. competition 
reaction and detection. 
 
The immunosensor scheme for the end user was faster and with fewer steps than 
the ELISA method. This improvement was due to the immobilisation of the 
antibody rather than aflatoxin M1 – BSA. The scheme requires three steps to be 
performed for 2 hours. These incubation times were not optimised and therefore 
the method could be preformed faster upon further optimisation.  
 
After synchronising the immuno-components to the electrode surface the effects of 
milk on the sensor was assessed. It was discovered that the milk matrix causes 
significant effects, chiefly from whey proteins. When an excess of calcium chloride 
was added to the milk matrix then the effects from the whey proteins was 
suppressed and a working calibration graph down to 39 ng L-1 was obtained. 
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The immunosensor is not solely suitable for milk, but initial investigations have 
shown that the immunosensor could be employed for aflatoxin M1 determination in 
urine, and therefore monitor human aflatoxin M1 consumption. The quenching 
effect seen from milk was not observed from urine, thus the addition of calcium 
chloride to the sample or any other sample pre-treatment was not required.   
Large error bars were a cause for concern with the calibration graphs obtained with 
the immunosensor therefore the causes was investigated. It was discovered that 
aging of the electrodes had caused some reduction in the electron transfer and 
thus increased resistance.  Additionally it was observed that the screen printing 
process was not fully reproducible and therefore partially responsible for the poor 
reproducibility.   
To improve the performance of the immunosensor the use of substituting the 
screen printed electrodes with arrays of microelectrodes was investigated and shall 
be discussed in Chapter 4.  
4. Development of microelectrode array immunosensor. 
 
 
 
 
 
CHAPTER 4 
 
DEVELOPMENT OF MICROELECTRODE ARRAY AS THE 
IMMUNOSENSOR 
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4.1 Introduction. 
The European Union maximum permissible limits for aflatoxin M1 in milk was 
achieved using screen printed carbon electrodes (Chapter 3). However the 
detection limit is close to the required limit of detection and reproducibility is poor. 
In this chapter microelectrode arrays were reviewed with the possibility whether it 
was possible to improve the signal and hence the detection limit.  
 
The term microelectrode is described for an electrode where one of its dimensions 
is in the µm range (Ŝtulik et al., 2000). Advances have been fuelled by medical 
applications where microelectrodes can be implanted to monitor 
electrophysiological pulses such in cardiac tissues (Hoffman, 2002) or oxygen 
levels in living tissues (Bond, 1994). For immunosensors the advantages of 
microelectrodes are greater mass transport, which results in a greater sensitivity, 
and an increased electrode signal to surface area ratio compared to larger 
electrodes.  This causes low noise levels for microelectrodes and therefore are 
very sensitive. The main disadvantage of microelectrodes is the low current 
generated from the devices requiring very sensitive potentiometers to record the 
signal. To overcome this obstacle, arrays of many microelectrodes are placed 
together, wired in parallel and the current is increased (Davis and Compton, 2005; 
Feeney et al., 1997; Wittkampf et al., 1997). 
 
Utilising the optimisation for the immunosensor with the screen printed electrodes, 
the method was transferred to electrochemical microarrays developed and 
provided by Tyndall National Institute in Ireland (Berduque et al., 2007; Berduque 
et al., 2005; Arrigan, 2004) with minor modification. Competitive calibrations were 
performed, with aflatoxin M1 in the milk matrix, on the microarray to determine its 
feasibility for the application and sensitivity improvements.  
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4.2 Materials and methods. 
4.2.1 Materials used for the microelectrode array. 
The materials used for the microelectrode array immunosensor are as described in 
Section 3.2.2. Briefly the capture antibody (anti-anti-aflatoxin M1) was obtained 
from Peirce (Cramlington, UK) and the anti-aflatoxin M1 antibody was obtained 
from Abcam Ltd (Cambridge, UK). The aflatoxin M1 – HRP conjugate was supplied 
as part of a diagnostic kit from R-Biopharm (Glasgow, UK). TMB, H2O2 and all 
other general chemicals were purchased from Sigma-Aldrich LTD (Gillingham, 
UK). All buffers and antibody solutions used were the same concentrations and 
ionic strengths as reported in Section 3.2.2. 
 
4.2.2 Antibody immobilisation onto the microelectrode array. 
The gold cell-on-a-chip microelectrodes (including on-chip reference and counter 
electrodes) were fabricated by standard deposition, etching and lithographic 
techniques and were produced by Tyndall national institute (Berduque et al., 2007; 
Berduque et al., 2005; Arrigan, 2004) and had a modified surface allowing covalent 
immobilisation of the bio-recognition molecules (Figure 4.1). The working, counter 
and reference electrodes were made from gold. The working electrode consists of 
35 elements, 20 µm x 20 µm wide, wired in parallel. 
Microelectrode array
Screen printed electrode
 
Figure 4.1: The microelectrode array from Tyndall National Institute and the in-
house fabricated screen printed electrode. 
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The surfaces had been silanised followed by attachment of a PDITC (1,4-
phenyldiisothiocyanate) cross linker compound for antibody attachment was 
carried out by Tyndall national institute as described by Lillis et al., (2006). The 
capture antibody (anti-anti-aflatoxin M1) from Pierce (Cramlington, UK) was diluted 
(96 µg mL-1) with carbonate buffer, (0.1M, pH 9.6) of which 1 µl of the antibody 
solution was placed onto the working microelectrode. The electrodes were then 
placed on a damp tissue in a Petri dish and stored overnight at 4oC to allow 
covalent attachment. The microelectrodes were washed with 10 mM PBS-T pH 7.4 
buffer twice and once with water using a dispensing bottle, ensuring that the buffer 
was not directly sprayed onto the working microelectrode, and then shaken dry.  
 
After drying, 3 µl of 0.1% NH4OH in water was added for 60 mins at room 
temperature to deactivate any un-reacted PDITC cross linker and then washed and 
dried. A 1 µL of 40 µg mL-1 anti-aflatoxin M1 antibody (Abcam, Cambridge, UK) 
was placed onto the microelectrode and incubated at 37oC for 2 hours in a Petri 
dish with damp tissue. The electrode arrays were then washed and dried as 
reported above and stored at 4oC until used.  
 
4.2.3 Assay development for the microelectrode array.  
To the antibody immobilised microelectrode 1 µl of sample or standard, mixed 1:1 
with aflatoxin M1 HRP (diluted 1:10 with 10 mM PBS, pH 7.4) was placed and 
incubated at 37oC for 120 minutes. 
 
For the detection, 1 mg of TMB was dissolved with 150 µl de-ionised water,  20 µl 
of this stock solution was taken with 2 µl of 30% hydrogen peroxide and made up 
to 1 ml using 10 mM citrate buffer, pH 5.2, in 0.1 M KCl at 37oC. A 4 µl aliquot of 
the TMB solution was placed onto the micro array immediately prior to analysis. 
The stock solution of TMB was prepared daily and stored in the dark prior to use.  
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The electrochemical measurement was performed by connecting the microarray to 
the Autolab using an interface provided by the Tyndall National Institute and the 
scanning potential was set to +168 mV and a pre-conditioning potential was 
applied before measurement for 5 seconds at a potential of +268 mV. Figure 4.2 
shows a diagram of the surface chemistry of the microelectrode array with the 
provided PDITC cross linker for covalent amine linkage.  
 
 
Figure 4.2: A schematic diagram for the covalent immobilisation of the capture 
antibody onto the microelectrode surface. The surface chemistry was performed by 
Tyndall National Institute and the capture antibody attachment and capping of the 
excess linker was performed at Cranfield.  
 
4.2.4 Surface analysis of the microelectrode array by AFM and SEM.  
The surface of two microelectrode arrays were analysed in detail to monitor and 
ensure correct immobilisation of the antibody. To one of these sensors the surface 
was prepared by immobilising the capture antibody before the surface analysis. 
This was done using the same concentration of reagents as the SPE 
immunosensor.  
A 1 µL aliquot of 96 µg mL-1 of capture antibody solution (Pierce, Cramlington, UK) 
was placed onto the microelectrode surface at pH 9.6 and incubated at 4oC 
overnight for immobilisation. The surface was washed with 10 mM PBS-T and H2O 
then the excess linker compound applied by Tyndall national institute was 
deactivated using 4 µL 0.1% NH4OH for 1 hour at 37oC. 
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The atomic force microscopy (AFM) images were obtained using a Dimension 
3000, manufactured by Digital Instruments (now Veeco Instruments, Cambridge 
UK). The tips used were silicon probes used in tapping mode. The probes were 
225 x 38 x 7 microns with a typical resonant frequency of 160 kHz. The scan speed 
applied was between 0.5 to 1 Hz. 
  
The SEM (scanning electron microscope) images and elemental scans were taken 
using a Philips XL30 SFEG (Guildford, UK) (scanning field emission gun).   
 
4.3 Results and discussions for the microelectrode array 
immunosensor. 
4.3.1 Surface characterization of the microsensors. 
SEM images were taken using sFEG rather than a conventional SEM since the 
sFEG has a thin needle of a tungsten crystal as its filament rather than a normal 
tungsten filament and therefore the resolution is much better than using a standard 
SEM. 
 
Using a high resolution scanning electron microscope (sFEG) at a low 
magnification images (x80 magnification) of the working microelectrode for the 
microsensors was taken. Figure 4.3 clearly shows the layout of the working 
microelectrode with the 35 arrays cut into the surface.  
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Figure 4.3: The whole working microelectrode of the untreated Tyndall 
microelectrode at 80x magnification using sFEG.  
 
The magnification was increased to 3500x magnification to study the differences in 
the surfaces of a single element between the untreated surface and the antibody 
treated surface. This is shown in Figure 4.4. 
 
A B
 
 
Figure 4.4: 3500X magnification of the single element in the electrode array.  
 
Figure 4.4A shows 3500x magnification of a single element for the untreated 
working microelectrode. The surface is tilted 30o to show the depth of the array. 
Figure 4.4B shows 3500x magnification of a single element for the treated working 
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microelectrode with the antibody present. The surface is at 0o. For the treated 
microelectrode 1 µL of 96 µg mL-1 of capture antibody was immobilised at 4oC 
overnight then excess linker compound was deactivated using 4µL 0.1% NH4OH 
for 1 hour at 37oC and sFEG images were taken immediately.  
 
Although the tilt angles of the two images are different there is little to observe at 
this magnification. Figure 4.4A clearly shows the change in profile of the cut out of 
the array.  
To observe differences in the surfaces the magnification was increased further to 
35000 times magnification. Figure 4.5 show these images.  
 
BA
 
 
Figure 4.5: 35000X magnification of a single microelectrode array.  
 
Figure 4.5A shows 35000X magnification of the surface of a single element for the 
untreated working microelectrode. Figure 4.5B shows 35000x magnification of the 
surface of a single element for the treated working microelectrode. For the treated 
microelectrode 1 µL of 96 µg mL-1 capture antibody was immobilised at 4oC 
overnight, then excess linker compound was deactivated using 4µL 0.1% NH4OH 
for 1 hour at 37oC and finally sFEG images were taken immediately.  
 
There are no major differences between the two images in Figure 4.5. On both 
there is some graining effect of the gold surface and possibly Figure 4.5B shows a 
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more uniform layer due to the protein surface. It should be noted though that the 
electron beam of the sFEG usually penetrates the surface to a depth of 10 µm 
therefore probably bypassing the proteinaceous surface. Furthermore the 
antibodies on the surface are not electron rich and hence not clearly visible by 
SEM techniques.  
 
Elemental scans of the two surfaces were taken to deem if one had greater carbon 
content due to the proteins. Figures 4.6, 4.7 and Table 4.1 show the results.  
 
 
 
Figure 4.6: The elemental scan from the sFEG for the untreated working 
microelectrode surface showing the elemental composition of the surface.  
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Figure 4.7: The elemental scan from the sFEG for the treated microelectrode 
working surface showing the elemental composition of the surface.  
 
For the treated microelectrode 1 µL of 96 µg mL-1 dilution of capture antibody was 
immobilised at 4oC overnight, then excess linker compound was deactivated using 
4 µL 0.1% NH4OH for 1 hour at 37oC and finally sFEG images were taken 
immediately.  
 
Table 4.1: The results of the elemental scans between the two surfaces.  
Element % by weight in 
untreated 
% by weight in 
treated  
Si  21.53 29.69 
Ti  1.45 1.63 
Au  77.02 68.69 
 
The data from Figures 4.6, 4.7 and Table 4.1 shows that there is some variability 
between the two sensors in relation to silicon and gold, however no carbon was 
detected. This again was most probably due to the penetration depth of the 
electron beam and the low density of the carbon layer.  
 
With scanning electron microscopy unable to provide robust evidence of the 
presence of proteins, atomic force microscopy was employed.  Atomic force 
microscopy has been increasingly employed to study biological samples since 
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analysis can be performed at room temperature and pressure and in liquid 
environment whereas SEM required analysis at low pressures and in a dry or near 
dry state. Furthermore as stated in Section 4.3.1, the surface is required to be 
electron rich. Therefore to study the surface morphology of proteins a 20nm gold 
layer has to be coated over the proteins (de Souza Pereira, 2001). 
Initially one array was isolated and scanned to quantify the dimensions of the 
arrays. Figure 4.8 shows a 3D image of a single element.  
 
 
Figure 4.8: Atomic force microscopy image of a single element for the untreated 
working microelectrode (image 40 µm x 40 µm). 
 
Topographic analysis of the data was performed to show that the element is 20.5 
µm wide and 0.48 µm deep. The data is shown in Figure 4.9.   
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Figure 4.9: Determination of the width and depth of a single element for the 
working microelectrode using atomic force microscopy. 
 
To investigate the surfaces of the two different samples firstly a detailed analysis 
was performed of the surface inside the arrays. Figures 4.10 and 4.11 show 3D 
images of the surfaces.  
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Figure 4.10: The surface of the interior of a single element for the untreated 
working microelectrode (1 µm x 1 µm) analysed by atomic force microscopy.  
 
 
 
 
Figure 4.11: The surface of the interior of a single element for the treated working 
microelectrode (1 µm x 1 µm).  
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Visually there is not an appreciable difference between the two images. For the 
untreated sample there is a more uniform layer, whereas with the addition of 
protein the uniformity is lost to a more sporadic layer.   
 
The roughness of the surface of the untreated working microelectrode was 
determined. Initially the bulk material was analysed, then the interior of the arrays 
was determined for both the treated and untreated. Figures 4.12, 4.13 and 4.14 
show the results.   
 
 
 
 
Figure 4.12: Determination of the roughness of the bulk surface for the working 
microelectrode analysed by atomic force microscopy. 
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Figure 4.13: The surface roughness of the untreated working microelectrode 
inside the element analysed by atomic force microscopy. 
 
 
 
 
Figure 4.14: The surface roughness of the treated working microelectrode inside 
the element.  
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The mean roughness for the bulk material is 0.90 nm, for the untreated inside the 
element 0.93 nm and 1.77 nm inside the treated element. This does show that 
there is a quantifiable difference between the two samples and concurs with the 
visual observations that the proteins cause a sporadic effect.  
Little data in the literature has been reported on the characterising effects of 
antibody adsorption to electrodes for immunosensor surfaces using atomic force 
microscopy. In the development of an ethanol enzyme based biosensor using 
carbon nanotubes, Tsai et al. (2007) reported that upon immobilising alcohol 
dehydrogenase onto a PVA coated nanotube, the surface roughness increased 
from a root mean square value of 112 nm to 127 nm.  
Vianello et al., (2007) reported the effect of adding horseradish peroxidase to a 
silanised glass surface. The untreated surface had a RMS roughness of 4.2 nm, 
which upon the addition of a monolayer of HRP increased by 1.4 nm to 5.6 nm.  
In an investigation by Parra et al., (2007) cholesterol oxidase was immobilised to 
gold electrodes and the change in RMS was 1.5 nm. 
In this investigation the immobilisation of the antibodies cause a change from 1.27 
nm to 2.37 nm agreeing with the observation of Tsai et al. (2007), Vianello et al., 
(2007) and Parra et al., (2007) that upon the addition of protein to a sensor surface 
the roughness RMS increases. Although for enzymes the increases of 1.4 nm by 
Vianello et al., (2007) and 1.5 nm by Parra et al., (2007) is comparable to the 
observations in this investigation, for an antibody, of 0.84 nm. 
 
Protein adsorption on the carbon screen printed electrodes produced in house 
could not be analysed by atomic force microscopy, since the surface was too rough 
for the instrument so show any variations between the treated and untreated 
surfaces.  
 
By using the same data as shown in Figures 4.13 and 4.14, topographic analysis 
was performed between the two samples. The results are shown in Figures 4.15 
and 4.16. 
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Figure 4.15: The surface topography of the untreated microelectrode analysed by 
atomic force microscopy. 
 
 
 
 
Figure 4.16: The surface topography of the treated working microelectrode.  
 
In a report on the effect of enzyme immobilisation to glass surfaces, Zhang and 
Tan (2001) reported that the peak to valley distance changed with protein 
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concentration on the surface. Using a glass surface the untreated surface 
corresponded to a peak to valley distance of 6 nm. With immobilising the enzyme 
(glutamate dehydrogenase) onto a glutaraldehyde activated surface the peak to 
valley distance grew from 20 nm after 15 minutes incubation to over 200 nm after 
24 hours. With depth of protein came an increase of activity as more and more 
protein became immobilised until aggregation occurred resulting in physical 
blocking of the enzyme and a decrease in activity.  
In a report from Ouerghi et al., (2002) on the immobilisation of antibodies onto a 
mica surface the mean peak to valley height increased by 2.5 nm with the 
immobilisation of the antibodies. In an additional report by Bergkvist et al., (1998) a 
change in the height of 1.98 nm was recorded. In this investigation with the 
presence of antibodies the peak to valley heights on the treated surface is 6.4 nm, 
whereas for the untreated microelectrode the peak to valley heights are 4.2 nm, a 
difference of 2.2 nm and very similar to the observations of Ouerghi et al., (2002) 
and Bergkvist et al., (1998). The theoretical height of an IgG antibody is 4 nm 
(Ouerghi et al., 2002) suggesting that many of the antibodies are bound to the 
surface in a ‘side-on’ orientation rather than bound perfectly by the based of the Fc 
fragment. It is for this reason why a cheaper polyclonal antibody has been 
immobilised onto the surface of the immunosensor rather than the expensive 
monoclonal anti-aflatoxin M1 antibody. 
 
The final atomic force microscopy investigation studied the surface under phase 
control. In Figure 4.17 the graining effect seen using the sFEG was again observed 
but upon the addition of the proteins (Figure 4.18) this effect is completely lost and 
a much more irregular pattern was observed.  
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Figure 4.17: The surface image taken using phase control for the untreated 
working microelectrode inside the element analysed by atomic force microscopy. 
 
 
 
 
Figure 4.18: The surface image taken using phase control for the treated working 
microelectrode inside the element.   
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In conclusion the data from the sFEG was unable to quantitatively determine, if 
there was a difference in the surfaces between the untreated sample and the 
sample with the antibody attached. Using atomic force microscopy, however, 
showed consistent evidence that the surface does change with the addition of the 
proteinacieous component. Both the surface roughness and topography indicated 
quantifiable differences and visual evidence was seen using 3D imaging and phase 
control. This evidence shows that the covalent immobilisation of the antibodies to 
the working microelectrode is successful and agrees with literature reports. 
 
4.3.2 Development of the microelectrode array immunosensor. 
Improved mass transport is the main benefit of microelectrodes compared to planar 
electrodes. This results in faster diffusion of the electrochemical species under 
investigation. For screen printed electrodes planar diffusion perpendicular to the 
microelectrode surface occurs.  For a microelectrode the diffusion is hemispherical 
and large compared to the surface area of the microelectrode. On a surface area to 
surface area ratio, the microelectrode has a much larger catchment of electro-
active particles (Wittkampf et al., 1997).  
When microelectrodes are placed into arrays, the advantages of a single 
microelectrode are kept. The current is increased significantly, so that the same 
diffusional space as a screen printed electrode can be attained at a fraction of the 
surface area, since the active area is the sum of the individual electrodes and the 
intervening insulator (Wightman & Wipf, 1989).  
 
The positioning of the microelectrode arrays is very important, so that the diffusion 
zones of the electrodes do not overlap as shown in Figure 4.19.  
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Figure 4.19: A schematic diagram of the hemispherical diffusion layers originating 
from microelectrode array. a) The electrodes in the array are too close together, 
overlapping and thus shielding causing a lower signal. b) Idealistic spacing of 
microelectrode where the hemispherical diffusion doesn’t not impinge on its 
neighbours. c) Diffusion effect for planar, screen printed electrodes (Davis et al., 
2005; Freire et al., 1999). 
 
In the case of this project the microarrays was designed and optimised by Tyndall 
national institute and detailed by Berduque et al. (2007). Hence the geometric 
format is outside the scope of this thesis.  
 
Using the successful immobilisation protocol several electrodes were prepared for 
aflatoxin M1 measurement. Before a calibration graph could be determined the test 
parameters had to be optimised for the electrochemical microarrays. The reference 
electrode on the microelectrode is made from gold, whereas for the screen printed 
electrodes it is printed using Ag/AgCl ink. Differential pulsed voltammetry was 
employed to find the maximum detection potential of TMB. Figure 4.20 shows the 
voltammogram.  
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Figure 4.20: Differential pulsed voltammetry for 0.5 mM TMB on the 
microelectrode with 10 mM citrate buffer in 0.1 M KCl. The working microelectrode 
was first capped using 1% NH4OH at room temperature for 1 hour before TMB 
addition.  
 
The maximum peak signal occurred at a potential of +168 mV therefore the 
detection of TMB using chronoamperometry was set at +168 mV and a pre-
conditioning potential of +268 mV was applied. Using these parameters a standard 
calibration plot was performed in pure buffer using the existing screen printed 
electrode method without the addition of PVA to block the surface.   
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Figure 4.21: Early development using the microelectrodes in pure buffer.  
 
The data in Figure 4.12 was obtained using chronoamperometry (+0.168 mV) for 
10 minutes. A 96 µg mL-1 of the capture antibody solution was covalently 
immobilised onto the working microelectrode (pH 9.6, 4oC). A 3 µl of 0.1% NH4OH 
in water was added for 60 mins at room temperature to deactivate any unreacted 
PDITC cross linker. Subsequently 1 µl of 40 µg mL-1 anti-aflatoxin M1 antibody was 
placed onto the microelectrode and incubated at 37oC for 2 hours in a Petri dish 
with damp tissue and again washed and dried. To the microelectrode 1 µl of the 
sample or standard + aflatoxin M1 HRP (diluted 1:10 with PBS) was added and 
incubated at 37oC for 120 mins before detection with TMB (0.5 mM) and hydrogen 
peroxide (1 mM) in citrate phosphate buffer pH 5.2 with 0.1 M KCl.   
 
Initial work using same protocol as the carbon based screen printed electrodes 
yielded a good calibration graph with the EU maximum permissible requirements of 
50 ng L-1 clearly detectable. The supplied information with the microelectrodes was 
incorrect with regards to the wiring configuration, therefore when connecting the 
microelectrode interface with the Autolab a low, but reliable signal was recorded. 
Upon configuring the interface correctly significantly higher signals were observed 
(substituting the working electrode connection with the auxiliary electrode 
connection). Due to the limited supply of electrodes available the points are not 
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reproduced. The calibration plot shows that levels below 10 ng L-1 can be detected 
so a further calibration plot using the same method was produced at lower 
concentrations. Figure 4.22 shows the results.  
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Figure 4.22: Investigation into the sensitivity of the microelectrodes for aflatoxin M1 
in pure buffer.  
 
Figure 4.22, does show that the microelectrodes are very sensitive and with further 
optimisation could be used at levels sufficiently lower than the current requirements 
of 50 ng L-1. Analytical sensitivity can be calculated by the amount of aflatoxin M1 
required to reduce the signal by 25%. In this case sensitivity is less than 1 ng L-1. 
 
With the microelectrodes performing well in pure buffer solutions, further 
examination was carried out to assess the performance in a milk matrix.  
Using the same pre-treatment for the milk samples as for the carbon based screen 
printed electrodes (Section 3.2.2) a calibration was performed using spiked milk 
samples, (Figure 4.23).  
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Figure 4.23: The performance of the microelectrode in milk.  
 
Figure 4.23 was obtained using by covalently immobilising 96 µg mL-1 of the 
capture antibody solution onto the working microelectrode (pH 9.6, 4oC). A 3 µl of 
0.1% NH4OH in water was added for 60 mins at room temperature to deactivate 
any unreacted PDITC cross linker. Subsequently 1 µl of 40 µg mL-1 anti-aflatoxin 
M1 antibody was placed onto the microelectrode and incubated at 37oC for 2 hours. 
To the microelectrode 1 µl of the sample or standard + aflatoxin M1 HRP (diluted 
1:10 with PBS) was placed and incubated at 37oC for 120 mins before detection 
with TMB (0.5 mM) and hydrogen peroxide (1 mM) in citrate phosphate buffer, pH 
5.2, with 0.1 M KCl at +168 mV.   
 
Again the maximum permissible requirements are met with the dynamic range 
occurring between 10 and 100 ng L-1 and the analytical sensitivity at 8 ng L-1 
clearly showing that the microelectrodes could be used as a replacement for 
screen printed technology. It should be noted that the microelectrodes were not 
blocked by PVA as with the carbon based screen printed electrodes and neither 
are they fouled by whey proteins as with the carbon based screen printed 
electrodes.  
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Upon observing SEM images of both the carbon SPE and the gold microelectrode 
at similar magnification it can be seen that the carbon surface is vastly rougher and 
therefore has a much larger surface area. This combined with the strong 
absorption of carbon would explain why proteins foul the carbon surface and not 
the gold (Figure 4.24). 
 
 
Figure 4.24: Comparison between the screen printed electrode surface and the 
microelectrode array using SEM.  
 
Figure 4.24A is the surface of the carbon SPE taken using sFEG (x3200) whereas 
Figure 4.24B is the surface of the gold microelectrode taken by sFEG (x3500) as 
described for Figure 4.4B. 
 
Since the gold surface does not require blocking with PVA makes manufacturing 
easier. It removed a 2 hours step and increases the electron transfer between the 
solution and the microelectrode making the sensor more sensitive.  
Compared to the carbon screen printed sensor the signal for the microelectrode 
was over ten times more sensitive. The improvement is partially due to the 
attributes of the microsensor size and dynamics, but also due to the use of gold 
over carbon. The carbon paste used for printing contains organic solvents and 
binding polymers to aid spreading and reproducibility of the printing. This however 
limits conductivity and changes the electrochemical behaviour by covering the 
individual carbon graphite particles. Additionally the bulk resistance for graphite is 
B A 
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7.84 x 10-6 ohms M-1 whereas for gold it is 2.06 x 10-8 ohms M-1 (ASM, 1990). 
These observations help explain why the total resistance for the carbon screen 
printed electrode (from terminal to exposed electrode) is 36.9 KΩ (+/- 7.57 KΩ 
where n=60) and for the gold microelectrode 25.5 Ω (+/- 1.81 Ω where n=4) some 
1000 times lower resistance. With lower resistance for the microelectrode at a fixed 
potential then the current will be greater and thus the sensitivity is improved. 
 
Few microelectrode array immunosensors have been published. In a report by 
Katz and Willner, (1996) for the detection of a dinitrophenyl antibody, detection limit 
was 0.2 mg L-1, although detection limit was calculated by the reduction in the 
current upon the antibody binding with the surface and blocking the surface, i.e. 
acting as an insulator.  
In a more traditional approach and one matching this project, Dill et al., (2004) 
produced an immunosensor for the detection of α1 acid glycoprotein by 
immobilising an anti-α1 acid glycoprotein antibody to a microelectrode surface and 
exposing the antibody against an HRP tagged α1 acid glycoprotein. The mediator 
used was OPD rather than TMB. The reported detection limit for this 
immunosensor is 5 ng L-1 and comparable to the limits observed in this project.  
 
4.4  Conclusions of the microelectrode array sensor.  
Using the successful development of the carbon based screen printed 
immunosensor the chemistry was transferred to the microelectrode array. Using 
atomic force microscopy for confirmation, the immobilisation of the antibody onto 
the gold surface was successful and similar trends as in literature reports were 
observed. However, this investigation was more thorough than any reported 
literature discovered. The antibodies immobilised in a ‘side on’ orientation, which 
reduces the efficiency of the antibody, Therefore the use of a cheaper polyclonal 
capture antibody for surface attachment before attachment of a monoclonal 
antibody was correct. Upon utilising the microelectrode arrays for aflatoxin M1 
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detection significant improvement was shown over the carbon based screen 
printed electrodes. This improvement was primarily attributed to the microelectrode 
dynamics over planar screen printed electrodes, but also the use of gold rather 
than graphite for the construction.  
 
The necessity for blocking the electrode surface to avoid fouling from the whey 
proteins in the milk matrix for the carbon based screen printed electrodes was not 
the required for the gold surface. This was attributed to the micro porous structure 
of the carbon surface and the higher absorption capacity of carbon.  
Few comparable publications for microelectode immunosensors are available. The 
most directly comparable report in terms of method and application is the report 
from Dill et al., (2004), who have produced an immunosensor for α1 acid 
glycoprotein with a detection limit of 5 ng L-1. In the present project the detection 
limit is 8 ng L-1. Improvements have been seen in this project of employing gold 
microelectrodes rather than carbon based screen printed electrodes. For high 
sensitivity applications, such as low detection limits, a boundary has been 
surpassed allowing for development of many new applications which have 
previously only been detected using elaborate instrumentation.    
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CHAPTER 5 
 
DEVELOPMENT OF A SYNTHETIC PEPTIDE RECEPTOR  
FOR AFLATOXIN M1 
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5.1 Introduction. 
Chapters 3 and 4 have described the successful design and optimisation of an 
immunosensor for aflatoxin M1. The aim of the project is to develop a robust sensor 
for the determination of aflatoxin M1 in hot humid environments. The developed 
sensor at its sensing layer utilised antibodies as the receptor, which are fragile 
glycoproteins and prone to losing their binding affinities with incorrect storage. 
Additional disadvantages of antibodies are reported in Section 5.1.1. Therefore to 
develop new sensor strategies the use of synthetic receptors was reviewed with 
focus on synthetic peptides. Chapter 5 details the design, optimisation and testing 
of synthetic peptides which can be implemented in the sensor for aflatoxin M1 
determination.  
 
5.1.1 Advantages of peptides over antibodies.  
Currently produced antibodies are prone to many problems. Variations can occur in 
the quality and concentration of the antibodies in each batch. Antibodies are raised 
in an animal host and require a long production time for the animal immune system 
to raise antibodies to the antigen (for polyclonal antibodies a production time of 6 
weeks is required, for monoclonal antibodies up to 6 months can be required). 
Additionally antibodies have a 3 dimensional proteinaceous structure and therefore 
susceptible to degradation upon storage (Nakamura  et al., 2005; Tothill, et al., 
2003; Tothill et al., 2001). The view of this project was to produce a robust and 
stable sensor, therefore the use of peptides as the sensing element was 
investigated. Peptides are synthesised completely by instrumentation and thus the 
reproducibility will be increased as well as being prepared faster than antibodies. 
Peptides are also more stable than antibodies, and also peptides are more 
beneficial than antibodies since immunity against low molecular weight analytes 
such as the mycotoxin patulin are difficult to produce (Nakamura et al., 2005; 
Morrill et al., 2002; Nakamura et al., 2001).  
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The ability of peptides to act as receptors has been known for some time. Emil 
Fisher at the start of the 20th century noted that peptides had special medicinal 
powers but it was not until 1953 when peptides were synthesised chemically by du 
Vigneaud, for which he received the Noble prize, did they receive further attention 
(Bruckdorfer et al., 2004). 
 
Today peptides are produced in the multi ton scale; for example the 
pharmaceutical product Fuzeon is a 36-mer peptide which is able to block the 
Human Immunodeficiency Virus (HIV) from entering the cells of human blood 
(Cooper and Lange, 2004).  
 
Ligand / receptor binding interactions are a central process to a number of key 
biological processes, for example signal transduction, gene transcription, 
physiological transcription and enzymatic processes (Lybrand, 1995). These 
processes either involve macromolecular to macromolecular binding of proteins to 
proteins or proteins to DNA, or macromolecules to small molecules. Since many 
key biological functions are controlled by the interaction of small molecules with 
macromolecules, a detailed understanding of these interactions can provide 
essential information for the development of therapeutic products and side 
reactions that can occur.   
 
With the challenge to produce anti-HIV drugs much work has been done to develop 
ligand/receptor computational modelling programs which have resulted in many 
successful peptide products for battling HIV. Fuzeon (or Enfurirtide) for example is 
a drug developed by computational method which inhibits the development of the 
HIV virus. Fuzeon is a peptide sequence taken from a glycoprotein, gp41, found on 
the surface of the virus and was extensively developed using computational 
chemistry.  
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5.1.2 Practical methods of peptide design.  
Original methods of synthetic peptide design used geometry and binding prediction 
tables to design a synthetic peptide towards a target. These procedures resulted in 
limited success (Moser et al., 1983; Fukushima et al., 1979; Gutte et al., 1979).   
 
A more successful approach was discovered in 1986 with the introduction of 
combinatorial chemistry (Tozzi et al., 2003a; Geysen et al., 1986). Combinatorial 
chemistry uses a large peptide library to test each peptide receptor against the 
target of choice. Each peptide sequence is constructed on a bead and the target is 
immersed in the cocktail of peptides. 
 
The target is tagged with either a fluorescent marker or an enzyme marker, the 
beads with the target are collected and the sequence is determined using a peptide 
sequencer at a rate of 3 sequences a day (Schmuck and Hell, 2003a; Lam et al., 
1991).  
 
An alternative approach reported by Houghten, (1985) used ‘tea bags’ with each 
bag containing a separate sequence (Nestler, 2000). The ‘tea bags’ method used 
small polypropylene mesh bags filled with Boc amino acid resin. The bags were 
numbered and sealed then peptide synthesis was performed manually creating 
247 different sequences with each bag containing one sequence.  
 
Nakamura et al., (2005) reported that a peptide sequence of more than four 
residues is required for binding with small molecules therefore a pentapeptide or 
hexapeptide should be developed. A full library of pentapeptides using natural 
amino acids consists of 205 peptides or 9 x 1013 different sequences. In reality not 
all 20 natural amino acids are used to build a combinatorial library. Cysteine is 
usually not included to eliminate disulphide crosslinking and the formation of 
dimers (Lam et al., 1991) additionally tryptophan can be omitted (Houghten et al., 
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1991) as well as methionine and lysine (Tozzi et al., 2002) to reduce synthesis 
problems. Therefore combinatorial chemistry can be restricted. 
5.1.3 History of computational ligand / receptor affinity calculation.  
The first computation chemical simulations were performed in 1964 (Rahman, 
1964) with the simulation of the motion of atoms in liquid argon. A year later 
computational quantium models were produced by Moody and Thomas (1965) to 
aid in sensor design with construction of ion selective electrodes. Decades on from 
the advent of computational chemical simulations, simulations were used in more 
complex applications such as ligand/receptor affinity calculations. 
 
Early computational ligand/receptor docking methods such as DOCK (Kuntz, 1992) 
were designed to dock ligands into receptors, however they only considered 
orientational and translational degrees of freedom which do not take into account 
the changes in the ligand conformation during docking (Baxter et al., 2000). More 
recently ligand flexibility has been considered however this increases the number 
of degrees of freedom and hence requires greater computing power, although the 
receptor is still assumed to be ridged (Alberts et al., 2005; Bertelli et al., 2001).  
 
To reduce computational time, further approximations can be made. CHARMm for 
instance (Chemistry at Harvard Macromolecular Mechanics) (Brooks, 1983) 
recognises amino acid groups as a single entity rather than separate atoms and 
therefore speeds up the computational time due to fewer degrees of freedom. The 
drawback of this is the difficulty in predicting hydrogen bonding since the position 
of the hydrogen has a large effect on the hydrogen bond strength (Goodford, 1985; 
Brooks, 1983). Docking methods have been developed for drug screening, so that 
many possible compounds can be screened in a short amount of time, but 
Abagyan and Totov (2001) reported that docking programs only have a 30 – 50% 
success rate, and each molecule takes between one to three minutes. Jackson 
(1995) and Illapakurthy et al. (2003) also reports that scoring functions are poor 
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and variations exist between different programs. Realising that binding prediction is 
the most difficult part of drug design, Wang and Wang (2001) have suggest a 
method of consensus scoring to reduce bias of some binding programs. By using a 
variety of scoring methods and converting the score into a rank, errors within the 
docking program can be removed. A similar approach is now taken by a program 
CScore by Tripos (Michigan, USA). 
With these concerns in mind for the development of peptides for aflatoxin M1 many 
docking programs each with different algorithms shall be employed to remove the 
bias that may occur if only one algorithm is utilised. 
5.2 Materials and methods used to design a synthetic peptide 
receptor for aflatoxin M1. 
5.2.1 Computer Modelling. 
The workstation used for the modelling studies was a Silicon Graphics Octane 
running IRIX 6.6 operating system. The workstation was configured with two 195 
MHz reduced instruction set processors, 712 MB RAM and a 12 GB fixed drive. 
This system was used for the software package SYBYL 6.9.1 Tripos Inc. (St. Louis, 
Michigan, USA). 
 
5.2.2 Obtaining the structure of aflatoxin M1. 
The first part of the work was to determine the structural conformation of the 
aflatoxin M1 molecule. A search was executed in the Protein Data Bank (PDB) for 
structures which contain the aflatoxin M1 molecule. Several structures were found 
which contained the AFB1 -8, 9-exo-epoxide bound to a DNA chain; however none 
contained the aflatoxin M1 molecule.  
 
Since no structure of the aflatoxin M1 molecule was available the structure was 
taken from text (Moreau, 1979) and sketched into the SYBYL package. Aflatoxin 
M1 does not contain any chiral centres. The molecule was then charged by the 
Gasteiger – Huckel method and molecular mechanics was applied to minimise the 
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structure using the Powell method. Figures 5.1A and 5.1B show these settings. 
The minimisation was run for 2000 iterations or until the convergence gradient 
reached 0.001 kcal mol-1 x A. The dielectric constant was changed from 1 to 80, 
thus simulating an aqueous environment. 
 
                             A                                                         B 
Figure 5.1: The settings used for minimisation of aflatoxin M1. The main window is 
shown in A, and B shows the modified energy setting used. 
 
In order to insure the structure obtained was that of the global minimum, simulated 
annealing was performed. The settings used were the default settings. Figure 5.2 
show these settings. After simulated annealing then the minimisation was 
repeated. The resulting structure was saved and used in subsequent experiments. 
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Figure 5.2: The settings used for simulated annealing. The energy setup used the 
same settings as shown in picture 5.1B 
 
5.2.3  Computer aided receptor design. 
Many experiments were performed to optimise the conditions required for a 
successful Leapfrog run. Figures 5.3A and 5.3B show the settings used. The data 
set for the monomers was set to the TRIPOS peptide library and the Leapfrog 
program was always used in the ‘Dream mode’. Only the 20 natural amino acids 
were used as the library of building blocks.  
5. Development of the synthetic peptide receptor. 
 
 163 
 
 
                                         A                                                           B 
Figure 5.3: The tailored parameters used for Leapfrog. (A) shows the individual 
settings for each move type and (B) shows the frequency of these moves.  
 
To tailor Leapfrog for our requirements many parameters were changed. From 
‘Energy Startup’ it was decided to include hydrogen bonding in the calculations and 
to ‘always link’ through active hydrogens. The other parameters changed were 
within the individual move types and relative move frequencies. For every Leapfrog 
run, ‘Bridge’ within the relative move frequencies was kept at zero. 
 
5.2.4 Investigation of 1GVE. 
To analyse natural receptors with the aflatoxins a PDB file (1GVE) of aflatoxin 
aldehyde reductase (AKR7A1) was found on the protein data bank. This was a 
structure determined by X-ray diffraction (Kozma et al., 2002). 
 
The 1GVE PDB file was imported into the SYBYL package, the surface water 
molecules were deleted and the structure was charged with Pullman charges. 
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A SYBYL module called SiteID was used to find the possible binding pockets of the 
enzyme to determine the relevant amino acids binding with the aflatoxin. The 
SiteID program was used with the default settings as shown in Figure 5.4.  
 
Figure 5.4: The default settings used for SiteID to elucidate the residues in the 
AKR7A1 enzyme with binding to aflatoxin M1. 
 
5.2.5 Validation of binding the scores from Leapfrog. 
The results from Leapfrog and SiteID were validated using a docking program 
called Flexidock. Flexidock is unique since the parameters can be changed to 
allow the protein backbone of the receptor to ‘flex’ whereas most docking programs 
assume that the receptor is ridged. Thus by creating a copy of the system version 
of the flexidock.par file to a local location, the file was changed to allow flexing and 
to use a dielectric constant of 80. These changes a
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Figure 5.5: The change in the settings in the flexidock.par file to allow a dielectric 
constant of 80 and flexing of the backbone. 
 
For all the experiments, all rotatable bonds and charges on the molecule were 
selected and the radius around the pocket was defined to 3 Ǻ. 
 
Dynamic runs were performed using the function ‘setup dynamics’. Depending on 
the experiment the lengths of the runs were altered. Initially a box was placed 
around the molecules of interest and the box was partially filled with water 
molecule so that the density was about 0.2 g ml-1. Later, the dynamics run was 
performed without any water molecules however the dielectric constant was set to 
80. This was done to reduce the amount of computer time required. In every 
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experiment the pressure was not set and the temperature was set to 300 K. Figure 
5.6 shows these settings. 
 
                         A                                                          B 
Figure 5.6: The settings used for the dynamics simulations. (A) the initial screen to 
setup the dynamics, modification of the temperature and length of the run is shown 
in (B). 
 
The designed peptides were synthesised, purified by HPLC and checked by mass 
spectroscopy by the Medical Research Council (MRC) clinical science centre 
(London, UK). Quality reports for the synthesised peptides can be found in the 
appendix (Section 8.3). 
 
An experiment was performed to use a LINUX package called GROMACS 
(Groningen Machine for Chemical Simulations) in order to carry out FEP (free 
energy perturbation) calculations. GROMACS is a GPL (General Public License) 
molecular dynamics software which is known for its fast calculation speed 
(www.gromacs.org). The program was installed onto a COMPAC Presario 
Personal Computer with a 1.99GHz Intel Celeron CPU, 192 MB of random access 
memory and 30GB fixed disk. The operating system was SuSe Linux 9.0. 
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GROMACS has no graphical user interface; hence it is entirely controlled from 
command lines. 
 
The approach used was to create a PDB file from the SYBYL package and to 
convert it into a GROMACS file using the GROMACS command  
pdb2gmx –f peptide.pdb –p peptide.top –o peptide.gro 
Then the peptide would be placed into a box and filled with water using the 
following commands; 
Editconf –f peptide –o –d 0.5 
Genbox –cp out –cs –p peptide –o b4em 
The peptide and box of solvent would then be minimised to reduce the strain and 
bad VdW forces caused by the addition of the solvent this was done using the 
following two commands; 
grompp –v –f –em –c b4em –o em –p peptide 
mdrun –v –s em –o –c after_em 
Finally the dynamics could be run by the following commands; 
grompp –v –f full –o full –c after_em –p peptide 
mdrun –v –s full –e full –o full –c after_full –g flog >& full.job & 
The parameter files were all kept to the default setting with the exception of the 
full.mdp where the number of steps and hence the length of the run was extended.  
 
5.2.6 Materials used in the affinity studies. 
For the affinity investigations aflatoxin M1 – BSA, lysine, glutaraldehyde, Tween 20, 
Tween 80, Triton X-100, and CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-2-
hydroxy-1-propanesulfonate) were all obtained from Sigma-Aldrich LTD 
(Gillingham, UK) as well as all general chemicals. Aminopropyltrioxysilane was 
purchased from VWR (Lutterworth, UK). The anti-aflatoxin M1 antibody was 
obtained from Abcam (Cambridge, UK) as well as the secondary alkaline 
phosphatase labelled antibody. BIAcore buffers, reagents and consumables were 
purchased through BIAcore (Uppsala, Sweden). Microwell plates from Nunc were 
ordered through VWR (Lutterworth, UK). BS3 linker compound was purchased from 
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Pierce (UK) as well as TMB ultra substrate / chromatogen solution. Aflatoxin M1 – 
HRP was obtained as part of the aflatoxin M1 Ridascreen Kit. Sodium hypochlorite 
was obtained from Sigma Aldrich LTD (Gillingham, UK). 
 
5.2.7  Monitoring of the affinity of the peptide for aflatoxin M1 using optical 
waveguide lightmode spectroscopy (OWLS). 
For the affinity studies, an IOS-1 optical waveguide lightmode spectrometry was 
used powered by a PSU1-3 (Artificial sensing instruments, Zurich, Switzerland). A 
Gilson minipuls 3 peristaltic pump was used for the fluid handling (Middleton, USA) 
at a flow rate of 10 µl min-1. Tygon tubing with an internal diameter of 0.51 mm 
(Ismatec, Switzerland) was used for the peristaltic pump.  
 
For the data manipulation the room temperature was recorded at the start of each 
run to calculate the binding constants. Standard 2400 waveguides were used 
throughout and obtained from Microvacuum (Budapest, Hungary).  The 
waveguides were silianized by first washing in a beaker of ultrapure water at 90oC 
for 10 minutes, and then the waveguides were placed into 10% 
aminopropyltrioxysilane at 60oC where the pH had been adjusted to 3.5 with HCl. 
The waveguides were kept at 60oC for one hour and then washed with distilled 
water. After washing the waveguides were placed onto aluminium foil and baked in 
an oven at 100oC overnight. Once baked, the waveguides were stored in distilled 
water until protein immobilisation and then stored in PBS at 4oC.  For immobilising 
the aflatoxin M1 - BSA, 2.5 % glutaraldehyde was pumped through the OWLS cell 
for 1.5 hours. After washing with water and then equilibrated with 10 mM PBS, 100 
mg L-1 of aflatoxin M1 - BSA was added to the system for a further 1.5 hours. The 
OWLS cell was then washed with 10 mM PBS (pH 7.4) and any unbound aflatoxin 
M1 - BSA was removed using 0.01 M hydrochloric acid. 
 
To block any un-reacted sites, 10 mM lysine was added to the system in a 
separate operation for 1.5 hours. To confirm the affinity of the anti-aflatoxin M1 
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antibody and to validate the instrument, the anti-aflatoxin M1 antibody (8 µg L-1) 
was allowed to react with the immobilised aflatoxin M1 - BSA until a plateau was 
reached. To regenerate the waveguides initially 0.1 to 0.01 M HCl was used and 
then additionally a mixture of detergents was used containing 0.3% Tween 20, 
Tween 80, Triton X – 100 and CHAPS. For experiments with the peptides, two new 
waveguides were prepared as previously described, with one of the waveguides 
using BSA and not aflatoxin M1 - BSA for immobilisation. The peptide 
concentrations used in the experiments was kept to 100 µl ml-1 throughout.  
 
All glassware and consumables were decontaminated from aflatoxin M1 by soaking 
in 10% sodium hypochlorite for 48 hours and then an equal amount of 5% aqueous 
acetone was added. The mixture was left for three hours and then disposed down 
the drain. 
 
5.2.8  Monitoring of the affinity of the peptide for aflatoxin M1 using BIAcore. 
Throughout the investigation using the BIAcore (Upsala, Sweden) all buffers, 
reagents and consumables were supplied pre-filtered from BIAcore, and all 
chemicals for analysis were degassed prior to use by placing the solutions in a 
reduced atmosphere. For immobilisations the antibodies and peptides were diluted 
in 10 mM acetate buffer (pH 4.5) to a concentration of 10 µg ml-1 as recommended 
in the BIAcore user manual. High versatility CM5 chips were used throughout 
which have an activated carboxyl group attached to the gold surface via a dextran 
substrate. Covalent immobilisation to the carboxyl group occurred through 
EDC/NHS coupling was computer controlled.  
For all experiments the running buffer was HBS-EP (0.01 M HEPES pH 7.4 buffer 
containing 0.15 M NaCl, 3 mM EDTA and 0.005% P20 surfactant) and 10 mM 
glycine in pH 2 HCl was used as a regeneration buffer. A BIAcore 3000TM was 
used throughout in this investigation.  
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5.2.9  Immobilisation of the peptides onto solid supports (ELISA plates) for 
chemical determination of the peptide / aflatoxin M1 complex. 
To immobilise the peptides onto the microwell plates, amine activated microwell 
plates from Nunc were used throughout. The attachment of the peptides to the 
microwell surface was carried out using BS3 linker compound at a concentration of 
10 mM in de-ionised water, and various peptide concentrations from 1 to 0.1  
mg ml-1
 
in immobilisation buffer. The immobilisation buffer was pH 8, 20 mM 
sodium phosphate with 0.15 M sodium chloride. Incubation times for the 
immobilisation were 30 minutes, followed by capping the excess linker compound 
with 1 M TRIS for 15 minutes, to stop aflatoxin M1 – HRP attachment to the un-
reacted BS3 linker compound. For joint immobilisation, the peptide and BS3 were 
added together to react in the same well for 30 minutes. For stepwise 
immobilisation, the BS3 was first reacted with the amine surface of the microwell for 
30 minutes, washed with de-ionised water, tapped onto tissue paper to dry, then 
the peptide was added and incubated for a further 30 minutes before a second 
washing and capping of the excess linker compound. All stages were performed in 
the dark at 21oC.  
 
For the testing of the peptides with aflatoxin M1 – HRP; pH 7.4 PBS-tween 20 
buffer was used as a washing buffer and the conjugate was diluted 1:5 in 10 mM 
PBS, pH 7.4. Once the peptide was immobilised to the microwell surface the 
aflatoxin M1 – HRP conjugate was added and incubated for 2 hours at 37oC. After 
the incubation the wells were washed with PBS-T and PBS then a ready made 
TMB Ultra substrate/chromogen solution (Pierce, Cramlington, UK) was placed into 
the wells and the colour intensity was recorded using a BMG Fluorstar galaxy 
ELISA plate reader (Aylesbury, UK).   
5. Development of the synthetic peptide receptor. 
 
 171 
5.3 Results and Discussions. 
5.3.1 Computational modelling results.  
 
Throughout this thesis the colour scheme used for the screenshots of the computer 
generated diagrams is as shown in Table 5.1. 
 
Table 5.1: The general colour scheme for the figures containing computer 
screenshots.   
 
Colour Atom/Bond 
Light blue (cyan) or white Hydrogen 
Grey Carbon 
Dark blue Nitrogen 
Red Oxygen 
Yellow Sulphur 
 
Initially the conformation of aflatoxin M1 was determined by sketching the molecule 
into the SYBYL package. The molecule was then charged using the Gasteiger-
Hückel method as described by Chianella et al., (2002) and with a combination of 
minimisation using the Powell method and with simulated annealing, the 
conformation of the global minimum was found, and hence the lowest energy state. 
The structure of this is shown in Figure 5.7 
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Figure 5.7: The low energy conformation of aflatoxin M1. 
 
The insertion of the aflatoxin M1 structure into the SYBYL is a key and fundamental 
step. If there is an error in the conformation of the starting structure then all 
subsequent work may also be incorrect.  
 
Typically the structure used for molecular modelling would have been 
experimentally found by NMR or crystal structure studies, however not all 
structures have been experimentally determined.  In this case the aflatoxin M1 
molecule has to be minimised to its lowest steric energy and hence a good 
representation of nature since no molecular modelling structure has previously 
been recorded. For example Figure 5.8 shows a simple energy diagram for ethane. 
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Figure 5.8: A schematic energy diagram for ethane. 
 
As the C-C bond is rotated then the energy of the molecule increases and 
decreases due to steric hindrance of the hydrogens. In the favourable positions the 
graph shows valleys or wells, these valleys are where the molecule is most likely to 
reside. Upon minimising a molecule, the algorithm searches for the valleys by 
moving a bond and recording the new energy value, if it is a decrease in value then 
it keeps moving the bond in that direction. When it gets to a scenario where all 
movements cause an increase in energy, then the algorithm assumes that it has 
found the global minima, i.e. the lowest point on the graph. 
 
On complicated systems there can be many local minima and the algorithm could 
incorrectly presume that the minima found is the global where actually it is only a 
local minima (Goodman, 1998). Simulated annealing is a process which detects 
the global minima and not an incorrectly assumed local minima (Donnelly, 1987). 
Simulated annealing was first reported by Kirkpatrick et al. in 1983 (Kirkpatrick et 
al., 1983). As with the physical meaning of annealing, the molecule is given energy 
through temperature, allowing the molecule to break through any energy valleys. 
Then the amount of energy is slowly removed from the molecule to simulate 
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cooling. Providing the energy is removed at the correct rate then the molecule will 
find the global minima.  
 
Upon comparing the result of the minimisation and simulated annealing, the 
structure of aflatoxin M1 obtained is consistent with the reports from Holtzapple et 
al. (1996) as described in Section 1.7.2. The backbone (rings B, C, D and E) are in 
the same plane and with ring A 102o from the plane.  
5.3.2 The determination of the binding interaction of the amino acids. 
To determine the best amino acids for binding, a program within the SYBYL suite 
called Leapfrog was employed. Leapfrog is a second generation de novo design 
application for the generation of receptor libraries. First generations programs were 
GROW (Moon and Howe, 1991), LUDI (Böhm, 1994). Leapfrog has previously 
been credited with providing structures with correct length, hydrogen bonding 
ability and hydrophobicity (Honma, 2003) whereas LUDI has been criticised for 
placing too much emphasis on van der Waals interactions and too little on 
hydrogen bonding (Fischer et al., 2001).  
 
A run was performed where the leapfrog move frequencies were adjusted so that 
the amino acids did not connect to form peptides (Join = 0, Fuse = 0, Bridge = 0, 
Crossover = 0). Leapfrog detected that the aflatoxin M1 has 36 active sites (see 
Figure 5.9), hence using the library which contains 20 amino acids, there are 720 
different combinations, however the amino acid can have many different 
orientations thus the Leapfrog run was set for 500,000 moves. This correlates to 
two days computer time. The results from this Leapfrog run are shown in Table 5.2. 
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Figure 5.9: The active sites of aflatoxin M1 determined by Leapfrog. 
 
Table 5.2:  Binding interactions of the amino acids with aflatoxin M1 and their 
binding scores. 
 
Amino Acid  Binding 
Score 
(Kcal 
mol-1) 
Amino Acid  Binding 
Score 
(Kcal 
mol-1) 
Isoleucine Ile -31.87 Tyrosine Tyr -17.12 
Cysteine Cys -29.36 Lysine Lys -16.37 
Phenylalanine Phe -29.18 Threonine Thr -13.44 
Valine Val -25.88 Aspartic acid Asp -12.40 
Leucine Leu -21.01 Serine Ser -10.28 
Methionine Met -20.73 Glutamine Gln -9.77 
Alanine Ala -20.71 Asparagine Asn -9.15 
Tryptophan Trp -20.28 Glutamic acid Glu -8.62 
Histidine His -17.41 Arginine Arg -2.26 
 
Only 18 amino acids are shown, glycine and proline did not produce a negative 
binding score, hence this reaction would be exothermic. Kyte and Doolittle (1982) 
5. Development of the synthetic peptide receptor. 
 
 176 
produced values to predict the hydrophobicity of the amino acids. These values are 
shown in Table 5.3. The higher the hydrophobicity value, the greater the 
hydrophobic nature of the amino acid.  
 
Table 5.3: The Hydrophobicity values of the amino acids as calculated by Kyte and 
Doolittle (1982). 
 
Amino Acid Hydrophobicity 
Value 
Amino Acid Hydrophobicity 
Value 
Arginine -4.5 Serine -0.8 
Lysine -3.9 Threonine -0.7 
Aspartic Acid -3.5 Glycine -0.4 
Glutamic Acid -3.5 Alanine 1.8 
Asparagine -3.5 Methionine 1.9 
Glutamine -3.5 Cysteine 2.5 
Histidine -3.2 Phenylalanine 2.8 
Proline -1.6 Leucine 3.8 
Tyrosine -1.3 Valine 4.2 
Tryptophan -0.9 Isoleucine 4.5 
 
When plotting the hydrophobicity value against the Leapfrog scores (Figure 5.10) it 
can be seen that the hydrophobic amino acids have greater binding than the 
hydrophilic acids towards aflatoxin M1. This is due to aflatoxin M1 being mildly 
hydrophobic.  
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Figure 5.10: Comparison of the predicted binding affinity of the amino acid with 
aflatoxin M1 against the hydrophobicity value of the amino acids. 
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5.3.3 Optimisation of Leapfrog. 
The Leapfrog parameters were changed to; join = 6, fuse = 2, bridge = 0, 
complement = 2. Bridge was initially turned on, however the function forms 
arrogates which require a name, and until the name is given the Leapfrog run is 
halted. Since Leapfrog runs were set on average for 999,999 moves (if set for 
1,000,000 then the program never stopped) which takes four days of computer 
time, with the bridge function on, the Leapfrog run took considerable longer. A 
value of 999,999 moves was deemed suitable since the improvement in binding 
score between 10,000 moves and 999,999 moves was considerable in terms of 
both peptide size and binding score as shown in Figures 5.11 and 5.12. 
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Figure 5.11: The evolution of the peptides with regards to size using the Leapfrog 
program.  
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Figure 5.12: The evolution of peptides with respect to binding score. The linear 
trendline clearly shows that the binding score improves with the number of 
iterations.  
 
Figure 5.11 shows that as the number of iterations is increased there is little 
increase in the size of the peptide until 5,000 moves has been performed, then 
between 50,000 moves and 500,000 moves the peptide size is evolves 
dramatically and then the speed of evolution slows down. With respect to the 
binding score with aflatoxin M1, Figure 5.12 shows that the number of moves is 
directly proportional to the binding score and therefore the longest run would yield 
peptides with the best affinity for aflatoxin M1.  
 
Dong et al., (2006) has reported using Leapfrog with the building parameters 
activated to produce de novo designed ligands for the development of PPAR 
(peroxisome proliferator activated receptors) agonists. The development was 
successful with computational predictions from Leapfrog validated with laboratory 
screening. As with the development of receptors against aflatoxin M1, Dong et al., 
(2006) did not use the Bridge command. Leapfrog has also been tested against 
receptor systems such as DHFR/methotrexate, Thermolysin and HIV protease 
(Cramer, 1993) and used extensively for the design of molecular imprinted 
5. Development of the synthetic peptide receptor. 
 
 179 
polymers (MIPS, Section 1.6.2) by Chianella et al., (2002), Piletsky et al., (2001) 
and Subrahmanyam et al., (2001). The ‘bridge’ command is one of Leapfrog’s 12 
commands, which links together two fragments using a monomer. Using the amino 
acid monomer set as the building blocks, the ‘bridged’ monomer will be identical for 
all amino acids and therefore is a nonessential move for building peptides. 
From reviewing the literature for MIP design, the number of Leapfrog moves 
applied varies from 30,000 to 100,000 which Figures 5.11 and 5.12 suggest may 
not be suitable and is not substantiated in the MIPS reports.   
 
A Leapfrog run of 999,999 moves was performed to test the settings. The ten best 
sequences achieved in this investigation against aflatoxin M1 are shown in Table 
5.4. 
Table 5.4: The results from a test of the Leapfrog settings. 
Sequence  Binding score (Kcal mol-1) 
Phe Cys -36.6 
Pro Ser Leu Gly Leu -36.2 
Pro Ser Leu Gly -34.5 
Ser Leu Gly -34.2 
Leu Gly -34.1 
Leu Gly -34.0 
Pro Ser Leu Gly Gly Leu -33.7 
Asp Ala Val -33.5 
Arg Phe -32.6 
Ser Leu -32.6 
 
A further Leapfrog run was performed by taking the ten best peptides from Table 
5.4 and using them as starting ligands, then continuing the development for 
another 500,000 moves.  The results are shown in Table 5.5. 
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Table 5.5:  The results from continuing the first Leapfrog test run. 
Sequence Binding Score (Kcal/mol-1) 
Phe Cys Gly -60.8 
Pro Phe Cys Gly -60.3 
Pro Phe Cys Gly Leu -57.0 
Pro Phe Cys Gly -56.0 
Phe Phe Cys Gly -53.5 
Phe Cys Phe -53.3 
Gly Phe Cys Gly -52.2 
Phe Cys Gly Gly -52.2 
Gly Phe Cys Gly -51.9 
Gly Phe Cys Gly -51.9 
 
The structure of the best sequence, Phe Cys Gly, is shown in Figure 5.13. 
Schneider and Böhm (2002) and Bohacek and McMartin (1997) both commented 
that do novo design programs can produce results which are difficult to synthesise. 
It can be seen in Figure 5.13 that the peptide backbone is incorrectly formed, as a 
result both ends of the peptide have an amino terminal.  
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Figure 5.13: The structure of the best peptide sequence from Table 5.5 interacting 
with aflatoxin M1. The Phe Cys Gly peptide is shown in ‘stick’ view with aflatoxin M1 
in ‘line’ view.   
 
To stop Leapfrog from producing ligands with an incorrect backbone, a further 
restriction was activated. Leapfrog was setup to link through ‘active hydrogens’ 
only. By changing this function then the correct peptides were formed, however 
when taking the peptides from one run and continuing their development then the 
imported peptides would again cause incorrect backbones. To rectify this problem, 
the imported peptides had to be individually checked and the correct sites for 
amino acid addition selected.  
 
Upon fault finding for incorrect peptides, it was discovered that larger peptides 
could be formed if the individual move type setting were changed. By changing the 
Weed value from 10 to 50, then a minimum of 50 ligands would be in process at 
any one time, thus existing peptides would be extended rather than new peptides 
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started from one amino acid monomer. This increased the computational time and 
the number of ligands being saved to the results database. To reduce 
computational time, the Save values were changed since accessing the results 
database during the run was taking considerable time. By changing the minimum 
number of atoms required to save to 40 and a minimum binding score to -25 Kcal 
mol-1 then small undesirable peptides were not saved. 
5.3.4 Generation of peptides using Leapfrog. 
With all the parameters optimised and faults rectified then a new run was started 
(LFPOUT20). Again this was done for 999,999 moves, the ten best results were 
taken and processed for a further 999,999 moves. The results of this run are 
shown in Figure 5.14. 
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Figure 5.14: The Leapfrog output for run LPFOUT 20 with the sequences listed 
using SLN (sybyl line notation, Ash et al., 1997) and alongside in three letter code. 
 
Further runs were done for a total of 700,000 moves (LFPOUT35) and 1,300,000 
(2 x 700,000) moves (LFPOUT36) the data for these runs are shown in Tables 5.6 
and 5.7. 
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Table 5.6: The results from LFPOUT35. 
Sequence Binding Score (Kcal mol-1) 
Pro Val Gly Pro Asn -36.0 
Pro Val Gly Pro Asp -35.3 
Pro Val Gly Pro -35.3 
Pro Val Cys -35.0 
Leu Met Cys Pro -33.2 
Pro Val Ile -32.9 
Pro Val Pro -31.8 
Pro Val Gly Gly -31.3 
Pro Val Gly Ala -31.3 
Pro Val Gly Phe -30.6 
 
Table 5.7: The results from LFPOUT36. 
Sequence Binding Score (Kcal mol-1) 
Pro Val Cys -38.5 
Pro Val Gly Pro Asp -38.4 
Pro Met Cys Pro -37.5 
Pro Val Gly Pro Asn Gly -36.8 
Pro Val Cys Pro -36.3 
Pro Val Gly Pro Asn Ala -36.2 
Pro Val Gly Pro -35.3 
Gly Met Cys Pro -35.1 
Pro Val Ile -35.0 
Pro Val Gly Pro Asn Pro -34.0 
 
LFPOUT36 was continued for a further 500,000 moves but no improvement in the 
results were seen.  
To check the scoring by Leapfrog, Flexidock was used. From the three Leapfrog 
runs (LFPOUT 20, 35, 36) the best binding score was seen by the peptide “Ile Cys 
Ser”. A calculation of the scoring by Leapfrog takes seconds, for Flexidock the 
calculation takes about 20 minutes, hence it can be assumed that there is greater 
accuracy in the Flexidock scores due to the increase in the number of calculations 
performed.  
5.3.5 Validation of peptides using Flexidock. 
Flexidock, part of the SYBYL program suite, is one of two docking programs from 
Tripos. Its unique ‘flexing’ of the receptors backbone allows for accurate 
5. Development of the synthetic peptide receptor. 
 
 185 
predictions in peptide binding. Original docking programs, such as DOCK (Kuntz, 
1992) calculated the binding interaction by placing many copies of the ligand into 
the receptor pocket simultaneously with different orientations and positions and 
then using energy minimisation algorithms, binding affinities were predicted. The 
backbone of the ligand and proteins were not flexed to reduce the number of 
degrees of freedom and therefore reduced computational time. The method was 
still computationally laborious and prone to providing false positives if the starting 
structures are not the same as the ideal structure (Lybrand, 1995).  
 
Flexidock is a combination of two algorithms, a genetic algorithm for changing the 
structure of the ligand and the binding site as well as an energy evaluation 
function. As with Leapfrog, the computational time is reduced since an intelligent 
optimisation process is applied. A starting structure is placed into the pocket and a 
change in the ligand is made. If the daughter structure is more preferential than the 
parent then the daughter structure is kept and a second evolution step is 
performed. If the parent structure is more preferential then the daughter is 
destroyed and a new daughter structure is made from the parent. As part of the 
genetic approach the backbone is allowed to flex and therefore simulates the 
binding of peptides to targets more accurately than traditional docking programs. 
Previously, Flexidock has been used successfully by Illapakurthy et al., (2003) and 
Bertelli et al., (2001) for docking ligands into cyclodextrins and 6-phosphogluconate 
dehydrogenase respectively.   
 
Flexidock’s binding predictions were first evaluated using the results from Tozzi et 
al. (2003b). Tozzi et al. reported that “Leu Leu Ala Arg” has good binding towards 
aflatoxin B1 whereas “Leu Leu Ala Ser” had poor affinity. Flexidock was used to 
dock these two peptides to the aflatoxin B1 molecule and it was determined that 
“Leu Leu Ala Arg” gave a result of -52.41 Kcal mol-1 whereas “Leu Leu Ala Ser” 
gave a result of only -9.15 Kcal mol-1 which confirmed the results achieved by 
Tozzi et al, (2003b) and increased the confidence in the Flexidock program. 
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The top ten sequences from LFPOUT20, LFPOUT35 and LFPOUT36 were 
recreated with a straight backbone and docked in triplicate with the aflatoxin M1 
molecule using the Flexidock program.  Table 5.8 shows these results. 
 
Table 5.8: Results from Flexidock validation of Leapfrog scores. 
 
Sequence First score 
(Kcal mol-1) 
and Rank 
Second score 
(Kcal mol-1) and 
Rank 
Third score 
(Kcal mol-1) 
and Rank 
Ile Cys Ser -22.75 (29) -22.73 (30) -22.80 (30) 
Ile Cys Pro -26.41 (20) -26.58 (19) -26.21 (21) 
Ile Cys -26.26 (21) -26.33 (20) -25.92 (24) 
Ile Cys Ile Cys -29.43 (7) -30.05 (8) -29.70 (8) 
Ile Cys Ile Ala -28.02 (14) -28.03 (16) -28.03 (14) 
Ile Cys Phe -26.15 (22) -26.16 (22) -26.14 (22) 
Ile Cys Ile -28.81 (12) -27.24 (18) -28.79 (11) 
Ile Cys Ala -22.46 (30) -23.93 (29) -22.83 (29) 
Ile Cys Cys -24.44 (26) -25.41 (24) -25.07 (27) 
Ile Cys Val  -23.30 (28) -25.43 (23) -27.28 (16) 
Pro Val Gly Pro Asn -31.00 (2) -30.91 (5) -31.18 (5) 
Pro Val Gly Pro Asp -29.88 (6) -30.55 (6) -28.81 (10) 
Pro Val Gly Pro -29.24 (8) -28.55 (13) -29.02 (9) 
Pro Val Cys -23.74 (26) -24.83 (27) -23.97 (28) 
Leu Met Cys Pro -30.74 (4) -34.02 (2) -31.86 (3) 
Pro Val Ile -27.12 (18) -28.09 (15) -25.16 (26) 
Pro Val Pro -27.61 (15) -25.38 (25)  -26.57 (19) 
Pro Val Gly Gly -25.84 (23) -23.94 (28) -25.94 (23) 
Pro Val Gly Ala -26.44 (19) -26.24 (21) -27.08 (18) 
Pro Val Gly Phe -27.56 (16) -28.22 (14) -31.32 (4) 
Pro Val Cys -24.72 (25) -25.15 (26) -25.57 (25) 
Pro Val Gly Pro Asp -30.93 (3) -30.92 (4) -30.30 (6) 
Pro Met Cys Pro -30.71 (5) -30.48 (7) -30.01 (7) 
Pro Val Gly Asn Gly -28.66 (13) -28.73 (12) -28.30 (13) 
Pro Val Cys Pro -25.19 (24) -28.85 (11) -27.79 (15) 
Pro Val Gly Pro Asn Ala -29.04 (10) -32.93 (3) -34.24 (1) 
Pro Val Gly Pro -29.08 (9) -29.48 (9) -28.56 (12) 
Pro Val Ile -29.00 (11) -27.55 (17) -26.44 (20) 
Gly Met Cys Pro -27.22 (17) -29.11 (10) -27.23 (17) 
Pro Val Gly Pro Asn Pro -39.24 (1) -34.70 (1) -33.86 (2) 
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By counting the rankings (as shown in brackets), the top three sequences are Pro 
Val Gly Pro Asn Pro, Leu Met Cys Pro and Pro Val Gly Pro Asn Ala.  
5.3.6 Optimisation of peptides for solubility and immobilisation. 
With the best three peptides determined the practical aspects of solubility and 
immobilisation were considered. 
The original strategy for analysing the binding of the peptide to the aflatoxin was to 
use a BIAcore instrument. The peptides would be immobilised to the gold coated 
BIAcore detector chip through a gold-cysteine interaction. This interaction would 
also be used when the peptide was transferred to a gold electrode surface as 
described by Katayama et al., (2000). Furthermore to move the active peptide 
region into the solution and reduce steric hindrance and improved binding 
capabilities (Tozzi et al., 2003b), two glycienes acting as a spacer arm were 
attached to the peptide along with the cysteine to make a distance of 8 atoms. 
Tozzi et al., (2002) suggests that an arm length of at least 4 atoms is required to 
remove steric hindrance. 
 
Using the hydrophobicity data from Kyte and Doolitle (1982) the hydrophobicity 
prediction for these peptides are; 
(1) Pro Val Gly Pro Asn Pro = -4.5 (hydrophilic) 
(2) Leu Met Cys Pro = 6.6 (hydrophobic) 
(3) Pro Val Gly Pro Asn Ala = -1.1 (mildly hydrophilic) 
With consideration of synthesis and stability, peptide (2) is hydrophobic which will 
cause problems when using the peptide and methionine could become oxidised 
therefore further investigation was inappropriate.  
 
To immobilise the peptides using two glycines and a cysteine, if the peptide has 
two cysteines then cross-linked disulphide aggregates occur. Grant, (2002) 
recommends replacing cysteine with serine to remove this problem; additionally it 
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is recommended that methionine is replaced by norleucine to increase stability, 
however, the tetrapeptide has now been changed significantly. 
 
Peptide number (3) is hydrophilic however by adding two glycines and a cysteine,  
it becomes hydrophobic.  Peptide (1) is hydrophilic and upon adding two glycines 
and a cysteine then it is still hydrophilic.  
 
In order to compare the results of the simulation with practical values obtained it 
was decided to synthesise the peptide sequence given by the paper published by 
Tozzi et al., (2003b) of Leu Leu Ala Arg. 
 
To add the spacer arm to the peptide sequence the optimal attachment was 
determined using detailed molecular dynamics.   
 
Molecular dynamics is based on the calculation of Newton’s equations of motion 
for molecular systems in which the trajectory (as a function of time) of all atoms in 
the system is determined and therefore the total energy of a molecular system (van 
Gunsteren and Berendsen, 1990). Molecular dynamics is suitable for molecules 
less than 100 atoms (Gunsteren and Berendsen, 1990). Both peptides are less 
than 100 atoms.  
 
Molecular mechanics was employed in a fashion similar to the thermodynamic 
cycle. First a dynamics run was performed with Cys Gly Gly Arg Ala Leu Leu and 
the aflatoxin M1. Then the run was performed again without the aflatoxin M1, and 
finally with the aflatoxin M1 and not the peptide. This will give an approximation of 
the binding energy but will not consider the change in entropy, however it does 
allow for full flexibility of the ligand and receptor. The values of total energy (the 
addition of kinetic and potential energy) were calculated by Equation 5.1. 
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Change in Energy = (Energy Reactant A + Energy Reactant B) – Energy of 
Product AB  Equation 5.1. 
 
This calculation is similar to that described by Moon and Howe (1991). In the 
previous section it was discussed that Flexidock is superior to the docking 
calculations done by Leapfrog. The molecular dynamics performed each took 
about 2 hours. This results in a greater accuracy in the calculation and a more 
reliable result. Using the different techniques of Leapfrog, Flexidock and molecular 
dynamics should remove bias which maybe observed if only one technique would 
be performed. Although molecular dynamics is the most detailed method 
performed, it is impractical to use it throughout since the number of docking 
calculations performed, to eliminate the early contenders, would have taken 
considerable time.  
 
For the dynamic runs the pressure was kept constant, allowing the temperature to 
rise and fall. For the lone peptide or aflatoxin M1, 10000 moves were performed but 
for the aflatoxin M1 with the peptide 100000 moves were set. After each run the 
data files containing total energy and time were analysed to check that the system 
had equilibrated and hence the run was significantly long enough.  
 
Table 5.9 shows the results for the peptide Leu Leu Ala Arg with different modes of 
addition for the two glycines and cysteine. 
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Table 5.9: The results of the dynamic runs for the optimisation of the attachment of 
the spacer arm to LLAR. 
Sample 
Potential 
Energy 
(Kcal mol-1) 
Kinetic 
Energy  
(Kcal mol-1) 
Total Energy 
(Kcal mol-1) 
AFM1 (aflatoxin M1) 57.50 29.76 87.25 
LLARGGC + AFM1 145.54 118.41 263.95 
CGGRALL + AFM1 147.03 118.57 265.60 
CGGLLAR + AFM1 141.94 118.54 260.47 
LLARGGC - AFM1 102.31 88.01 190.32 
CGGRALL - AFM1 103.23 88.57 191.80 
CGGLLAR - AFM1 98.76 86.07 184.82 
 
By incorporating Equation 5.1 yields Table 5.10. 
 
Table 5.10: The change in energy for the optimisation of the attachment of the 
spacer arm for LLAR. 
Peptide 
 
Potential 
Energy 
(Kcal mol-1) 
Kinetic 
Energy 
(Kcal/mol-1) 
Total Energy 
(Kcal/mol-1) 
CGGRALL -13.699 0.24 -13.45 
CGGLLAR -14.318 2.714 -11.604 
LLARGGC -14.27 0.64 -13.62 
 
Table 5.10 shows there is little variation in the energy between the three 
sequences. The sequence RALLGGC was not calculated since the synthesis of 
peptides with arginine on the amino terminal is difficult (Grant, 2002).  
 
From the data it was concluded that LLARGGC would be the best peptide due to 
the lowest total energy. Furthermore having the arginine in the middle of the 
sequence should increase the solubility (Grant, 2000). This energy calculation 
through molecular dynamics process was repeated for the peptide PVGPNP. 
Through solubility concerns, a Flexidock run was performed with the asparagine 
replaced by arginine. The Flexidock result for PVGPNP was -29.91 Kcal mol-1 and 
for PVGPRP it was -32.61 kcal mol-1. This change results in a change on the 
hydrophobicity of -1 or an improvement of 20%. 
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The change in energy calculated by dynamics for this change in the sequence is 
shown in Table 5.11. 
 
Table 5.11: Comparison between the changes in energy resulting in the 
substitution of one amino acid.  
Sample Potential 
Energy  
(Kcal mol-1) 
Kinetic 
Energy 
(Kcal mol-1) 
Total Energy 
(Kcal mol-1) 
PVGPRP + AFM1 140.03 99.22 240.05 
PVGPNP + AFM1 142.53 102.74 245.28 
 
The data from Table 5.11 is in correlation with the Flexidock scores showing 
PVGPRP is slightly preferential over PVGPNP.  
Using the same procedure as the investigation on the placement of the spacer arm 
as used with LLAR the optimisation of the spacer attachment was performed again 
for PVGPRP. The results are shown in Table 5.12 and Table 5.13.  
 
Table 5.12: The results of the dynamic runs for the optimisation of the attachment 
of the spacer arm to PVGPRP. 
 
Sample Potential 
Energy  
(Kcal mol -1) 
Kinetic 
Energy  
(Kcal mol-1) 
Total Energy 
(Kcal mol-1) 
AFM1 57.50 29.76 87.25 
CGGPVGPRP +AFM1 175.56 133.45 309.01 
PVGPRPCCG +AFM1 173.98 133.30 307.27 
CGGPVGPRP – AFM1 137.20 104.23 241.43 
PVGPRPCCG – AFM1 137.02 101.19 238.20 
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Table 5.13: The change in energy for the optimisation of the attachment of the 
spacer arm for PVGPRP. 
Sample Potential 
Energy 
(Kcal mol-1) 
Kinetic 
Energy 
(Kcal mol-1) 
Total Energy 
(Kcal mol-1) 
CGGPVGPRP -19.14 -0.54 -19.67 
PVGPRPGGC  -20.54 2.35 -18.18 
 
So from the data in Table 5.13, CGGPVGPRP was synthesised since the total 
energy is more negative and therefore more preferential than PVGPRPGGC. 
Having a proline on the carbon terminal can result in diketopiperazine formation 
during peptide chain elongation, hence the final product may contain a truncated 
sequence minus the proline. This can delay the synthesis (Patel, 2004). An 
interesting observation is that the total energy change for CGGPVGPRP (-19.67 
Kcal mol-1) is more endothermic than the total energy change for LLARGGC (-
13.62 Kcal mol-1) suggesting that the computationally derived receptor should have 
superior binding to the reported peptide. Figure 5.15 shows the final peptide 
sequence binding with aflatoxin M1. 
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Figure 5.15: The de novo designed synthetic peptide receptor binding with 
aflatoxin M1. The peptide receptor (CGGPVGPRP) is shown in spacefill view and 
the aflatoxin M1 in stick view.   
 
5.3.7 Studying natural receptors for aflatoxins. 
To aid the design of the peptides, it was chosen to study natural receptors. Within 
the Protein Databank a structure of an enzyme was found for aflatoxin B1 aldehyde 
reductase (AKR7A1). Figure 5.16 shows the structure of the enzyme and Figure 
5.17 shows the reaction of the enzyme. From the reported literature the enzyme is 
found to have affinity for aflatoxin B1 aldehyde and aflatoxin B1. Since the structure 
of aflatoxin B1 and M1 is similar the enzyme was analysed using the SYBYL 
software for the amino acids which interact with the aflatoxin M1. 
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The protein databank file was imported into the SYBYL suite and the water 
molecules were deleted. Then the program SiteID was employed to find possible 
binding pockets within the enzyme.  
 
Figure 5.16: Structure of AKR7A1 (1GVE) as taken from the protein databank. 
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Figure 5.17: The substrate aflatoxin B1 dialdehyde and the enzyme product 
dihydroxy aflatoxin B1. 
 
The results of the search is shown in Figure 5.18, the peptide chain is shown as a 
ribbon and the sphere indicate the voids in the enzyme and hence the potential 
binding sites.  
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Figure 5.18: The results from SiteID showing the voids in the enzyme and thus 
possible binding sites. 
 
The site corresponding to the white spheres correlates with the location identified 
with the published reports (Kozma et al., 2002). Figure 5.19 shows in detail this 
area. The amino acids labelled are predicted to be involved in the binding. 
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Figure 5.19: The binding site of aflatoxin B1 aldehyde reductase. 
 
The literature from Kozma et al. (2002) stated that the active amino acids were; 
Asp40, Lys 73, Tyr 45, His 109, Arg 17, Arg 231, Arg 327, met 13, Leu 227, Tyr 
228 and Phe 224. The SiteID program predicted the relevant amino acids were; 
Arg 18, Glu 14, Met 13, Gly 11, Lys 73, His 109, Ser 139, Phe 193, Gly 284, Met 
285, Asn 294, Pro 195, Val 264, Leu 196, Gly 198, Arg 218, Gly 199, Arg 204. 
The only Met 13, Lys 73 and His 109 are in both sets.  
 
The amino acids identified by either the literature or the SiteID program were 
extracted and Flexidock was used to validate the amino acids and also to remove 
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any amino acids not contributing to the binding. The results from Flexidock showed 
that the following fragments were relevant;  
 
Arg 17, Arg 18. 
Phe 193, Asn194, Pro 195, Leu 196, Ala 197 
Gly 199 
Arg 204 
Val 9, Leu 10 
Thr 202 
 
These fragments were then taken and placed into a molecular dynamics box with 
the aflatoxin M1 and the box was filled with 0.223 g ml-1 of water. The dynamics run 
was for set 100,000 fs. Upon replaying the trajectory only Val 9, Leu 10 was the 
only fragments which interacted with the aflatoxin M1 molecule, presumably since 
both have hydrophobic properties. Figure 5.20 shows the positions of the 
fragments at the end of the run.  
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Figure 5.20: The final snapshot of the dynamics run for the interaction of 
fragments from 1GVE with the aflatoxin M1, in the presence of water molecules.  
 
This experiment gave no extra information to aid peptide design and therefore this 
approach was not followed further in this study. 
 
5.3.8 Evaluation of the GROMACS software. 
 
Democritus and Lucretius in 55 BC first suggested the idea of small hard atoms 
however it was van der Waals who using the Joule-Thompson effect showed that 
there are attractive forces between atoms (Goodford, 1985). The underlying term 
calculated in molecular modelling is energy. The total energy of the molecules is 
the sum of the potential and kinetic energy. An analogy used to describe molecules 
is the ‘ball and spring’ model. If the ball is pulled from a stationary position, the 
system is high in potential energy and low in kinetic energy, then when the ball 
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released then the ball will have high momentum and hence high kinetic energy and 
low potential energy, however in both scenarios the total energy is the same.  This 
total energy is termed the ‘internal energy’ (∆U) and is related to enthalpy (∆H) by 
Equation 5.2 where P equals pressure and V for volume. 
 
∆H = ∆U + P ∆V  Equation 5.2 
 
Molecular mechanics cannot calculate exactly the internal energy of a molecule, 
but it makes an approximation by adding up all the internal forces within a molecule 
such as van de Waals and columbic interactions. This term is called EMM and often 
referred to as the ‘Steric energy’ and is calculated by Equation 5.3 where Ebonds is 
the energy due to bond stretching, Eangles is the energy due to bond bending, Evdw 
is the energy due to van der Waals interactions between atoms, Etorsion is the 
energy due to bond rotation, Echarge is the energy due to the interaction of atoms 
with varying charge and Emiscellaneous is the energy due to additive effects such as if 
a bond is stretched then it maybe easier to bend the bond. A comprehensive 
account of these terms is given by Goodman, (1998). 
 
EMM = Ebonds + Eangles + Evdw + Etorsion +Echarge + Emiscellaneous   Equation 5.3 
 
Within a mechanics model there is no external pressure (P = 0) thus from equation 
5.1 ∆H ≈ ∆U ≈ ∆EMM (Goodman, 1998). 
 
If an external source of energy is applied to the molecule in the form of heat then 
we would expect the conformation of the molecule to change, however the total 
energy of the molecule does not change. The change is due to entropy.  
Entropy is a measure of disorder, the higher the disorder of a molecule then the 
higher the entropy. It is a very difficult term to calculate through molecular 
dynamics however it allows us to calculate a very important value, ∆G. 
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∆G is the Gibbs free energy and it allows us to tell if a reaction is favourable, it is 
calculated by equation 5.4. 
 
∆G = ∆H –T∆S or ∆G = ∆EMM – T∆S  Equation 5.4 
 
Where ∆H is the change in enthalpy, ∆S is the change in entropy and T is the 
temperature measured in Kelvin. If the change in entropy is small then it can be 
assumed that ∆G ≈ ∆EMM. 
 
∆G is it advantageous to know since it is related to the dissociation constant as 
shown in Equation 5.5. 
 
-∆G = RT ln Kd  Equation 5.5 
 
Where R is the gas constant (8.314 JK-1mol-1), T is the temperature in Kelvin and 
Kd = [Concentration of A]/[Concentration of B]. 
 
Considering the reaction, A  B, if ∆G is positive (surplus energy) then there 
would be more of B than A hence the reaction is favourable. Using ∆G, it would be 
possible to predict the affinity of a receptor for a ligand (Honma, 2003). As 
previously stated entropy is not an easy value to calculate, hence other methods 
for obtaining the free energy have been reported. The most common method is 
called free energy perturbations (FEP) (Reddy and Erion, 2001). If there are two 
ligands L1 and L2 and one protein (P), the binding ratios for L1 and L2 for the protein 
can be calculated. By performing a run where L1 is bound to the protein and during 
the dynamics run it is mutated from L1 into L2, this gives a value of ∆GPL. This is an 
example of alchemy and not physically possible, however it can be performed in 
computational space. By setting up a second dynamics run with L1 in solution at 
the start and then mutate the ligand into L2, this gives a value of ∆GL.  Figure 5.21 
shows a thermodynamic cycle for this reaction.  
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Figure 5.21: A thermodynamic cycle for a free energy perturbation calculation. 
 
Since it is a cycle, the sum of all the ∆G values will equal zero (Equation 5.6) 
therefore  
 
∆G1 – ∆G2 = ∆GL – ∆GPL  Equation 5.6 
 
From the dynamics run values for ∆GPL and ∆GL are known, thus a value for  
∆G1- ∆G2 can be obtained as shown in Equation 5.7. 
 
∆G1 – ∆G2 = RT ln (K1 / K2)  Equation 5.7 
 
Therefore the dissociation constant is determined and a ratio how favourable the 
protein is for ligand one compared to ligand two. 
This has a drawback since it is only a relative value for the binding of one ligand 
compared to another.  
 
A different technique can be performed where L1 is mutated into dummy atoms. 
These are atoms which have no charge or VdW forces, in other words the ligand 
disappears. This would give a value of the binding constant; however this has had 
limited success at accurate prediction and depends on the speed and length of the 
dynamics run (Donnini and Juffer, 2003; Honma, 2003; Goodman, 1998; Pearlman 
and Rao, 1998).  
 
FEP is slow and computer intensive, for faster predictions, docking methods can 
be used but at the expense of accuracy (Honma 2003, Josephy-McCarthy, 1999).   
P + L1         PL1 
P + L2         PL2 
-∆GL +∆GPL 
+∆G1 
- ∆G2 
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From the literature there is a strong argument stating that the prediction of binding 
scores is unreliable and by using molecular dynamics to determine ∆G provides a 
more robust prediction. The software package GROMACS was evaluated since it 
boasts being the fastest dynamics package available, thus able to calculate the 
interaction of water molecule with the aflatoxin M1 and peptide but at a density of at 
1 g ml-1, allowing a good approximation of ∆G. 
 
The package was installed onto a Laptop personal computer with an Intel 
processor since the software had been tailored for such an environment. The 
procedure described in the literature utilising the thermodynamic cycle requires 
atoms to change charge or weight. This function is not available in the SYBYL 
package. The best peptides from the Leapfrog runs were saved using the SYBYL 
package as a PDB file and then converted using the gromacs software into a GMX 
file. Unfortunately the encoding of the Leapfrog results into PDB files by SYBYL 
produced incompatible PDB files.  An example of the errors caused is the amino 
acid isoleucine was encoded as ISO and not ILE. This could be adjusted manually 
and the error has been reported to the software manufactures. Additionally for 
GROMACS to run as fast as possible, only the essential hydrogen atoms of the 
amino acids were present, non essential hydrogen atoms were deleted. This might 
be appropriate if a large protein was being studied however the removal of several 
hydrogen atoms on a small peptide may have a significant effect on the binding 
prediction. 
 
A further problem, and the greatest, was importing the aflatoxin M1 molecule into 
the gromacs program. PDB files are generally used for describing proteins and 
some common cofactors such as NADH. To import aflatoxin M1 a PDB file had to 
be created and modified. Within the GROMACS program is a database of angles, 
charges and weights for typical atoms and bonds found in proteins and common 
cofactors, these are used to create a GMX file from a PDB file. The structure of 
aflatoxin M1 contains several contradictions according to the database. Ring A for 
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example as shown in Figure 5.22, contains a five membered ring, however it is a 
heterocyclic ring with an oxygen present (furan) and it contains one double bond. 
Hence this ring could classify as three different structure types. Thus when the 
aflatoxin M1 molecule was finally accepted by the GROMACS program the 
structure of the aflatoxin M1 was different to that determined from the minimisation 
results from SYBYL as shown in Figure 5.23. Rings D and E are not in the same 
plane as rings B and C, furthermore ring A is twisted, as would be seen in aflatoxin 
M2. 
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Figure 5.22: The complexity of ring A. 
 
 
Figure 5.23: The GROMACS version of aflatoxin M1 with a twisted backbone.  
 
In conclusion the investigation suggests that the GROMACS software was not 
suitable for the calculation of ∆G since the software is developed for biological 
applications such as drug discovery and is unsuitable for chemical structures such 
as aflatoxin M1. More time would be needed to investigate fully the conversion of 
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structures other than proteins or common co-factors from PDF file format into GMX 
file format. 
 
In conclusions to the molecular modelling, the peptides LLARGGC and 
CGGPVGPRP have been deemed as suitable receptors by the computer modelling 
and the peptide sequences were sent to the Medical Research Council (London, 
UK) for synthesis.  
5.3.9 Affinity studies using the OWLS instrumentation.  
OWLS or optical waveguide lightmode spectroscopy is a label free method for 
monitoring ligand receptor reactions. The method uses a He-Ne laser to produce 
an evanescent field by utilising a planar waveguide. The waveguide has a 
diffraction grating cut into the surface to project the evanescent field into the 
solution. At a particular angle of incident the laser would be coupled into the 
waveguide and detected at the end. The angle of coupling is dependant on the 
refractive index of the solution and surface mass on the waveguide. By recording 
the intensity of the light at the end of the waveguide against the angle of incident 
(α) then minute changes in the mass on the surface can be detected (~1 ng cm2). 
The OWLS system can be coupled to a liquid flow cell for detecting antibody and 
peptide ligand reactions. Figure 5.24 shows a schematic diagram of the OWLS 
system.  
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Figure 5.24: A schematic diagram of the OWLS system. Left) The whole 
waveguide and liquid cell is rotated back and forth by 2α, at a particular angle on 
incident (α) the He-Ne laser will be coupled into the waveguide and detected at the 
detectors. The angle α is dependant on the refractive index of the solution and the 
surface mass. Right) The aflatoxin M1 – BSA is covalently immobilised onto the 
surface and either antibody or peptide is flowed through the system during 
operation.  
 
To monitor the interaction of the peptides with aflatoxin M1, the aflatoxin M1 
conjugate used in the ELISA (BSA - aflatoxin M1) was immobilised onto the glass 
surface of the waveguide. The waveguide was silanised using 3-
aminopropyltrioxysilane as described by Trummer et al., (2001) in Section 5.2.7. 
Following silanisation, whilst monitoring using the OWLS instrument, the aflatoxin 
M1 – BSA was attached. Figure 5.25 shows the sensorgram of this immobilization.  
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Figure 5.25: The printout of the immobilization of aflatoxin M1 – BSA onto the 
silanised surface using optical waveguide lightmode spectroscopy.  
 
In Figure 5.24 initially ultrapure water was pumped through the system (1), and 
then (2) 2.5 % glutaraldehyde was allowed to react to the surface amino groups of 
the aminopropyltrioxysilane, the system was purged with water (3) and equilibrated 
with PBS buffer (4). Once the signal has stabilized (5), 100 mg L-1 BSA - aflatoxin 
M1 was added over the waveguide and allowed to react with the immobilised 
glutaraldehyde for 1.5 hours.  10 mM PBS (pH 7.4) was then used to remove any 
unbound BSA – aflatoxin M1 (6) (a small decrease in the signal was observed as 
the reversibly bound aflatoxin M1 – BSA is removed). Then the waveguide was 
washed with 0.01 M hydrochloric acid (7) and then stored in PBS (8).  
 
In a subsequent operation, surplus unreacted glutaraldehyde sites on the 
waveguide were blocked using 10 mM lysine to stop any non-specific binding of 
the antibody or peptides.  
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To verify the dynamics of the system, the anti-aflatoxin M1 antibody / BSA aflatoxin 
M1 interaction was studied since the affinity of the antibody complex is proven. 
Figure 5.26 shows that the anti-aflatoxin M1 antibody has affinity for the 
immobilised aflatoxin M1, as would be expected.  
 
Figure 5.26: The printout of the saturation of the aflatoxin M1 - BSA coated 
waveguide with anti-aflatoxin M1 antibody using optical waveguide lightmode 
spectroscopy.  
 
In Figure 5.26 the waveguide was first equilibrated with PBS and anti-aflatoxin M1 
antibody was allowed to react with the waveguide (1). The absorbance reaches a 
plateau (2) and the buffer was switched to 0.01 M HCl.  The eluent is changed 
back to PBS (3) and allowed to stabilise. With PBS still in the system, the baseline 
at (4) is higher than at (1) suggesting that the regeneration was not completely 
successful.      
 
5. Development of the synthetic peptide receptor. 
 
 208 
The antibody was injected until the adsorption curve reached a maximum, at this 
point the mass of the antibody on the surface was 0.185 µg cm-2. Assuming a 
relative molecular mass of 150,000 Daltons for the antibody, then 1.67 x 1023 
molecules cm-2 were immobilised. From the immobilization of aflatoxin M1 – BSA, 
8.55 x 1021 molecules cm-2 were immobilised. Hence 5.12% of the aflatoxin M1 - 
BSA was available for binding.  
 
Previous reports have suggested 0.01 M HCl is suitable for regeneration however 
this was for a polyclonal antibody (Székács et al., 2003). From the sensogram in 
Figure 5.26 it can be seen that 0.01 M HCl does not totally regenerate the surface 
presumably since the antibody binding strength is greater being a monoclonal 
antibody (Figure 5.26, 4). Upon restoring the system to PBS the baseline does not 
return to its original state before the injection of antibody. The mass of the protein 
on the surface after regeneration is 0.107 µg cm-2 hence the regeneration with 0.01 
M HCl removed 42%. This shows that either longer regeneration regimes are 
required or different regeneration agents.     
 
Most commonly HCl is used for the regeneration, however in a separate 
experiment a mixture of detergents was used for regeneration. The anti-aflatoxin 
M1 antibody which survived the HCl wash was removed. The detergent mixture 
was; Tween 20, Tween 80, Triton X-100 and CHAPS although after exposure of 
the waveguide to the detergents, the anti-aflatoxin M1 antibody / aflatoxin M1 – BSA 
affinity was significantly reduced possibly due to denaturing the protein.  
 
In order to produce affinity constants for this interaction, many different 
concentrations of the anti-aflatoxin M1 antibody are required to be injected. The 
interaction of the anti-aflatoxin M1 antibody and the BSA aflatoxin M1 is so strong 
that it is difficult to regenerate the waveguide, so that the anti-aflatoxin M1 antibody 
is removed fully from the immobilised BSA aflatoxin M1 without denaturing the 
aflatoxin M1 – BSA conjugate.  
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To assess the affinity of the peptides for the aflatoxin M1 - BSA, a new waveguide 
with aflatoxin M1 - BSA immobilised was prepared. Solutions of 100 µg ml-1 of each 
of the peptides were injected into the system and allowed to react for 1.5 hours. 
This procedure was repeated for a separate waveguide with just BSA immobilised 
to check for any non-specific binding of the peptide for BSA rather than aflatoxin 
M1. The sensorgrams in Figures 5.26 and 5.27 below shows these interactions.  
 
 
Figure 5.27: The printout showing the peptide’s affinity for BSA alone to test for 
unspecific binding using optical waveguide lightmode spectroscopy.  
 
In Figure 5.27 initially the system was equilibrated with PBS then (1) 100 µg ml-1 
LLARGGC was injected onto the waveguide for 1. 5 hours. The eluent was 
changed to 10 mM PBS, pH 7.4 (2) then the signal decreases immediately. The 
signal is allowed to stabilize and then the second peptide is injected (3) 100 µg ml-1 
CGGPVGPRP for 1.5 hours and again the eluent was changed to 10 mM PBS, pH 
7.4 (4).  
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It can be seen from Figure 5.27 that upon the injection of LLARGGC the signal 
increases with time suggesting some electrostatic interaction. When changing the 
eluent to PBS then the signal decreases immediately thus the binding is reversible 
rather than irreversible. With the injection of CGGPVGPRP the same trend as the 
LLARGGC peptide is seen, again demonstrating little irreversible binding. Hence 
the two peptides have little affinity for the BSA.  
 
 
Figure 5.28: The printout of the peptide affinity for aflatoxin M1 using optical 
waveguide lightmode spectroscopy.  
 
In Figure 5.28 the system was first equilibrated with 10mM PBS, pH 7.4 and then 
100 µg ml-1 CCGPVGPRP was injected for 1.5 hours (1). After the peptide injection 
the eluent was switched back to PBS to remove any unbound peptide (2). 
Following the PBS a small injection of 0.1 M HCl was injected to remove the bound 
peptide (3). After the HCl, 10mM PBS (pH 7.4) was injected to stabilize the system 
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(4). In the same procedure as CGGPVGPRP the LLARGGC peptide at a 
concentration of 100 µg ml-1 was injected (5) and then PBS was again applied (6).  
 
The sensorgram in Figure 5.28 shows the reaction of the peptides to aflatoxin M1- 
BSA. The mass on the surface for the PBS before the CGGPVGPRP peptide 
injection is considerably lower than the PBS buffer after the CGGPVGPRP 
injection thus suggesting that the peptide has irreversibly bound to the immobilised 
aflatoxin M1. For the LLARGGC peptide, the signal steadily increases after the 
injection during the incubation. Upon changing the solution to PBS alone the signal 
stays at the same level. When comparing this to the BSA waveguide, the BSA 
waveguide shows an instant decrease in the signal thus demonstrating that both 
peptides have affinity for the aflatoxin M1 and not BSA.  
 
When the experiment was repeated, on a different day, the signal decreased with 
the peptide injection and continued to decrease during the run. This was assumed 
to be due to contamination of the waveguide. The waveguide had been 
regenerated using 0.1 M hydrochloric acid and with a mixture of detergents 
(CHAPS, Tween 20, Tween 80, Triton X – 100 at 0.3%) however the affinity of the 
peptide and antibody has decreased. This is possibly due to using too harsh 
regeneration conditions which has denatured the BSA – aflatoxin M1 immobilised 
on the surface.  
 
An additional problem was encountered during the OWLS work; the formation of 
bubbles in the measurement cell caused the termination of many runs. All solutions 
were degassed prior to use by degassing in a reduced atmosphere. This gave 
initial success however due to the experiments taking place during the summer in a 
room lacking temperature control, the fluctuations in temperature caused the 
solutions to become aerated. This effect can be reduced by storing all the solutions 
in a temperature controlled water bath. Unfortunately the experiments with the 
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OWLS instrument had to be aborted due to the unavailability of aflatoxin M1 - BSA, 
as occurred with the ELISA development.  
 
5.3.10 Affinity studies using the BIAcoreTM. 
Using a BIAcore instrument for monitoring the peptide – aflatoxin M1 interaction 
was a natural progression from the OWLS instrument. The BIAcore uses surface 
plasmon resonance (SPR) for monitoring receptor – ligand interaction. 
Reproducibility was the biggest problem with using the OWLS instrument and the 
BIAcore offers better sample handling through the use of micro fluidics and a 
temperature controlled environment. The BIAcore does have the disadvantage that 
it is not as sensitive as the OWLS instrument as the manufacture advises using 
compounds with molecular weights above 1000 Daltons. The peptide molecular 
weights are 689 (LLARGGC) and 849 (CGGPVGPRP) Daltons, which was the 
reason for utilising the OWLS first for affinity studies.  
 
Initially the BIAcore was tested by monitoring the interaction of the polyclonal 
capture antibody used in the electrochemical sensor against the monoclonal anti-
aflatoxin M1 antibody to validate the instrument. Using the immobilisation wizard as 
part of the BIAcore program the optimal surface coverage of about 5000 RU as 
dictated by the software was easily reached (5049).  
Using the kinetics wizard as part of the BIAcore control program the association 
constant (ka) was calculated as 6x106 M-1 and dissociation (kd) at 1.7x10-7 M-1. For 
an antibody a ka of 109 would be expected however the capture antibody would be 
expected to lose some of its affinity during immobilisation. This experiment showed 
that the BIAcore is able to monitor receptor-ligand interactions. The sensorgram of 
the kinetics wizard is shown in Figure 5.29.   
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Figure 5.29: The sensorgram for the binding of immobilised capture antibody with 
the anti-aflatoxin M1 antibody performed using the BIAcore kinetics wizard.  
 
In Figure 5.29 immobilisation was achieved using the BIAcore immobilisation 
wizard with BIAcore 10mM acetate buffer, pH 4.5. The running buffer of BIAcore 
HBS-EP (0.01 M HEPES buffer (pH 7.4), 0.15 M NaCl, with 0.005% Surfactant 
P20) was used to dilute the anti-aflatoxin M1 antibody. Regeneration was 
performed automatically using a 10 mM glycine-HCl pH 2.0 buffer. Concentrations 
of anti-aflatoxin M1 antibody stated as µg ml-1. Plots taken from the average of 
triplicate measurements.  
 
When plotting the maximum signal for the association curve against the 
concentration then a linear trendline is observed as shown in Figure 5.30 
demonstrating the reproducibility of the affinity. 
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Figure 5.30: The reproducibility of the BIAcore kinetics wizard program and the 
capture antibody to anti-aflatoxin M1 antibody binding. Data taken from the 
sensorgram at 589 seconds. Error bars denote the standard deviation of triplicate 
measurements. 
 
Upon immobilising the anti-aflatoxin M1 antibody onto the surface, again the 
optimal level was again reached (4813). Using the BIAcore kinetics program the 
interaction of aflatoxin M1 – HRP with the anti-aflatoxin M1 antibody was reviewed 
before implementing the peptide.  
 
A problem arose with the filtering of the aflatoxin M1 – HRP conjugate. All solutions 
for the BIAcore require filtration due to the narrow bore of the micro fluidic tubing; 
however the conjugate did not pass through the filter. Initially nylon and PVDF 
filters were used which are hydrophilic, meaning that they are suitable for the 
filtration of aqueous samples. When using the hydrophilic filters the filter quickly 
became blocked even though the pure conjugate solution was being used. When 
using PTFE filters, which are hydrophobic, again the filters became blocked. 
The cause of the poor filtration is due to the aflatoxin M1 – HRP being supplied in a 
75% solution of ammonium sulphate. The high ammonium sulphate solution is 
required for stabilising the conjugate and results in a viscous solution that cannot 
be filtered (Jordan, 2007). Any solution that would pass through the filter would 
have a lower enzyme activity for aflatoxin M1-HRP since filtration destabilises the 
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conjugate, therefore filtration is strongly not advised by the manufactures 
(Donnelly, 2007).  
Without a source of aflatoxin M1 – BSA, use of the BIAcore is difficult since the 
aflatoxin M1 molecule alone is too small for detection. An additional problem 
occurred when trying to immobilize the peptides to the CM5 dextran chip. Using the 
same protocol as proven for the antibodies, the immobilization wizard failed to 
complete since the peptide did not behave as the program expected. After 
exhaustive attempts at trying to achieve the optimal level the program aborted.  
 
The wizard’s procedure was re-enacted using manual commands and it can be 
seen from Figure 5.31 that saturation was observed after the 6th injection and the 
change in signal was only 80 RU. This is considerably less than the expected 3000 
RU stipulated by the wizard and demonstrates the difficulties in using low 
molecular weight compounds with the BIAcore.  
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Figure 5.31: Manual immobilisation of CGGPVGPRP using the BIAcore. Injection 
volume was constant at 25 µl of peptide per injection.  
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5.3.11 Chemical methods for investigating the affinity of the peptides. 
With the OWLS showing initial evidence that the peptides have affinity and the 
BIAcore not being applicable, chemical techniques were employed. Other authors 
investigating peptide / ligand interaction had used tritium labelled ligands and 
recorded peptide / ligand binding using a scintillation counter; Tozzi et al., (2002) 
and Giraudi et al., (1999a). Since this equipment was unfeasible the peptides were 
immobilised onto the surface of microwell plates and the interaction between the 
peptide and the aflatoxin M1 – HRP conjugate was monitored through colorimetric 
reaction of TMB with HRP. 
 
For the experiments involving the microwells a linker compound BS3 was employed 
rather than glutaraldehyde, since it was believed, that a short spacer arm could 
cause steric hindrance between the surface of the plate and the HRP conjugate 
enzyme.  
The immobilisation using BS3 was performed as detailed with the manufactures 
instructions.  
 
Initially two experiments were performed, one where the linker compound was first 
attached to the activated surface, washed and then the peptide attached (stepwise 
immobilisation); and a second experiment where the peptide and the linker 
compound was added to the activated surface together (joint immobilisation). 
Figure 5.32 shows a schematic diagram of the attachment.  
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Figure 5.32: A schematic diagram of the peptide immobilisation on to the surface 
of a microwell plate. Clockwise: the BS3 linker compound and the activated plate 
are added together, the BS3 bind to the surface by breaking the O – N bond for a 
stronger C – O bond. After washing the peptide is added and the same chemical 
process occurs leaving the peptide covalently attached. 
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The immobilisation efficiency is clearly shown in Figure 5.33 and 5.34. For both the 
peptides greater range and the highest signal were observed when the peptide and 
BS3 were added together into the activated microwell plate. This is surprising since 
it would be expected that by using a one step (joint) method, then an array of 
compounds and agglomerations would be formed as observed by Sinz, (2003) and 
Hermanson, (1996). 
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Figure 5.33: The immobilisation of LLARGGC onto the surface of a microwell plate 
using different protocols. Error bars denote standard deviation where n=3, blank 
reading = 0.20 ± 0.017). 
 
5. Development of the synthetic peptide receptor. 
 
 219 
0.15
0.20
0.25
0.30
0.35
0.00 0.20 0.40 0.60 0.80 1.00 1.20
Concentration of CGGPVGPRP imobbilised  (mg ml-1)
A
bs
o
rb
an
ce
 
(40
5n
m
)
CGGPVGPRP (step immob.)
CGGPVGPRP (joint immob.)
 
 
Figure 5.34: The immobilisation of CGGPVGPRP onto the surface of a microwell 
plate using different protocols. (Error bars denote standard deviation where n=3, 
blank reading = 0.20 ± 0.017). 
 
Although the graphs only contain 3 data points, the r2 value for LLARGGC and 
CGGPVGPRP are 0.9961 and 0.9513 respectively. The gradient for the LLARGGC 
and CGGPVGPRP plots were 0.0554 and 0.0332 respectively. These results 
suggest that LLARGGC has better specificity (due to a higher r2 value) and affinity 
for aflatoxin M1 - HRP since the gradient is larger for LLARGGC than 
CGGPVGPRP. Therefore the peptide reported in literature which had been 
developed using a combinatorial library out performed the de novo designed 
peptide. It should be noted however that both peptides positively recognised the 
aflatoxin M1 – HRP conjugate, confirming the evidence from the OWLS machine 
that both peptides have affinity for aflatoxin M1. Additionally the data shows that 
BS3 is suitable as a linker compound for immobilising peptides to the surface of 
microwells without the loss of activity.  
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5.4 Conclusion. 
It was shown in Chapter 4 that the microelectrode arrays improved the detection of 
the immunosensor from the screen printed electrodes. The aim of the project was 
to design and produce a robust sensor, therefore the use of chemically synthesised 
peptides was investigated to replace the antibody in the sensing layer and improve 
storage stability.   
 
Computational chemistry has previously been carried out to design new peptide 
receptors for HIV drugs; therefore a similar approach was taken to produce a 
receptor against aflatoxin M1. The structure of aflatoxin M1 was successfully re-
created within the SYBYL program suite and Leapfrog was employed to develop 
receptors against aflatoxin M1. Previous authors have reported using de novo 
design of peptides with a pre-known starting sequence (Mascini et al., 2004; 
Schmuck and Hell, 2003b) whereas this project started ab initio. 
 
A receptor library of 30 candidates was built, all with some predicted affinity. The 
candidates were reduced to three using a more detailed docking program called 
Flexidock. From the group of three one was reviewed in detail with respect to 
solubility and immobilisation using molecular dynamics. A frequent criticism of 
computational docking programs is false positive results due to bias in the 
calculation. It was hoped that by using three completely different algorithms then 
bias should be removed. From the computational work, one peptide CGGPVGPRP 
was chosen and laboratory tests were performed to determine the binding affinity. 
For comparison an additional peptide, LLARGGC, was taken from literature for 
having affinity with aflatoxin B1 and investigated simultaneously. In the 
computational tests it was predicted that CGGPVGPRP would have better binding 
than LLARGGC. Additional investigations using computational methods were 
carried out by analysing enzyme structures and utilising different computational 
programs, however neither approach gave fruitful information. 
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Several laboratory methods were carried out. Initially optical waveguide lightmode 
spectroscopy was investigated, and proven effective at monitoring the interaction 
of alfatoxin M1 – BSA with anti-aflatoxin M1 antibody used in the ELISA test. Upon 
reviewing the peptides it was shown that both peptides have affinity towards 
aflatoxin M1 however, problems with waveguide regeneration, run reproducibility, 
fluid handling and environmental factors caused difficulties when attempting to 
replicate results which were required to calculate binding affinities.  
 
BIAcore was also investigated for determining the binding affinities. The detection 
of compounds using the BIAcore with a mass less than 1000 Daltons is not 
recommended. This investigation has validated the recommendation and has 
shown that the OWLS was indeed more appropriate for the analysis of small 
molecules than the BIAcore. The microfluidic system on the BIAcore makes 
operation much easier and reproducible but comes at a price since the instrument 
is not as robust as the OWLS instrument. The OWLS instrument does not require 
the filtration of the consumables since the internal diameter of the fluid handling 
tubing was 0.5 mm. Furthermore the OWLS can withstand the use of solvents, 
which could aid the dissolution of the aflatoxin M1 – HRP conjugate which is not 
possible with the BIAcore. Further work would needs to be carried out on 
dissolution and filtration techniques for the aflatoxin M1 – HRP conjugate or use of 
an aflatoxin M1 – BSA conjugate which would allow the monitoring of a large 
detectable molecule by the BIAcore.  
 
By covalently immobilising the peptides onto the surface of microwell plates and 
detection using a labelled HRP conjugate, the affinity was again demonstrated. It 
was shown that the amount of labelled HRP conjugate bound to the plates was 
proportional to the concentration of the immobilised peptide where the linear 
regression (r2) was ≥ 0.95. These tests show conclusively that both peptides have 
affinity for aflatoxin M1, however also demonstrating the difficulties in measuring 
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ligand / receptor affinities using small molecules which as also been observed by 
Giraudi et al., (1999b) and Falter et al., (1994).  
 
The peptide sequence reported in literature (Tozzi et al., 2003b) was shown using 
practical tests to have greater affinity to aflatoxin M1 than the computationally 
designed peptide. This observation is the inverse of the computer molecular 
dynamics predictions. Many authors have documented the inaccuracy in docking 
algorithms (Alberts et al., 2005; Abagyan and Totrov; 2001; Wang and Wang, 
2001; Baxter, 2000; Jackson, 1995). Commonly docking programs assume that the 
protein receptor is rigid and the amino acid side chains are fixed in position, upon 
comparison to the receptors in this work the receptor is a highly flexible peptide 
where the side chains placement will have significant impact on the binding ability. 
This assumption error or the intelligent approach of de novo design, rather than a 
systematic search, was the fault for the literature method by Tozzi et al., (2003b) 
outperforming in the laboratory the de novo designed peptide. 
 
Further work should be performed to investigate the affinities of the peptides 
sequences with an aim to accurately quantify the affinity of each peptide to the 
aflatoxin M1. 
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6.1 Immunosensor and ELISA development. 
The ELISA method has been developed and optimised using an alkaline 
phosphatase labelled antibody and results show that the procedure is suitable for 
detecting aflatoxin M1. Initially the work by Ammidia et al, (2004) and 
recommendations by Crowther (2001) were used as a foundation for the 
development.   
 
During the optimisation of the ELISA system several blocking agents were tested 
with particular focus on polymers due to their increased stability over 
protienaceous compounds. Both Micheli et al. (2005) and Ammida et al, (2004) 
used polyvinyl alcohol as the blocking agent however work carried out by 
Studentsov et al., (2002) reported that using polyvinyl pyrrolidone rather than 
polyvinyl alcohol was found to be preferential. In this project it was confirmed that 
polyvinyl pyrrolidone outperformed polyvinyl alcohol as a blocking agent.  
 
Incubation times were optimised for the test and overall the time of analysis was 
3.5 hours which is comparable to the commercial tests available at 3 hours. After 
optimisation and validation of the ELISA test, milk was applied and the resolution of 
the test was reduced. Traditional clean-up methodologies were investigated to 
remove the matrix interference of the milk. These methods were; Carrez 
clarification to remove high molecular weight compounds such as proteins and fats 
(Gökmen and enyuva, 2006; Rufián-Henares and Morales, 2006), deproteinate 
using lead acetate (Goldblatt, 1969), the removal the fats in the milk using solvents 
(Thomas et al., 1998; Delgado Zamarreño et al., 1992) as well as cold 
centrifugation as recommended by the commercial kits. None of the sample pre-
treatment methods removed the matrix effects observed and did not improve 
sensitivity of the test.  
 
From literature reports of Magliulo et al. (2005) and El-Nezami et al., (1995) it was 
suggested that extensive pre-treatment is required for the detection of aflatoxin M1 
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in milk using ELISA, whereas Micheli et al., (2005) reports that milk that has only 
been mildly centrifuged does not cause any interference and Thirumala-Devi et al., 
(2002) reports that milk only requires mild centrifugation followed by filtration 
through standard filter paper is required. Hence there is a 50:50 divide to whether 
milk caused interferences to ELISA tests or no interferences. In this project 
extensive interference was observed. 
 
Before further work could be performed, supplies of the immobilised antigen 
(aflatoxin M1 – BSA) were depleted and insufficient equipment and skills were 
available for production of the immobilised antigen in house due to a complex 
procedure of synthesising an aflatoxin M1 intermediate.  
Critically, the development of the ELISA demonstrated that the commercially 
sourced antibody was suitable for using as a sensing receptor for the 
electrochemical immunosensor.  
 
6.2 Screen printed electrode immunosensor development. 
Firstly screen printed sensors were produced in-house and characterised with 
cyclic voltammetry by scanning potassium hexacyanoferrate (III) at different scan 
rates.  
 
In a change from the ELISA protocol the antibody was immobilised onto the solid 
substrate via a capture antibody and a competition reaction between aflatoxin M1 
and aflatoxin M1 – HRP was performed. An initial calibration graph was produced 
however the graph didn’t meet the requirements for the EU maximum permissible 
limits of 50 ng L-1. A literature review was performed on screen printed 
immunosensors with specific attention to HRP based systems. The main 
discrepancy between the work from Micheli et al., (2005) with Butler et al., (2006), 
Fanjul-Bolado et al., (2005) Badea et al., (2004) and Volpe et al., (1998) was the 
measuring potential. Micheli et al., (2005) reported using -100 mV for TMB 
6. Final discussions and conclusions. 
 
 226 
detection and other authors reported +100 mV. Upon comparing the two potentials, 
+100 mV was discovered to give the greatest signal.    
 
Additional optimisation investigations were performed such as electrochemical pre-
cleaning of the electrodes before antibody immobilisation, as described by 
Grennan et al., (2000); Espinosa et al., (1999) and Wang et al., (1996), or using 
proteinaceous blocking agents. These methods did not improve the sensitivity of 
the test, however, pre-conditioning the electrode before detection of TMB as 
described by Conneely et al., (2007) and Lu et al., (2006) did significantly improve 
the performance of the sensor. When milk was applied to the test, all sensitivity 
was lost, therefore the causes of the matrix interference was investigated. 
 
Milk is a highly multi-component matrix and many authors such as Pemberton et 
al., (1999) and Mayer et al., (1996) have reported that it causes electrochemical 
interference, however none have identified the cause. For the investigation into the 
electrochemical interference one component at a time was investigated. Firstly the 
effect of lipids was investigated. Milk was defatted enzymatically by raising the pH 
of the milk and allowing the natural lipases to digest the lipids to volatile fatty acids 
(Hui, 1993) additionally a second sample was tested, non fat milk. The samples 
were mixed with potassium hexacyanoferrate (III) in 0.1 M KCl and using cyclic 
voltammetry, voltammograms were taken. In neither case did the quenching effect 
from the milk subside thus demonstrating that lipids are not the cause of the 
interference.  
 
Milk is high in lactose (4.6%) which is electrochemically active (Hanko and Rohrer, 
2000, Mayer et al., 1996) so the presence of lactose was investigated by spiking 
potassium hexacyanoferrate (III) in 0.1 M KCl, with 4.6% lactose, and again taking 
cyclic voltammograms. No quenching effect was observed with the lactose, 
demonstrating that lactose is not the interfering substance.  
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Finally milk was fractionated into a casein free sample by the addition of HCl until a 
pH of 4.6 was obtained (Hui, 1993; Walstra, 1984), and a fraction free from both 
casein and whey using HCl and trichloroacetic acid using the methods described 
by Vernozy-Rozand et al., (2004), then both fractions were spiked again with 
potassium hexacyanoferrate (III). Although the casein free fraction showed 
quenching effects, the whey and casein free fraction showed no signs of 
quenching, suggesting that whey proteins were the cause of interference. In a 
conformational test, ammonium sulphate was added to a milk sample to precipitate 
the proteins and the solution was tested with potassium hexacyanoferrate (III) and 
again no quenching was observed.  
 
When reviewing literature reports on the absorption of whey proteins onto the 
surfaces of stainless steel pasteurisation elements, α-lactalbumin has high affinity 
towards metal surfaces and causes ‘milk stone’ during milk processing (Cosman et 
al., 2005). During adsorption the protein goes through dramatic conformational 
change resulting in the loss of centrally bound calcium ions. An experiment was 
performed in spiking the milk sample with an excess of calcium chloride and 
repeating the calibration where the resulting calibration did not incur interferences 
from the milk matrix and detection of aflatoxin M1 was achieved. With reviewing 
observations of other authors with the interfering effects of milk, they correlate that 
α-lactalbumin is the cause of interference. The molecular weight of α-lactalbumin at 
14,176 Daltons correlates with the reports of Mayer et al., (1996) that the electrode 
fouling was eradicated by the use of dialysis membranes at 12,000 – 19,000 
daltons. Cosman et al., (2005) reinforces this observation. In a method utilising 
TLC as the detection method, Diaz et al., (1993) suggested the use of dialysis 
membranes for the clean-up of milk with membranes at 8,000 to 15,000 Daltons. 
Upon the addition of CaCl2 to milk as a pre-treatment step the quenching effects of 
milk were lost, and a successful calibration was recorded with an analytical 
sensitivity of 39 ng L-1.  
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The calibration graphs using the screen printed sensors had larger error bars than 
other literature reports (Micheli et al., 2005). Investigations were carried out to 
elucidate the causes of the poor reproducibility. Using new electrodes in the assay 
had increased the reproducibility from a relative standard deviation of 9.5% to 
7.8%; however this is still significant. In a second investigation the reproducibility of 
the screen printer was accessed. It was observed that from a sheet of electrodes, 
only 60% had unilateral resistance. The causes for the poor reproducibility were 
attributed to the age of the screen printer and the drying process.  
 
The efficiency of the calcium chloride pre-treatment developed in the project was 
evaluated by using the Ridascreen ELISA kit. ELISA kit standards and standards 
prepared using the CaCl2 pre-treatment was tested side by side and it was shown 
that the CaCl2 pre-treatment results showed some underestimation. Mendonça and 
Venâncio (2005) and Dosako et al. (1980) suggest that aflatoxin M1 has affinity for 
casein proteins and whey proteins. The binding of aflatoxin M1 with casein is due to 
the hydrophobic pockets formed by the high number of proline residues in casein 
(Bakirci, 2001; Henry, et al., 1997). It could be postulated that by increasing the 
ionic strength of the milk by adding calcium chloride then the aflatoxin M1 has 
increased affinity for the casein through hydrophobic interaction and thus remains 
partially bound during analysis.   
The underestimation requires that all samples and calibration standards need to be 
treated the same for this bias to be uniform and thus accountable. More critical is 
the fact that the standard deviations for the laboratory prepared samples using 
calcium chloride were higher than those obtained using the kits and therefore more 
work is required to improve the repeatability of the extraction.  
 
Using the calcium chloride pre-treated samples the developed immunosensor was 
compared to a developed HPLC method and the commercial ELISA method. The 
HPLC had superior limits of detection compared to the ELISA and the 
immunosensor which had similar limits of detection. The working range for the 
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ELISA was worst with the immunosensor and HPLC having similar working ranges. 
Although the HPLC showed better reproducibility at low levels of aflatoxin M1 at 
higher levels the immunosensor had marginally better reproducibility. With 
consideration of cost of analysis the immunosensor is considerable cheaper than 
ELISA and HPLC and furthermore the immunosensor is portable and can be 
operated in the field. Therefore out of the technologies tested the immunosensor is 
best suited for fulfilling criteria of a simple, robust, low-cost analysis methods for 
aflatoxin M1 analysis in milk.   
 
In a final investigation with the screen printed electrode it was demonstrated that 
the developed immunosensor could be employed for the detection of aflatoxin M1 
in urine, which is very encouraging since no previously reports about biosensors 
for aflatoxin M1 in urine has been published. 
 
6.3 Microelectrode array development. 
The current maximum permissible limits of detection set by the EU for aflatoxin M1 
is 50 ng L-1 however this level was set by the ALARA process, (As Low As 
Reasonable Achievable) and therefore with the increasing use of HPLC MS/MS it 
is reasonable to suspect that the current levels maybe decreased in future time 
causing further analytical challenges for other methodologies. The results obtained 
from this project shows that should this occur, then screen printed technology may 
suffer. However, the requirements of a simple, robust, low-cost analysis method for 
aflatoxin M1 analysis in milk can be answered using microelectrodes.  
 
Covalently immobilising the antibody onto the gold surface of the microelectrode 
array with PDITC, as described by Lillis et al., (2006), was a new method of 
immobilisation compared to the developed screen printed electrode immunosensor 
which relied on passive absorption onto carbon. To ensure correct covalent 
attachment occurred, atomic force microscopy and scanning electron microscopy 
6. Final discussions and conclusions. 
 
 230 
was employed. Little reported evidence of microscopy being employed as a tool for 
immunosensor construction could be discovered.  
 
Scanning electron microscopy uses a beam of electrons as the detection source, 
which penetrates the surface by 10 µm, bypassing the proteinaceous surface of the 
immunosensor and therefore not suitable for monitoring the covalent attachment of 
the antibodies. Atomic force microscopy does not have this limitation and gave 
detailed images into the immunosensor chemical construction. Quantifiable 
differences between the immunosensor and a blank microelectrode array were 
roughness and topographic measurements.  
 
It was observed that with the immobilisation of the antibody onto the surface, the 
surface roughness increased from 1.27 nm to 2.37 nm. In three separate 
investigations into the addition of enzymes onto surfaces Tsai et al. (2007), 
Vianello et al., (2007) and Parra et al., (2007) all reported that upon the addition of 
protein to a sensor surface the roughness increased following the same trend as 
this investigation. Although for enzymes, the increases of 1.4 nm by Vianello et al., 
(2007) and 1.5 nm by Parra et al., (2007) which is comparable to the observations 
in this investigation, for an antibody, of 0.84 nm 
 
The topographic measurements showed that with the addition of the capture 
antibody caused an increase of 2.2 nm which is very similar to the observations of 
Ouerghi et al., (2002) and Bergkvist et al., (1998) who reported changes of 2.5 nm 
and 1.98 nm respectively. With the theoretical height of an antibody at 4 nm, this 
data showed that many of the antibodies are immobilised in a ‘side on’ orientation 
and therefore inefficient. This proves the logic of immobilising a cheap polyclonal 
antibody rather than immobilising an expensive monoclonal antibody.  
 
Initial optimisation was carried out to determine the optimum potential for TMB 
detection on the microelectrode array since the microelectrode array consists of a 
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gold working, auxiliary and reference electrode whereas for the screen printed 
electrode the working and auxiliary is carbon based and the reference electrode is 
Ag/AgCl. 
Transferring the receptor chemistry from the screen printed electrode to the 
microelectrode array was a success with detection significantly superior to the 
screen printed electrode. In addition the necessary PVA blocking for the screen 
printed electrodes was not required for the microelectrode array and this was 
attributed to the comparably low active surface area of the gold electrode to the 
carbon. The sensitivity improved from 39 ng L-1 for the screen printed electrodes to 
8 ng L-1 for the microelectrodes, both in the milk matrix. This improvement is 
greater than first sight considering that the sample volume for the microelectrode is 
only 16% of that for the screen printed electrode.  
 
The superior detection is due to the microelectrode dynamics over planar screen 
printed electrodes but also the use of gold rather than graphite for the construction. 
Due to a limited supply of microelectrode arrays from Tyndall University (Ireland) 
full optimisation could not be achieved. It could be postulated that since diffusion 
alone is the source of mobility of the analyte in the screen printed electrodes, 
ELISA and microelectrode arrays, a reduction of the test volume will yield shorter 
incubation times and faster assay times. The incubation times for the assay at 2 
hours was taken from the optimisation of the ELISA assay where the test volume 
was 50 times greater.  
 
The screen printed electrode is the cheapest technology reviewed in this 
conclusion due to the low cost of electrode production. Compared to the cost of 
manufacturing for screen printed electrodes, microelectrode arrays are significantly 
more expensive with the microelectrode array estimated at 5 euros each by Tyndall 
institute.  
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In conclusion, employing gold microelectrodes rather than carbon based screen 
printed electrodes, allows new applications of high sensitivity and low detection 
limits to be analysed without requiring elaborate instrumentation. If future detection 
limits for aflatoxin M1 are reduced then microelectrode arrays can be successfully 
utilised outside of the laboratory.   
 
6.4 The development of synthetic receptors.  
With the aim of producing a robust sensor, the use of a synthetic receptor rather 
than a natural antibody was investigated for the sensing layer. Antibodies have the 
disadvantages of being proteinaceous and therefore fragile due to denaturation, 
long production times, variations between each batch and high cost of production 
(Nakamura  et al., 2005; Tothill, et al., 2003; Tothill et al., 2001).  
Previous authors have proven that synthetic peptides have affinity for small 
molecules such as estradiol (Giraudi et al., 2003; Giraudi et al., 1999a), estrogen 
(Tozzi et al., 2002) and aflatoxins (Tozzi et al., 2003b). Using this premises 
synthetic receptors were selected for the replacement of the antibodies in the 
sensing layer. 
 
The development of synthetic peptides as receptors in medicine has gained 
significant momentum due to computational drug design. Using the same 
approach, synthetic peptides sequences with affinity for aflatoxin M1 were 
produced in silico by de novo design programs.  
 
The structure of aflatoxin M1 was determined using computational methods 
described by Chianella et al., (2002) and the results concurred with the published 
results from Holtzapple et al. (1996). A list of amino acids with affinity to aflatoxin 
M1 was calculated and these followed a trend with hydrophobicity. Isoleucine was 
found to have the greatest affinity.   
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Leapfrog was employed to develop peptides which would have favourable binding 
with aflatoxin M1. After optimisation of the parameters, a virtual combinatorial 
library of 30 peptide sequences was produced by Leapfrog. The results from 
Leapfrog were scrutinised using Flexidock and the best peptide had a sequence of 
Pro Val Gly Pro Arg Pro.  
 
A spacer/linker arm of two glycines and a cysteine was attached to the peptide. 
The addition of the cysteine was chosen to aid immobilisation of the peptide to the 
gold microelectrode surface or BIAcore surface as described by Katayama et al., 
(2000). Furthermore the addition of glycine was required to move the active 
peptide region into the solution and reduce steric hindrance and improved binding 
capabilities (Tozzi et al., 2003b). Detailed molecular dynamics was used to 
determine the most idealistic attachment of a spacer/linker arm without any loss of 
affinity of the peptide. As a reference, a sequence from literature with good affinity 
to aflatoxin B1 was also processed by molecular dynamics for the idealistic of the 
placement of a linker arm with view to compare the de novo designed peptide to 
one determined combinatorially. The data from the molecular dynamics suggested 
that the binding of the de novo designed peptide sequence would be more 
energetically favourable than the combinatorially design sequence.         
 
Two other computational investigations were performed to source information. A 
search was executed for known receptors for aflatoxins. The search resulted in 
only one structure, an enzyme, aflatoxin aldehyde reductase (Kozma et al., 2002). 
Upon study of this structure using computational methods, the only fragment to 
show binding with aflatoxin M1 was Leu Val, hence no new information was 
determined. In another investigation a software package called GROMACS was 
evaluated for determining ∆G using the thermodynamic cycle for the binding 
interactions between the peptides and aflatoxin M1, however due to the software 
being developed for proteins it was deemed unsuitable for experiments with 
aflatoxin M. 
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With the computational methods delivering a peptide sequence and modifying a 
literature sequence, the sequences were tested by a host of laboratory methods.  
 
Firstly optical waveguide lightmode spectroscopy (OWLS) was utilised. With 
sensitivity expected to be greater than the BIAcore, the affinity of the peptide 
sequences were investigated. Initially the instrument was validated with the testing 
of the anti-aflatoxin M1 antibody against aflatoxin M1 – BSA. The OWLS instrument 
was able to monitor the binding interaction of the antibody, with 5% of the antibody 
molecules binding to the immobilised aflatoxin M1. Upon regeneration of the sensor 
to remove the bound anti-aflatoxin M1 antibody using the conditions stated by 
Székács et al., (2003), only 42% of the antibody was removed. This suggested that 
harsher regeneration conditions was required and that the polyclonal antibody 
used by Székács et al., (2003) had poorer binding strength than the monoclonal 
antibody provided by Abcam (Cambridge, UK). When harsher regeneration 
conditions were performed, then a decrease of the affinity of the complex was 
observed, due to denaturation of the BSA protein and possible formation of 
aflatoxin M2a from aflatoxin M1.  
 
Without a reproducible sensor surface, kinetic data could not be determined. On 
new waveguides aflatoxin M1 – BSA and BSA alone was immobilised. The peptide 
sequences were allowed to bind to both surfaces and the resulting sensorgrams 
were recorded. Both peptides showed reversible binding for the BSA alone sensor 
surface, but irreversible binding for the aflatoxin M1 – BSA sensor demonstrating 
that the peptides has affinity for aflatoxin M1. Due to environmental conditions and 
a limited supply of aflatoxin M1 – BSA further investigations could not be 
performed.  
 
To improve reproducibility between runs, BIAcore technology was investigated 
following the OWLS investigation. The BIAcore machine does not recommend use 
of receptors below 1000 Daltons since it is below the level of sensitivity and when 
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using the peptide sequences, both with a weight below 1000 Daltons, the 
instrument failed to automatically recognise the binding of the peptide to the 
surface of the BIAcore sensor. Furthermore BIAcore has the advantage of high 
reproducibility with handling low quantities of liquids. This is performed using 
micro-fluidics. A requirement of the micro-fluidics is for all solutions to be filtered 
prior to analysis, and this was not possible for the aflatoxin M1 – HRP conjugate, 
which became trapped when filtered. Therefore BIAcore was not suitable for this 
investigation.  
 
Initial investigations using chemical techniques, akin to ELISA, showed that when 
immobilising the peptide sequences to the surface of a microwell plate via BS3 
coupling, then with the addition of aflatoxin M1 – HRP, the bound activity of HRP is 
proportional to the peptide concentration on the surface. The repeatability using 
linear regression was 0.99 and 0.95 for LLARGGC and CGGPVGPRP 
respectively. 
 
Both the OWLS investigations and the chemical investigations showed that the 
peptides have affinity for aflatoxin M1. Further work must be performed to quantify 
the binding association. Previously reported investigations in the binding affinity of 
small molecules have been performed using scintillation which was outside the 
scope of this project. There are many other possible techniques for monitoring the 
binding of small molecules which could be carried out as described in Section 7.2.   
 
6.5 Future developments. 
In summary, the project was to answer the criteria of Proctor, (1994) ‘There is an 
urgent need for simple, robust, low-cost analysis methods, for the major 
mycotoxins, which can be routinely used in developing country laboratories.’ 
Through screen printed electrodes, this criterion is answered for aflatoxin M1 to 
European Union maximium permissible limits of 50 ng L-1, and using 
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microelectrode arrays the detection limit can be lowered for future requirements. 
The microelectrode array, being made up of many microelectrodes, has potential 
for future development where each electrode is a sensor for a different mycotoxin 
and thus producing a multi-analyte affinity sensor. At present the microelectrode is 
produced so that the electrodes are wired in parallel, not individually, and therefore 
are not suitable for this application. Tyndall national institute are continuing the 
development in microelectrodes and nanoelectodes to meet this requirement.  
 
Work to replace the antibody with a synthetic peptide receptor demonstrated that it 
is possible to design a de novo sequence which as binding comparable to literature 
reports. Further work is required to quantify this binding and incorporate the 
peptide into the immunosensor. 
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7.1 Further work for the sensor. 
7.1.1 Stabilisation of reagents. 
The sensor has been successfully designed to be cheap, rapid and easy to use 
however geographically aflatoxin M1 contamination tends to occur in poorer 
countries with hot climates. To make the sensor robust, synthetic receptors have 
been investigated however other reagents required for the immunosensor also 
need to be robust.  
 
Currently the detection for the immunosensor requires the use of hydrogen 
peroxide and TMB, both of which require storage at 4oC.  Work reported by Frey et 
al. (2000) has shown that TMB can be stabilized with the substitution of water as 
the solvent for N,N-dimethylacetamide and with the addition of 
tetrabutylammonium borohydride. Initial work carried out as part of this project has 
shown that this system can be incorporated into the protocol for aflatoxin M1 
determination and stable at elevated temperatures in the presence of light.  Further 
work is required to optimise the N,N-dimethylacetamide / tetrabutylammonium 
borohydride for this assay. 
 
7.1.2 Optimisation and validation of the aflatoxin M1 immunosensor for 
urine.  
As shown in Section 3.3.8, the analysis of urine rather than milk was briefly 
investigated.  It was clearly shown that the immunosensor is applicable for the 
detection of aflatoxin M1 in urine with an analytical sensitivity of 25 ng L-1. The 
levels of aflatoxin M1 reported with means in the region of 0.49 µg L-1 to 7.1 µg L-1 
lie midway in the dynamic region of the plot and therefore the early investigations 
are very encouraging. Further work should be carried out to ensure that the results 
are reproducible and validated against HPLC. 
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7.2 Further work for synthetic peptide receptor.  
Giraudi et al., (2000) and Falter et al., (1994) have reported that working with small 
molecules to determine binding constants is difficult and this has been 
demonstrated in the project. To determine the binding constant many new methods 
could be performed as described below.  
 
7.2.1 Study the binding forces of the peptide and antibody using chemical 
force microscopy. 
Chemical force microscopy is a technique very similar to atomic force microscopy. 
To the sensing tip an antibody is immobilised and the tip is scanned over a surface 
with the immobilised aflatoxin M1 and the force required to break the antibody / 
aflatoxin M1 complex is measured in piconewtons. Once the data has been 
obtained for the antibody, then the antibody is substituted for the peptide and the 
force is again measured. This technique will give a quantitative comparison for the 
strength of the complex for the antibody and each peptide.  
 
7.2.2 Incorporate a marker onto the peptide to trace the peptide. 
The marker could either be electrochemical, fluorescent or an enzyme, and by 
immobilising the aflatoxin M1 then chemically the presence of the peptide could be 
monitored. If the marker is fluorescent then it might be fruitful to select a marker 
which has an excitation wavelength which will overlap the emission wavelength of 
the aflatoxin M1. This technique is referred to as FRET (Fluorescence Resonance 
Energy Transfer). The transfer of energy from one component to the other only 
occurs if the two components are in close proximity to each other as shown in 
Figure 7.1. 
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Figure 7.1: A schematic diagram of the energy transfer from aflatoxin M1 to a 
fluorescent tag on the peptide. The tag shown is 7-diethylaminocoumarin-3-
carboxylic acid, succinimidyl ester which is attached to the peptide through amino / 
carboxylic acid dehydration reaction. 
 
This is a useful technique for monitoring the binding of the aflatoxin M1 to the 
peptide.  
 
If an electrochemical or enzymatic marker is introduced then the peptide can be 
monitored using the current detection protocol for the sensor. One concern is that if 
the marker was an enzyme then the enzyme will be significantly larger than the 
peptide and therefore may affect the binding.   
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7.2.3 Monitoring the binding by Nuclear Magnetic Resonance (NMR).  
Using NMR it would be able to monitor the interaction of the peptide with the 
aflatoxin M1 molecule by recording the change in chemical shift of the peptide 
against the change in aflatoxin M1 concentration. By plotting the data then the 
binding constant can be determined.  
 
The method would also give a value closer to the theoretical value given from the 
computational models since both the peptide and aflatoxin M1 molecules would be 
unmodified and in free solution rather than anchored, which causes a change in 
affinity.  
 
Initial investigations were performed using 13C NMR and 1H NMR to obtain the 
spectra of aflatoxin M1 and the peptides however insufficient experience at 
Cranfield University in NMR meant that investigations had to be aborted.    
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8.1  Buffers.  
 
10 mM Phosphate buffered saline (PBS), pH 7.4 
0.24 g KH2PO4 
1.44 g Na2HPO4 
8.00 g NaCl 
0.20 g KCl 
800 ml H20 
Adjust pH to 7.4 and bring volume to 1 litre with reverse osmosis water 
 
0.5M Acetate Buffer, pH 5.2 
68 g Sodium Acetate Trihydrate  
Adjust to pH 5.2 with Acetic acid 
Make up to 1 litre with reverse osmosis water 
 
0.1 M Carbonate buffer, pH 9.6 
0.85 g Na2CO3 
1.43 g NaHCO3 
250 ml reverse osmosis water 
 
0.05M Tris Buffer, pH 7.5 
1.51 g Tris base 
2.19 g NaCl  
230 ml H2O  
Adjusted to pH 7.5 with HCl and made up to 250 ml with reverse osmosis water 
 
0.1M Citrate buffer, pH 5.2 
4.6 g citric acid 
7.1 g Na2HPO4 
500 ml reverse osmosis water 
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8.2 Derivation of method costs. 
Table 8.1: Derivation of the costs for each method.  
 Commercial ELISA 
Cost of Instrument * 4000 
Service * 500 
Kit per sample (£360/24) 13.84 
  
 HPLC 
Cost of instrument * 30,000 
Service * 3,000 
Cost of immuno-affinity column per 
sample 
11.00 
Cost of reagents (mobile phase, vials, 
etc.) per sample 
3.00 
Total consumables per sample 14.00 
  
 Immunosensor 
Cost of instrument 2500 
Cost of service N/A 
Cost of reagents (AB’s, conjugate, 
sensor) 
1.81 
  
* Cost of instrumentation for ELISA and HPLC provided by Norman (2007) 
Prices correct as of September 2007.  
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8.3 Peptide synthesis reports. 
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